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The telomeric single-stranded 3’ overhang, a conserved feature at the ends of
linear chromosomes, is thought to contribute to the important functions of end protection
and telomere length homeostasis. Here, I investigated the mechanism by which the
overhang is generated and maintained at mammalian telomeres.
First, I evaluated the terminal chromatin structure of mouse telomeres using
conventional micrococcal nuclease (MNase) assays and a novel method to examine the
terminal nucleosomes adjacent to the telomeric overhang. In wild type mouse embryonic
fibroblasts (MEFs), the telomeric overhang was protected from MNase digestion of
chromatin in nuclei. In addition, the induction of various DNA damage responses at
telomeres, through the deletion of shelterin components, had no apparent effect on the
chromatin organization of telomeres and did not cause overt eviction of nucleosomes
from the telomere terminus.
Next, I identified a role for the shelterin-associated Apollo nuclease in generating
the telomeric overhang at ends synthesized by leading-strand DNA replication. Deletion
of Apollo in mouse cells resulted in an overhang defect specifically at leading-end
telomeres.

Consistent with a requirement for the overhang in end protection, cells

lacking Apollo activated an ATM-dependent DNA damage response at a subset of

telomeres in S phase and displayed fusions between a fraction of leading-end telomeres
on metaphase spreads.
I next elucidated the mechanism by which the single-stranded telomere binding
protein, POT1b, suppresses the accumulation of excessive telomeric overhangs in mouse
cells. I found that POT1b inhibits 5’ resection by Apollo at telomeres synthesized by
both leading- and lagging-strand DNA replication while promoting the telomeric function
of the Ctc1/Stn1/Ten1 (CST) complex. Though the role of CST is not well understood,
Ctc1 and Stn1 were originally identified as accessory factors of DNA polymerase
α/primase and may contribute to fill-in synthesis of the telomeric C-rich strand.
Finally, to identify additional factors that contribute to overhang dynamics, I
tested the hypothesis that the factors involved in 5’ end resection at a DNA double strand
break also act at telomeres in wild type cells. I uncovered a role for exonuclease 1 in a
transient telomere end-processing step that occurs at both newly-synthesized telomeres.
The Exo1-mediated telomere end-processing step does not appear to require Nbs1 or
BLM, and its physiologic role remains unknown.
This thesis supports a model in which leading- and lagging-end telomeres have
different requirements for end-processing by the nucleases Apollo and Exo1. The binding
of POT1b on appropriately generated single-stranded overhangs at both newlysynthesized telomeres limits overhang size and prevents accelerated telomere shortening
by inhibiting Apollo and facilitating the activities of the CST complex.
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PART I: THE STRUCTURE AND FUNCTION OF MAMMALIAN TELOMERES
Sequence and structural features of chromosome ends
Linear chromosomes terminate in specialized nucleoprotein structures called
telomeres. In humans, telomeric sequences consist of duplex TTAGGG repeats1-4 and
end in a single-stranded 3’ overhang that protrudes ~30-500 nt beyond the
complementary strand5-7.

Lower eukaryotes including yeast and ciliates have short

telomeres of a few hundred base pairs8-11, while telomere length in mammals ranges from
an average of 10-15 kb in primates, whales, and many large animals to 20-50 kb in
rodents, rabbits, and bats (Table 1.1)4,12,13.
Table 1.1. Sequence features of telomeres in different organisms.

Electron microscopy has revealed the presence of structures known as t-loops at
telomeres in a number of vertebrates, including human, mouse, and chicken14,15. T-loops
of heterogeneous size distribution form by strand invasion of the single-stranded
telomeric overhang into the double-stranded telomeric repeats. In support of this model,
incubation of E. coli single-stranded binding (SSB) protein with isolated telomeric DNA
results in the detection of one to two SSB molecules bound to the displaced single-
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stranded telomeric DNA (D-loop) at the base of the t-loop14. Importantly, telomeric 3’
overhangs are required for in vitro t-loop formation16.

Figure 1.1. Telomere binding proteins. Telomeric complexes in vertebrates, yeast, and ciliates consist of
duplex DNA binding proteins and single-stranded end binding proteins that are, in some organisms,
connected through additional linking proteins. (adapted from ref. 28).

	
  
The composition of telomeric protein complexes as well as the structure and
function of individual telomere binding proteins exhibit considerable divergence across
species (Figure 1.1). In mammalian cells, six proteins comprise the telomeric complex
known as shelterin: TRF1, TRF2, Rap1, TIN2, TPP1, and POT1 (POT1a and b in
rodents, Figure 1.2, reviewed in 17). Among the members of shelterin, TRF1, TRF2, and
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POT1 directly contact telomeric DNA. TRF1 and TRF2 are ubiquitously expressed,
abundant, duplex telomeric binding proteins containing C-terminal Myb/SANT domains
that recognize the half site 5’-YTAGGGTTR-3’18-22. The two proteins have similar
homodimerization (TRFH) domains while differing in their N-termini, which is acidic in
TRF1 and comprised of a basic glycine-arginine rich (GAR) domain in TRF223. TRF2
has the ability to induce t-loop formation in model telomeric substrates in vitro16. A
conserved region in TRF2 not present in TRF1, spanning amino acids 284 to 297 of the
mouse protein, recruits Rap1 to telomeres24 (Figure 1.2). This interaction between TRF2
and the RCT domain of Rap1 is required for the stability of the Rap1 protein24,25. TRF1
and TRF2/Rap1 have been reported to localize to chromosome internal sites containing
telomeric sequences26,27, though their functions at such sites are not well understood.
POT1 localizes to telomeres through its interaction with TPP129-31 and binds
single-stranded telomeric DNA with its N-terminal oligonucleotide/oligosaccharide
binding (OB) folds32-34 (Figure 1.2).

In vitro, POT1 can bind both internally and

terminally placed telomeric repeats; its minimal binding site is the (TAGGGTTAG)
nonamer while binding optimally to two telomeric repeats34. The in vitro binding of
POT1 to single-stranded oligonucleotides shows some preference for the 3’ end, which is
modified when POT1 is in complex with TPP135. Nonetheless, in vivo, POT1 is predicted
to bind both the terminal overhang as well as the displaced D-loop that forms at the base
of the t-loop. TPP1/POT1 complexes are less abundant than duplex DNA-binding
shelterin components, but expected to be in excess of their single-stranded substrate36.
Mouse POT1a and -b share approximately 70% sequence similarity with each other and
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with human POT137,38 and have similar binding affinities for single-stranded telomeric
DNA39.
Finally, TIN2 bridges the entire shelterin complex through interactions with
TRF1, TRF2, and TPP1 (Figure 1.2)31,40-43. TIN2 can simultaneously interact with the
TRFH domain of TRF1 and a region in TRF2 just C-terminal of the Rap1-binding
domain (Figure 1.2)40,44,45. TIN2 also interacts with the C-terminus of TPP131,41,45. The
entire six-subunit shelterin complex as well as subcomplexes containing TRF2/Rap1,
TIN2, and TPP1/POT1 but not TRF1 have been isolated from HeLa cells, but the in vivo
significance of shelterin subcomplexes has not been determined40.

Figure 1.2. Interactions between the components of human shelterin. The domain organizations of the
six shelterin components, and their interactions with each other and with DNA. (adapted from 28).

	
  
The core components of shelterin also interact with a number of accessory factors
that perform diverse functions at telomeres. TRF1-interacting factors include tankyrase
146, BLM47, Ku48, and PinX144 while TRF2 interacts with Nbs149, ERCC1/XPF50,
Apollo/SNM1b51-53, Fen154), and Mus8155, among others. In contrast to shelterin, these
accessory factors are not found at all telomeres, their localization to telomeres can be
transient, and they generally have non-telomeric functions.

Structural studies of

interactions between peptides of TRF1 and TIN2 and between peptides of TRF2 and
Apollo have led to the proposal that a common docking site in the TRFH domains of
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TRF1 and TRF2 can interact with a F/YxLxP motif found in a number of binding
partners44.
In addition to binding shelterin and being organized in t-loops, mammalian
telomeres are nucleosomal12,56,57, in contrast to the telomeres of yeast and ciliates58-60. In
mammalian cells, telomeric chromatin resembles bulk chromatin in its composition,
consisting of the canonical core histone components, but the nucleosomal repeat length is
short, and the nucleosomal core particle shows hypersensitivity to MNase12,56,57. In
addition, telomeric chromatin is enriched for heterochromatic marks, such as
trimethylation of H3K9 and H4K20, and the results of studies in mice have shown that
the loss of such marks correlates with abnormally elongated telomeres61-63. Short human
telomeres show evidence of an unusual chromatin structure, as deduced from the more
diffuse nature of micrococcal nuclease (MNase) digestion patterns57, but the molecular
basis of this change is not known.

Mechanisms of telomere length maintenance
The end-replication problem
Telomeres across species have evolved to solve two major problems that threaten
the viability of cells with linear chromosomes: the end-replication problem and the endprotection problem. The former, recognized by Watson64 and Olovnikov65, refers to the
inability to completely duplicate linear DNA, a problem intrinsic to DNA replication due
to the 5’ to 3’ directionality of DNA polymerases and their requirement for a 3’ OH
provided by an RNA primer. The biochemical requirements for eukaryotic replication
were deduced from in vitro experiments reconstituting replication on DNA containing a
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simian virus 40 (SV40) origin of replication66-69, which depends on cellular factors as well
as the viral SV40 T antigen70-72. In this system, the initiation of DNA synthesis requires
the four-subunit DNA polymerase α/primase complex, replication protein A (RPA), and
SV40 T antigen71,73. With regards to the end-replication problem, both the inability of
DNA polymerase α/primase to initiate DNA synthesis starting from the very end of a
template and the removal of the terminal RNA primer would be expected to result in the
loss of sequence information.
An in vitro reconstitution system using SV40 T antigen and human 293T cellular
extracts to replicate linear DNA containing an SV40 origin of replication has further
corroborated the existence of the end-replication problem74.

Though SV40-based

replication is most efficient on circular templates67, this system was optimized for linear
DNA and was used to show that leading-strand DNA synthesis can proceed to the ends,
leaving blunt duplex termini74. On the other hand, lagging-strand DNA synthesis was
unable to replicate an average of 200 nt of the terminal DNA and left 3’ overhangs as
predicted by the end-replication problem74. This was shown for linear DNA containing
either telomeric or nontelomeric sequences at their termini, though this system could not
address the contribution of additional factors at telomeres in vivo that could affect the
ability for leading or lagging strand replication to proceed to chromosome ends.
The recognition that most telomeres end in a single-stranded overhang extended
the end-replication problem to chromosome ends synthesized by leading strand
replication. Continuous leading-strand synthesis to the end of a linear chromosome
would result in either a blunt end or, if the template is not copied entirely, a recessed 3’
end. The presence of a 3’ overhang at telomeres predicted the existence of helicases and
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nucleases that would resect the template strand of leading-end telomeres, causing newly
synthesized leading-ends to shorten with every round of replication75.
Telomerase
In most eukaryotic organisms, the end-replication problem is solved by the
telomerase ribonucleoprotein, which uses its RNA component, TERC/TR, to template the
synthesis of telomeric G-rich sequences by the catalytic reverse transcriptase subunit,
TERT.

Exceptions to telomerase-dependent telomere maintenance include a

retrotransposon-based mechanism used by Drosophila melanogaster76-78 and the
Alternative Lengthening of Telomeres (ALT) pathway employed by telomerase-negative
cancer cells comprising ~10% of all classified cancers79. ALT has been proposed to
involve recombination-based mechanisms but the details have not been elucidated80.
A terminal transferase-like activity that extends the ends of chromosomes was
predicted based on the finding that linearized plasmids containing the Tetrahymena
telomeric sequence could be maintained in yeast through the addition of repetitive G-rich
sequences11,81. The responsible enzymatic activity was isolated from Tetrahymena and
attributed to a ribonucleoprotein, named telomerase82,83.

The RNA component was

cloned and introduction of mutant alleles into the macronuclei of T. thermophila resulted
in the addition of mutant telomeric sequences to chromosome ends, defects in cell
division, and morphological abnormalities associated with senescence84,85.

The

importance of the telomerase RNA component extends across species; its deletion in
mouse results in the loss of 5 kb of telomeric sequence in every generation that results in
compromised organ function and organismal viability after 4-5 generations86.
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A genetic screen for S. cerevisiae mutants unable to add telomeric repeats to
linearized plasmids allowed the further identification of genes important for telomerase
activity and supported the hypothesis that telomere shortening during successive cell
divisions ultimately compromises cell viability87. Years later, the catalytic subunit of
telomerase was purified from Euplotes aediculatus and found to contain a reverse
transcriptase domain88. Sequence analyses revealed homology with the S. cerevisiae Est2
gene, which had previously been implicated in telomere function through genetic analysis
of telomere maintenance mutants89 and was now identified to encode the catalytic subunit
of telomerase88,90,91.
Assembly of a catalytically active telomerase holoenzyme in human cells requires
several steps involving distinct nuclear compartments. TERT, TERC, and dyskerin
comprise the major components of the telomerase holoenzyme isolated from human
cells92, though a number of additional telomerase-associated factors have been identified
in recent years. The trafficking of telomerase through nuclear structures known as Cajal
bodies is thought to be important for complex assembly and potentially for the
recruitment of telomerase to telomeres. Cajal bodies have been described as important
sites for post-transcriptional RNA modification and biogenesis of RNPs. Telomerase
RNA co-localizes with Cajal bodies throughout the cell cycle93. Dyskerin, in complex
with NHP2, NOP10, and GAR1, binds the H/ACA domain of telomerase RNA, also
found in small nucleolar RNAs (snoRNAs) and small Cajal body RNAs (scaRNAs).
Mutations in TERC-binding proteins compromise RNA stability and RNP assembly. In
addition, the ATPases pontin and reptin interact with TERT and dyskerin during S phase
and facilitate telomerase RNP accumulation in human cells94.
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A newly identified

member of the telomerase complex, TCAB1, appears to be required for the accumulation
of TERC in Cajal bodies and affects telomere elongation in vivo without affecting
telomerase activity95. How the trafficking of catalytically active telomerase RNP through
Cajal bodies contributes to its action at telomeres remains to be determined.
The regulation of telomerase expression and its mode of action vary depending on
the organism. In humans, telomerase activity has been demonstrated in the germline,
primary tumor samples, and cancer cell lines but is suppressed in somatic tissues96. In
contrast, primary cells from rodents and other small mammals show constitutive
telomerase activity and correspondingly longer telomeres, suggesting that the regulation
of cellular lifespan by telomere shortening might not apply for these small animals13.
Whereas yeast telomerase acts in G297,98 and preferentially elongates the shortest
telomeres in a cell99,100, telomerase in human cancer cells appears to act indiscriminately
at most chromosome ends immediately following their synthesis in mid-S phase101.
In addition to the synthesis of G-rich repeats by telomerase, telomere maintenance
also requires coordinated synthesis of the C-rich strand. In ciliates and budding yeast, Cstrand synthesis is coupled to the action of telomerase and involves lagging-strand DNA
polymerases97,102,103. On the other hand, in human cells where telomerase acts throughout
S phase, fill-in synthesis does not occur until late in G2 through incremental steps distinct
from the conventional process of lagging strand DNA replication101.
In the absence of telomerase, human cells lacking telomerase undergo terminal
sequence loss at a rate of 50 bp per end per cell division104. While most mouse cells
constitutively express telomerase, primary Mus spretus cells lacking detectable
telomerase activity lose 75 bp per end per cell division105, which is consistent with the
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rate of telomere shortening observed in successive generations of Mus musculus deficient
for telomerase RNA86. Mammals and other vertebrates exhibit faster telomere shortening
than yeast, which lose only 3-5 bp/end/cell division in the absence of telomerase87,89.

Telomere length regulation
In cells that express telomerase, proteins that bind the telomeric duplex array act
as a counting mechanism to inhibit telomerase in cis as telomeres become long. The
basis for this model came from studies in S. cerevisiae showing that the extent of
telomerase-mediated repeat addition to an induced short telomeric seed sequence was
limited by the insertion of Rap1-binding sites106. In human cells, shelterin components
negatively regulate telomere elongation (Figure 1.3). When wild type TRF1 is
overexpressed in the human telomerase-positive HT1080 cancer cell line, telomeres
progressively shorten at a rate of 3 to 11 bp per population doubling while telomerase
activity is unaffected107. Conversely, expression of a dominant negative truncated form
of TRF1 results in telomere elongation107.

The information about telomere length

conveyed by TRF1 bound to duplex repeats is transduced to the telomere terminus by
POT1. A dominant negative allele of POT1 lacking its OB fold can still localize to
telomeres, presumably through its interaction with TPP1, but results in telomere
elongation when introduced into telomerase-positive human cells108. Consistent with
their role in mediating POT1 recruitment to telomeres, TIN2 and TPP1 have also been
implicated in the cis-inhibition of telomerase30,31,42,109. To date, no component of mouse
shelterin has been assigned a role in the negative regulation of telomerase.
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Figure 1.3. Human telomerase and its regulation by shelterin. The main components of the human
telomerase ribonucleoprotein are shown in association with the 3’ terminus of the telomeric overhang.
Shelterin negatively regulates TERT through POT1 binding of the terminal overhang, while TPP1 has been
proposed to recruit telomerase and increase its processivity. (adapted from 28)

	
  
The estimated number of telomerase molecules in a single human cell does not
substantially exceed the number of telomeres92, suggesting that telomerase must be
recruited to its site of action. In yeast, two pathways dependent on Ku and Cdc13
regulate the accumulation of Est2p at telomeres. Chromatin immunoprecipitation has
shown a bimodal association of Est2p with telomeres in late G1/early S and again in late
S/G2 when telomere elongation occurs110.

Ku interacts with the telomerase RNA

component TLC and promotes the association of telomerase at telomeres in late G1/late
S111,112. The second phase of telomerase association at telomeres involves the singlestranded telomere binding protein Cdc13p. Est1p connects Cdc13 to Est2 by interacting
with both proteins; fusing Cdc13 directly to Est2 bypasses the requirement for Est1p in
telomerase recruitment113.
Telomerase recruitment in mammalian cells is less well characterized. While
POT1 negatively regulates telomerase in vivo, in vitro studies have suggested that TPP1,
in complex with POT1, can interact with telomerase, enhance its processivity, and
facilitate telomere elongation35,114. The interaction between TPP1 and telomerase requires
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its OB fold114. Several studies have attributed TPP1 to the recruitment of telomerase in
vivo115,116, but it has so far been difficult to dissociate the role of TPP1 in telomerase
recruitment from its function in end protection. Expression of a TPP1 mutant lacking its
OB fold impairs telomerase recruitment in human cells but is also unable to suppress the
telomere dysfunction phenotypes associated with TPP1 depletion115. In addition, the low
abundance of telomerase makes it difficult to detect endogenous TERT.

So far,

immunofluorescence for TERT and FISH for TERC have been the only methods used to
evaluate the recruitment of endogenous telomerase in human cells117,118.
Telomere length homeostasis in physiological settings depends not only on the
recruitment and modulation of telomerase activity but also on the regulation of
processing events that occur during telomere replication. In theory, the rate of telomere
shortening in the absence of telomerase depends on the balance between telomeric Cstrand synthesis and nucleolytic degradation of telomeres (at leading-ends), processes
that are not well-characterized but likely to be regulated. Telomere maintenance also
requires the suppression of aberrant processes that can drastically alter telomere length.
In cases of telomere dysfunction, discussed in the next section, aberrant telomere
recombination or nucleolytic degradation might be predicted to induce rapid telomere
shortening.

Mechanisms of chromosome end-protection
The end-protection problem
The end-protection problem refers to the ability for natural chromosome ends to
be distinguished from sites of DNA damage.
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Nearly 80 years ago, McClintock

recognized that broken chromosome ends were unstable, prone to fusion and breakage
cycles119, while the analysis of chromosome rearrangements occurring in Drosophila after
X-ray irradiation revealed the absence of chromosomes with terminal deletions120.
Natural chromosome ends were thus proposed to possess specific features that protect
them from behaving like broken chromosome ends, and the term “telomere” was coined,
from the Greek “telos” for “end” and “meros” for “part”120. While many features of
telomeres could in principle predispose them to being recognized as sites of DNA
damage, the end-protection problem as it is now defined primarily concerns the ability for
telomeres to evade detection as a DNA double strand break. The methods used by
different organisms to solve the end protection problem are likely to reflect the DNA
damage response pathways to which chromosome ends are vulnerable in different
species.

The mammalian DNA damage response
The cellular response to a DSB generally involves the activation of cell cycle
checkpoints and repair of the break through pathways that differ depending on the
context of the damage (reviewed in 121,122). In mammalian cells, DNA damage in different
phases of the cell cycle activate the G1/S, intra-S, or G2/M checkpoints, which promote
cell cycle arrest through the ATR (ataxia telangiectasia and Rad3 related) and ATM
(ataxia telangiectasia mutated) kinase pathways. An additional replication checkpoint
refers to the mechanism that prevents premature mitotic entry when DNA replication is
slowed or stalled.
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Activation of the ATM and/or ATR kinases results in a rapid response mediated
by post-translational protein modifications and a slow transcription-dependent
maintenance of cell cycle arrest. The rapid signaling cascade initiated by ATM and/or
ATR results in the activation of the transducing kinases, Chk1and/or Chk2, which in turn
phosphorylate

Cdc25

phosphatases

and

target

them

for

ubiquitin-mediated

degradation123-128. Cdc25 phosphatases activate different cyclin/Cdk complexes that
promote cell cycle progression. When ATM is activated in G1 or S phase, degradation of
Cdc25A leads to the accumulation of inactive phosphorylated Cdk2 in complex with
cyclin E or A129; the resultant inability for Cdk2 to activate Cdc45 blocks the firing of
replication origins130,131. Rapid proteolysis of cyclin D1 upon DNA damage has also been
reported to contribute to the inhibition of Cdk2, which mediates G1 arrest132. Meanwhile,
the slower transcription-mediated response to DNA damage involves phosphorylation of
p53 by ATM/ATR and Chk1/Chk2133-136, which promotes transcription of the CDK
inhibitor p21137. The binding of p21 to cyclin-Cdk2 and -Cdk4 complexes prevents the
phosphorylation of Rb, thus inhibiting the transcription of S-phase genes138,139. Finally,
the activation of ATM and/or ATR in G2 results in the degradation of Cdc25 and
upregulation of Wee1, which together cause the accumulation of inactive cyclin B/Cdc2
complexes that are unable to promote mitotic entry123,125.
One mode by which natural chromosome ends could prevent the activation of cell
cycle checkpoints is to evade initial sensing by the DNA damage machinery. Activation
of the ATM kinase pathway requires the Mre11/Rad50/Nbs1 sensor complex140-142.
Structurally, the MRN complex consists of a globular domain that contacts DNA and an
extended coiled-coil formed by Rad50, which also contains a conserved hook domain
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thought to mediate dimerization143,144.

Mre11 dimers bind DNA and facilitate the

bridging of two ends145, while Nbs1 regulates both the DNA-binding and nuclease
activities of Mre11146. Nbs1 contains adjacent FHA and BRCT domains that interact with
other DNA damage factors146,147. All three components of MRN are essential in mice
while hypomorphic mutants exhibit a range of cellular phenotypes including S/G2 cell
cycle checkpoint defects, reduced ATM activity, and chromosome instability (reviewed
in 148).
The ATR kinase pathway is activated by the cooperative binding of RPA to long
stretches of exposed single-stranded DNA, which promotes the recruitment of ATRIP149.
Interactions between TopBP1 and ATRIP as well as the clamp loader Rad17 and the
Rad9/Hus1/Rad1 (9-1-1) clamp at the 5’ end of the single stranded DNA promote ATR
activation and the subsequent phosphorylation of downstream targets150-155
The signaling cascade initiated by activated ATM and/or ATR involves the
recruitment and post-translation modification of a number of DNA damage factors.
These include the MRN complex156,157, the histone variant H2A.X158,159, 53BP1160, and
MDC1161-163 which localize to DSBs induced by IR and spread to cover several hundred
kilobases surrounding the site164, forming large foci detectable by immunofluorescence.
The interplay between kinases, ubiquitin ligases, and deubiquitinating enzymes that alter
the binding and signaling capabilities of various DNA damage factors is thought to
modulate the response165-171.
The two major pathways that repair a DNA double strand break are nonhomologous end joining and homology directed repair. The non-homologous end joining
pathway is an error-prone mechanism of repairing DSBs that has been most extensively
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studied in the context of V(D)J recombination during immune cell maturation. Factors
involved in classical non-homologous end-joining include the end-binding factor
Ku70/86172,173, Artemis174, DNA-PKcs175, and DNA ligase IV/XRCC4176-178.

In the

absence of Ku70/86 or DNA ligase IV, alternative end joining pathways can mediate
repair in various contexts179-181. These pathways appear to utilize alternate ligases and
end-binding factors, though many details remain unclear.
In contrast to nonhomologous end joining, the more accurate homology directed
repair pathway occurs during S/G2 phase in the presence of a homologous sister
chromatid. Homology directed repair is initiated by extensive 5’ resection exposing long
single-stranded DNA ends that are coated by Rad51 filaments in a BRCA2-dependent
process182-184.

The ensuing sequence of events involve strand invasion into the

homologous duplex region, second end capture and DNA synthesis, and ultimately
dissolution or resolution of Holliday junction intermediates.

Additional genetic

requirements for efficient HDR in mammalian cells include BRCA1, Rad54185,186. The
mechanisms by which nucleases mediate initial 5’ resection and final HJ resolution will
be discussed in more detail in a later section.

End protection by shelterin
The role of shelterin in suppressing DNA damage signaling and aberrant repair
events at mammalian telomeres has been revealed by conditional gene deletion in mice
(Figure 1.4). Of the shelterin components, only Rap1 and POT1b are non-essential for
mouse embryogenesis, though their deletion still gives rise to pathological
outcomes24,37,187.
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Figure 1.4. End protection by shelterin. Functions of mouse shelterin components deduced from
conditional deletion of individual genes. TPP1 deficiency phenocopies the deletion of both POT1a and
POT1b188, while TIN2 deletion results in a range of phenotypes including activation of both ATM and ATR
and phenotypes associated with POT1a/b deletion189. It has not been ruled out that TPP1 and TIN2 can
directly regulate aspects of the DNA damage response.

	
  
Repression of the ATM kinase is mediated by TRF2190. Inhibition of TRF2 by the
introduction of dominant negative alleles in human cells or conditional gene deletion in
mouse embryonic fibroblasts activates an ATM-dependent DNA damage response190,191.
Early events in this response include the localization of DNA damage factors such as
53BP1 and γ-H2AX to telomeres, forming telomere-dysfunction induced foci (TIFs) at a
majority of telomeres in nearly all cells192,193. Activated ATM phosphorylates Chk2 and
p53, resulting in transcriptional upregulation of p21, and apoptosis or cell cycle arrest191.
Both the formation of TIFs and the phosphorylation of downstream effectors depend on
Nbs1, consistent with the proposed role of the MRN complex as the sensor that activates
ATM194,195.

Other DNA damage response factors, such as MDC1 and H2AX, also

contribute to robust formation of TIFs at telomeres lacking TRF2, but are not absolutely
required to activate ATM and execute the checkpoint194,196. Removal of TRF2 from
telomeres in any phase of the cell cycle results in similar DNA damage responses197.
In addition to activating an ATM-dependent DNA damage signal, telomeres
lacking TRF2 engage in fusions that depend on Ku and Ligase IV (as well as the
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XPF/ERCC1 in human but not mouse cells)193,198. In cells lacking TRF2, telomeric NHEJ
occurs primarily in G1 phase, while NHEJ of telomeres in S phase is repressed by a Cdkdependent mechanism197. ATM signaling is required for NHEJ of deprotected telomeres
in G1194, while factors that are not required for ATM signaling nevertheless contribute to
NHEJ. Depletion of MDC1 or deletion of 53BP1 in the context of TRF2 deficiency
respectively slow or abolish telomere fusions despite little effect on ATM activation or
downstream phosphorylation events196,199. 53BP1 increases the chromatin mobility of
deprotected telomeres199.

Whereas 53BP1 deficiency does not affect V(D)J

recombination involving NHEJ between ends in close physical proximity200,201, the
requirement for 53BP1 to promote fusions of deprotected telomeres199 and of distant ends
in V(D)J recombination and class switch recombination202,203 led to the proposal that
53BP1-mediated chromatin mobility becomes critical specifically between ends separated
by a significant distance.
One proposed model to explain the suppression of ATM and NHEJ by TRF2 is
that t-loop formation promoted by TRF2 prevents the loading of Ku and MRN on DNA
ends in G1194. Interestingly, co-deletion of TRF2 and Nbs1 repressed chromosome
fusions in G1 but resulted in the appearance of a low level of chromatid-type fusions on
metaphase

spreads,

replication194,195.

between

telomeres

synthesized

by

leading

strand

DNA

In the absence of Nbs1-mediated DNA damage signaling, TRF2

deletion still induces significant overhang loss, even though telomeric NHEJ events are
infrequent and limited to leading-end telomeres194. These observations led to the proposal
that TRF2 recruits or activates a nuclease that generates the 3’ overhang at leading end
telomeres. In the absence of TRF2, the MRN/ATM pathway promotes resection at the
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unprotected ends, thereby providing an alternative means of generating overhangs at the
leading-end telomeres. Consistent with this proposal, the fusion of leading-end telomeres
is a highly specific phenotype associated with TRF2 deletion or depletion from MRN- or
ATM-deficient cells194,195,204.

In this model, suppression of telomere NHEJ in S/G2

requires the presence of telomeric overhangs, which are presumably constitutive at
chromosome ends synthesized by lagging strand DNA replication while leading-ends
require processing by either TRF2-associated or MRN-dependent nucleases.
In addition to suppressing DNA damage signaling and NHEJ at telomeres, TRF2
also has a role in preventing aberrant homology directed repair. The N-terminal GAR
domain of TRF2 can stabilize Holliday junctions in vitro205,206, and human cells
expressing a dominant negative form of TRF2 lacking this basic region undergo aberrant
t-loop HDR whereby the HJ at the base of the t-loop is resolved, generating an
extrachromosomal telomeric circle207.

Such extrachromosomal telomeric circles have

been detected in human ALT cell lines that presumably maintain telomeres through
recombination208. In addition, TRF2 stabilizes and recruits its binding partner Rap1 to
telomeres, where Rap1 and Ku act in parallel to repress telomeric sister chromatid
exchanges (T-SCEs), an indication of elevated HR at telomeres24,26,198. The mechanism
by which Rap1 represses homology directed repair remains to be elucidated.
While TRF2 suppresses ATM signaling at telomeres, POT1 suppresses ATR190,209.
Depletion of POT1 by shRNA in human cells results in a transient telomere damage
response210,211. Deletion of POT1a and POT1b in mouse cells leads to ATR-dependent
TIF formation and phosphorylation of the Chk1 kinase as well as the accumulation of
extensive single-stranded telomeric overhangs37,38,190.
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The DNA damage response is

abolished by the re-introduction of POT1a but not POT1b37. On the other hand, POT1b,
but not POT1a, represses excessive overhang formation37, a function that will be
discussed in the next section, which focuses on the regulation of terminal telomere
structure.

The DNA damage response induced by POT1a/b deletion results in

endoreduplication, whereby a long G2 phase is followed by re-entry into a second
replication cycle without an intervening mitosis37,212. Telomeres lacking POT1a and –b
also engage in sister telomere fusions, suggesting a role for the POT1 proteins in
suppressing postreplicative end joining events37. Finally, co-deletion of POT1a/b and Ku
results in a low level of T-SCEs, suggesting that the POT1 proteins also repress
homology directed repair at telomeres39.
POT1a has been proposed to repress ATR activation by excluding RPA from
telomeres190,213, despite evidence that RPA is more abundant than POT1a/b, and the in
vitro binding affinities of POT1a, POT1b, and RPA for telomeric substrates are similar39.
The observation that TIN2 deletion results in similar phenotypes as the loss of POT1a/b
has led to the proposal that RPA exclusion is achieved through the tethering of
TPP1/POT1 to telomeres by TIN2189. An alternative model has invoked a role for the
recently discovered transcribed telomeric RNAs (TERRA) in promoting the ability for
POT1 to exclude RPA214.
More recently, shelterin has been implicated in solving a problem not directly
associated with end protection per se but rather with the semi-conservative replication of
telomeric repeats. When challenged with low levels of the DNA polymerase inhibitor
aphidicolin, telomeres behave similarly to common fragile sites elsewhere in the genome
and become susceptible to fork stalling and chromosome decondensation and/or
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breakage215,216. Deletion of the shelterin factor TRF1 greatly exacerbates the appearance
of fragile telomeres and TRF1-associated helicases, such as BLM, have been proposed to
stabilize aberrant G-quadruplex structures that could arise during replication, thereby
facilitating fork progression through telomeric repeats215,216. The fragile telomere
phenotype has now been observed in a number of settings, though its repression may
slightly differ in human and mouse cells. A role for TRF2/Apollo in facilitating the
replication of telomeric repeats has been described in human cells whereas gene deletion
in mouse cells has revealed no such role217. This may be attributed to mechanistic
differences in the recovery from replication fork stalling in mouse and human cells, since
human cells appear to be more sensitive to drug treatments that stall forks. Following
treatment with a prolonged (24 hour) pulse of hydroxyurea, mouse embryonic cells are
able to restart replication while similarly treated human cells exhibit inefficient
recovery218,219.	
  
	
  
Consequences of telomere shortening
Replicative senescence
Human fibroblasts have a finite lifespan in culture220.

After ~50 population

doublings, cells enter a state of replicative senescence characterized by growth arrest in
G1, changes in cell morphology, positive β-galactosidase staining221, and other alterations
in gene expression.

The discovery that introducing telomerase into normal human

epithelial cells and fibroblasts can indefinitely extend their in vitro lifespan established
the contribution of telomere shortening to replicative senescence222.
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The in vitro growth behavior of cultured human fibroblasts has been described as
a two-stage process223. When telomerase-deficient normal human fibroblasts arrest at the
G1/S transition after a fixed number of population doublings (senescence, also known as
M1 stage), inactivation of both p53 and Rb by the introduction of SV40-LT allows the
cells to bypass arrest and proliferate for ~20 additional PDs223,224. Nevertheless, these
cells enter a stage known as crisis (M2) during which the rate of cell division balances
that of cell death. Immortalized cells that emerge from crisis have either reactivated
telomerase or an alternative lengthening of telomeres (ALT) pathway but display marked
cytogenetic abnormalities and aneuploidy that presumably confer transformation
potential225.

Telomere dysfunction and cancer
Depending on the context, telomere shortening can either act in a tumor
suppressive capacity or promote cancer development by increasing genome instability.
Progressive telomere shortening is predicted to limit the proliferative capacity of
hyperplastic cells in vivo by the activation of cell cycle checkpoints in response to
telomere dysfunction. Indeed, the inactivation of telomerase has been shown to impair
tumorigenesis in several mouse models of cancer226,227.
However, telomere dysfunction can promote genome instability by instigating
breakage-fusion-bridge cycles that generate extensive chromosome rearrangements or by
inducing endoreduplication that results in an unstable polyploid state. In fact, mice null
for the telomerase RNA component show an increased incidence of spontaneous tumors
in later generations, which has been linked to the increasing appearance of chromosome
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fusions and aneuploidy228. In p53-deficient mice with a high incidence of lymphomas,
loss of telomerase increases the rate of tumorigenesis and shifts the tumor spectrum to
epithelial carcinomas that have more commonly been attributed to aging in humans229,230.
Evidence of telomere dysfunction and fusions during the progression of human
cancer has been demonstrated for chronic lymphocytic leukemia231. Measuring the
telomere length distribution of the XpYp telomere in different CLL patients showed that
shorter telomeres correlated with poorer prognoses, with patients in stage A, B, and C of
disease having respective mean telomere lengths of 5, 3.5, and 2 kb231. PCR-based assays
to detect specific fusion events between the XpYp and 17p telomeres demonstrated a
high fusion rate in patients, especially those with poor prognosis disease, compared to
control subjects231. The telomere dysfunction observed in vivo was suggested to be a
driving factor in genome instability and clonal evolution of advanced disease.

Inherited disorders of telomere dysfunction
A number of inherited disorders exemplify the consequences of telomere
dysfunction in humans232.

The most well-studied is dyskeratosis congenita, a rare

syndrome characterized by skin and mucous membrane abnormalities including
hyperpigmentation, nail dystrophy, and leukoplakia233.

Patients with this disease

succumb to bone marrow failure and exhibit predisposition for certain cancers. Genetic
anticipation, whereby the disease manifests at a younger age in later generations, reflects
progressive telomere shortening in the germline. Autosomal recessive, X-linked, and
autosomal dominant forms of the disease have been identified and attributed to mutations
in various components of the telomerase RNP, including TERT234,235, TERC236,
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dyskerin237,238, Nop10239, Nhp2240, as well as the shelterin protein, TIN2241,242. Recently, a
patient with a severe form of DC known as Hoyeraal-Hreidarsson syndrome was found to
express a splice variant of the telomere-associated Apollo nuclease that abolishes its
ability to function at telomeres, though the disease-causing mutation was not identified243.
In addition to DC, familial forms of idiopathic pulmonary fibrosis244 and aplastic
anemia245,246 have also been attributed to mutations in telomerase components. Although
accelerated telomere shortening has been correlated with a multitude of other disorders
associated with aging, in most cases a causal relationship remains to be established.

The contribution of the single-stranded overhang to telomere function
Functions of the telomeric overhang
A conserved feature of terminal telomere structure is the presence of a singlestranded 3’ overhang of variable length (refer to Table 1.1).

Found at nearly all

chromosome ends in a cell5, the telomeric overhang contributes to the solutions of both
the end-replication and end-protection problems, as outlined in previous sections. A 3’
single-stranded overhang is required for repeat synthesis by telomerase, which does not
display activity on a blunt duplex end247. The single-stranded telomeric repeats also serve
as the docking site for telomere binding proteins that regulate and/or recruit telomerase
32,33,108

. Importantly, the length of the telomeric overhang correlates with the rate of

telomere shortening in human cells lacking telomerase248. Overhang generation at newly
synthesized telomeres is thus thought to be tightly regulated since insufficient overhangs
might compromise telomerase function, while excessive 5’ end resection could accelerate
telomere shortening in the absence of telomerase.
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The telomeric overhang is presumed to contribute to end protection in mammalian
cells both by mediating t-loop formation and by binding POT1 proteins.

Electron

microscopy has been used to detect t-loops formed in vitro by incubating TRF2 with 500
bp duplex telomeric substrates containing variable terminal structures. In the presence of
substrates containing 3’ telomeric overhangs, t-loops were detected at ~11-19% of DNA
molecules16. On the other hand, <3% of the detected molecules formed t-loops in the
presence of substrates with blunt ends, 5’ overhangs, or 3’ overhangs consisting of nontelomeric sequences16. Removal of the overhang by ERCC1/XPF is required for NHEJ of
telomeres lacking TRF250, suggesting that the presence of an overhang may suppress
telomere fusions even when t-loop formation is abolished. The observation that deletion
of POT1a and POT1b results in post-replicative sister telomere fusions suggests that an
overhang unbound by POT1 proteins is specifically vulnerable to fusions in S phase37. In
POT1a/b-deficient cells, the absence of chromosome-type fusions could be explained by
the ability to re-sequester the telomere terminus in t-loops as cells progress through
G2/M, thereby suppressing NHEJ in G1.
There has been no formal demonstration that overhang loss directly activates the
DNA damage response, partly because there has been no way to abolish the overhang
without compromising shelterin function. In fact, when NHEJ of telomeres lacking
TRF2 is inhibited by co-deletion of Ku, Ligase IV, or 53BP1, ATM activation persists in
the absence of detectable overhang loss, suggesting that overhang loss is not necessary
for persistent DNA damage signaling193,198,199. It may be that the ability to form t-loops
depends on the presence of both TRF2 and the telomeric overhang, thus loss of either
TRF2 or the overhang is sufficient to activate DNA damage responses. Though it was
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proposed that short overhangs could trigger replicative senescence, it has since been
shown that the telomeric overhangs in several primary human cell lines remain stable in
length through senescence249.

Overhang length dynamics in different organisms
A long-standing question in the telomere field concerns the generation and
regulation of the telomeric overhang. Studies of terminal telomere structure in a number
of organisms have yielded extensive information about overhang dynamics in different
settings and have identified factors that modulate overhang length.

However, the

nucleases involved in generating the telomeric overhang in mammalian cells (particularly
at leading-end telomeres) had not been identified when this thesis work was begun.
Several end-processing steps modify overhang length in S phase (Figure 1.5).
The 3’ overhang at leading-end telomeres is thought to be generated by nucleases and
helicases75, while lagging-end telomeres constitutively terminate in 3’ overhangs due to
both the inability to begin synthesis at the very end of the template as well as degradation
of the last RNA primer. Telomerase can extend overhangs either immediately upon
completion of replication in human cancer cells101, or in late S phase in budding yeast97.
Telomerase-independent processing can also result in the transient generation of long
overhangs in late S/G2250.

As cells progress through G2/M, overhangs once again

become short through a poorly understood process thought to involve fill-in synthesis of
the C-rich strand101,250.
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Figure 1.5. Overhang dynamics during S phase. In human cells, telomeres replicate throughout S phase
and undergo changes in overhang length corresponding to different processing steps. In step (1), overhangs
are generated at newly synthesized telomeres by degradation of the template strand at the leading-end
telomere (1a) or degradation of the RNA primer at the lagging-end telomeres (1b). Next, in telomerasepositive cells, the telomeres are elongated by telomerase throughout S phase (2). In step (3), further
degradation of the C-rich strand can occur, resulting in the appearance of long overhangs in late S/G2 phase.
In step (4), which occurs as cells progress through G2/M, overhangs return to the short length found in G1,
through fill-in synthesis of the C-rich strand.

	
  
Evidence for the strict regulation of overhang generation and telomere end
processing first emerged from studies revealing precise sequences at the extreme
terminus of ciliate telomeres. In the mature macronuclei of Oxytricha and Euplotes
crassus, the last nucleotides on both the telomeric G-rich and C-rich strands are precisely
defined9,10, though more heterogeneous structures appear transiently during the period of
active telomere synthesis in the sexual stage of the ciliate life cycle when macronuclei are
formed251. In Tetrahymena, the G-rich telomeric strand ends with a 14-15 or 20-21 nt
overhang terminating in 5’-T2G4T-3’, while the sequence of the recessed C-rich strand is
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3’-AACC-5’ or 3’-AACCC-5’102.

Analyses of overhang generation in Tetrahymena

suggested that both the G and C rich strands undergo processing by nucleases that are not
sequence-specific, since altering the telomeric sequence by mutating the telomerase RNA
template does not abolish the specificity of cleavage102. Thus, the properties of singlestranded telomeric binding proteins, rather than intrinsic sequence specificity of
nucleases, were proposed to define the boundaries of end processing.
In S. cerevisiae, short ~14 nt overhangs are present at telomeres in G1 and
additional processing generates long overhangs in S phase252-254. This transient overhang
elongation requires the passage of the replication fork but is independent of telomerase255.
Constitutive overhang generation depends upon Mre11, which is also required for
telomerase-mediated extension256,257, whereas the generation of transiently long overhangs
does not require Mre11258. Instead, the appearance of transient overhangs in S phase is
abolished only when both the Sae2 and Sgs1 are deleted, suggesting that redundant
pathways can generate the transiently elongated overhangs259.
Telomeric overhangs of 30-500 nt have been detected at >80% of human
telomeres by a number of techniques, including a primer extension based method and
DNA length analysis after complete digestion of duplex genomic DNA, which leaves the
overhang intact5,7,260.

In telomerase-negative human cells, overhangs at leading-end

telomeres appear to be shorter than those at lagging-end telomeres, while the presence of
telomerase equalizes the size distribution of overhangs between the two newlysynthesized telomeres7. While the last nucleotides of the G-rich strand are variable, the
terminal nucleotides on the C-rich strand end in 3’-CCAATC-5’ at >80% of telomeres,
suggesting that 5’ end-processing of both newly synthesized telomeres in human cells is
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well regulated261. Depleting MRN components transiently reduces the overhang by ~2030 nt in telomerase-positive human cells but not in telomerase-negative settings, thus
MRN was proposed to have a role in modulating telomerase action at human telomeres262.
Altered telomeric overhangs have been documented in some human diseases263-265, though
whether they are a cause or consequence of disease has not been well established.

Role of single-stranded DNA binding proteins in overhang regulation
Across species, different single-stranded DNA binding proteins bind the
overhang, modulate its length, and have roles in end protection (refer to Figure 1.1). The
common structural feature of these telomeric end-binding proteins is the presence of OB
folds that bind single stranded telomeric sequences with subnanomolar affinity266. The
first end-binding proteins isolated were the ciliate TEBPα/β proteins that form a
heterodimer in Euplotes and Oxytricha267-270.

Though a role in end protection was

proposed, the lack of genetic tools precluded further investigation into their in vivo
functions.
The development of budding yeast as a model system provided powerful genetic
tools to gain insight into the in vivo functions of end-binding proteins, despite significant
divergence of the telomeric binding proteins from those found in other yeasts. As
previously noted, the S. cerevisiae Cdc13-Stn1-Ten1 complex binds to the singlestranded telomeric overhangs271 and is required for telomerase recruitment and end
protection272-275. Temperature sensitive cdc13 mutants undergo extensive resection of the
C-rich strand and activation of a RAD9-dependent cell cycle checkpoint276.

The

requirement for CST in end protection is specific to S phase and is primarily
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accomplished by Stn1/Ten1, since expression of a chimeric protein comprised of the
DNA-binding domain of Cdc13 fused with Stn1 is sufficient to suppress the end-capping
defects of cdc13 mutants277. Interactions between CST and DNA polymerase alpha
contribute to its telomere capping function278. Structural comparisons between yeast
Stn1/Ten1 and human RPA2/3 have recently led to the proposal that CST functions as a
telomere-specific RPA complex279,280.
In addition to CST, the Rap1-associated Rif1 and Rif2 factors, as well as Ku, also
protect telomeres from increased resection of the C-rich strand. In yeast, like mammalian
cells, Ku binds to DNA ends without sequence preference. Deletion of Ku in any cell
cycle phase leads to the accumulation of single stranded telomeric DNA due to 5’ end
resection by the Exo1 nuclease281-285. While the deletion of either Rif1 or Rif2 alone does
not lead to significant resection, co-deletion of Rif1 in cdc13-1 mutants results in
increased temperature sensitivity due to excessive MRX-dependent resection286. Thus,
Rif1 appears to protect telomeres from degradation in a redundant manner with CST.
Single-stranded telomeric DNA binding proteins in S. pombe and human were
identified based on limited sequence similarity to Oxytricha TEBPα and named POT1 for
protection of telomeres32,108.

Besides containing OB folds, the POT1 proteins lack

sequence and structural similarities with Cdc13 but perform some similar functions.
Deletion of pot1+ in S. pombe results in a severe end protection defect reflected by Crich strand degradation in the S phase immediately following inactivation of pot1 in
synchronized G1 cells followed by ~5 kb of rapid telomere loss and growth arrest after
approximately 10 generations32,287. Depletion of POT1 in human cells does not produce
such a dramatic overhang phenotype; however, a role for POT1 in regulating terminal

	
  

31

telomere structure was suggested by the fact that POT1 depletion abolished the
specification of the last 5’ nucleotide of the C-rich telomeric strand210.
The two POT1 proteins found in mouse cells act in distinct ways to protect the
telomere terminus.

As mentioned previously, POT1a specifically suppresses ATR

signaling while POT1b regulates terminal telomere structure37. Deletion of POT1b in
mouse cells results in the telomerase-independent accumulation of long single-stranded
telomeric overhangs, and accelerated telomere shortening187.

POT1b-deficient mice

survive embryogenesis, but display pathologic features resembling the human disease
dyskeratosis congenita, such as hyperpigmentation, nail dystrophy, testicular atrophy, and
bone marrow failure, which are exacerbated by telomerase haploinsufficiency187. Thus,
POT1b was proposed to limit degradation of the telomeric C-rich strand. The nuclease(s)
responsible for aberrant processing have not been identified, though Exonuclease 1 was
ruled out based on the observation that co-deletion of POT1b and Exo1 did not mitigate
the phenotype187.
Recently, a mammalian complex, composed of the OB-fold containing proteins
Ctc1, Stn1, and Ten1, has been proposed to be the ortholog of the yeast CST complex
based on structural similarities288,289.

Ctc1 and Stn1 were originally identified as

accessory factors of DNA polymerase alpha/primase, which stimulate de novo RNA
primer synthesis as well as primer-dependent elongation in reconstituted systems290.
Mammalian CST has been reported to localize to a subset of telomeres as well as
replication foci elsewhere in the genome288,290. The telomeric localization of human Stn1
has been reported to be independent of POT1, while an interaction between Stn1 and
TPP1 has been identified288,291. Depletion of Ctc1 or Stn1 in human cells results in the
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accumulation of single stranded telomeric DNA at both terminal and internal sites,
potentially reflecting distinct roles. Functions proposed for mammalian CST include Crich strand fill-in synthesis following telomerase action at the telomere terminus and
recovery from fork stalling288,289, though no direct evidence for such roles has so far
emerged.

CST has also recently been implicated in the negative regulation of

telomerase292. Whether shelterin cooperates with or promotes the function of CST in
order to inhibit the action of telomerase in cis is an interesting question to be answered.
It is noteworthy that in the cases of telomere deprotection induced by deletion of
shelterin components, the phenotype with respect to C-strand degradation and telomere
shortening is much milder than that observed in end-binding mutants from other model
organisms. Such relatively low rates of degradation could suggest that, in diseases
related to telomere dysfunction, unregulated nucleolytic activities at telomeres contribute
relatively less to genome instability compared to aberrancies in cell cycle progression
and/or fusion events. Nonetheless, the recent identification of additional factors that can
protect mammalian telomeres from extensive resection in a redundant manner with
shelterin has revealed that chromosome ends are protected from degradation in more
ways than previously imagined293. Indeed, the nucleases that act at protected and
deprotected telomeres may yet prove to contribute significantly in the pathogenesis of
telomere dysfunction related disorders.

Candidates for overhang generation in mammalian cells
In this thesis, the following general categories were considered as candidates in
generating the telomeric overhang at leading end telomeres (and/or additional 5’
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resection at lagging end telomeres): 1) novel telomere-specific nuclease(s), 2) known
shelterin-associated nucleases that also have non-telomeric functions, 3) nucleases
involved in DSB resection that localize to telomeres due to the transient recognition of
chromosome ends as DNA damage during replication.
The identification of a novel telomere-specific nuclease with a dedicated function
in 5’ end processing at telomeres was considered possible but unlikely. In theory, the
final nucleotide could be specified by an endonuclease that localizes to telomeres and
mediates specific cleavage between the two 5’ cytosines of 5’-(AATCCC)n-3’ repeats.
Studies on the terminal structure of ciliate telomeres have suggested that end-binding
proteins rather than sequence-specific nucleases regulate the sequence specificity of the
telomere terminus102. A 100 kDa protein with in vitro nuclease activity that specifically
cleaves telomeric C-rich strands ending in 3’-AA-5’ or 3’-CA-5’ has been isolated from
Tetrahymena, though the in vivo function of this activity is not known294. Extensive mass
spectrometry approaches to isolate shelterin-associated factors have yielded a number of
nucleases, but none appear to be telomere specific. The failure to isolate such a factor
suggests that if a novel telomeric nuclease does exist, its association with telomeres is
likely to be weak and/or transient. Thus, biochemical approaches to isolate a novel
telomeric nuclease were not attempted here.
Another possibility is that nucleases and/or helicases with non-telomeric roles are
recruited by shelterin to mediate 5’ end processing at telomeres.

The members of

shelterin are known to interact with nucleases (Apollo/SNM1b51,52,295, FEN154,
ERCC1/XPF50),

helicases

(BLM47,296,

WRN296,297),

and

factors

that

modulate

nuclease/helicase activity (Nbs149, ATM298, SLX4299). Since TRF2 has been proposed to
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recruit a factor that generates overhangs at leading-end telomeres194, nucleases known to
associate with TRF2, including Apollo/SNM1b and Fen1, as well as nucleases recruited
by the scaffolding protein SLX4, were particularly attractive candidates.
Finally, a third hypothesis is that telomeres are transiently recognized as DNA
damage, in which case factors involved in DNA DSB resection might be recruited and
resect the 5’ ends.

This hypothesis stems from chromatin immunoprecipitation

experiments that have detected DNA damage factors at telomeres in cells progressing
synchronously through S phase following cell cycle arrest by double thymidine or
aphidicolin300,301.

The associations of ATM, ATR, and other components of these

pathways with telomeres occur at two points in S phase, once in early/mid S and again in
late S/G2300,301. The recombination proteins Rad51, Rad52 and XRCC3 also appeared to
localize to telomeric DNA during late S phase300. While the first peak of association
between DNA damage factors and telomeres was attributed to fork stalling during
telomere replication, the late S phase association was attributed to end processing events
that occur after the completion of replication. The caveat of this interpretation is that the
experiments involved drug treatments that can induce low levels of DNA damage, and
the telomeric localization of various DNA damage factors could reflect distinct repair
activities rather than physiologic processes.
A largely genetic approach was undertaken to identify factors involved in
overhang generation and dynamics. The expectation that the nucleases and/or helicases
involved in telomere end processing might be redundant led to the choice of Mus
musculus as the preferred organism for genetic manipulations.

A large number of

nucleases, helicases, and associated factors were considered as potential candidates
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(Table 1.2), thus the next section of this introduction concerns the general properties and
mechanisms of the DNA nucleases that may function at telomeres.
Table 1.2. Candidates for overhang generation

Listed are all candidates considered for a role in overhang generation and/or dynamics, with
tested candidates listed in black (in parentheses are those candidates that were tested but not
discussed here) and untested factors listed in gray. Candidates are grouped based on whether they
have been reported to interact with shelterin (in any context).
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PART II: NUCLEASES IN EUKARYOTIC DNA REPLICATION AND REPAIR
General classes and properties of eukaryotic structure-specific DNA nucleases
Deoxyribonucleases that hydrolyze the phosphodiester backbone of DNA
contribute to a multitude of important cellular transactions.

Nucleolytic activities

associated with DNA replication ensure the fidelity of DNA polymerases and the
appropriate processing of Okazaki fragments generated during lagging strand replication.
In addition, nucleases mediate the repair of different kinds of DNA damage arising from
both spontaneous reactions within the cell (eg. deamination, alkylation, oxidation) and
exogenous sources (e.g. UV, X-ray irradiation, chemicals).

Endonucleases and

exonucleases cleave their substrates upon recognition of specific sequences or structures.
Whereas a diverse collection of bacterial sequence-specific restriction
endonucleaseshave been identified302, sequence-specific nucleases are less common in
eukaryotes. Some examples include the S. cerevisiae HO303-305 and I-SceI nucleases306,307
that belong to the LAGLIDADG family of homing endonucleases. The sequence
specificity of bacterial restriction enzymes is conferred by the ability to distort specific
bases in the center of cognate palindromic sequences302. In comparison, eukaryotic
homing endonucleases recognize longer sequences and tolerate more degeneracy302.
Since a telomere sequence-specific nuclease was considered an unlikely candidate
for overhang generation, I will focus here on the eukaryotic structure-specific nucleases
and their roles in various contexts of DNA replication and repair. Structure-specific
nucleases are grouped primarily based on their conserved catalytic domains and include
the flap endonucleases, the XPF/ERCC4 family, and the UvrC class of nucleases.
Despite their diverse in vitro and in vivo activities on various DNA substrates, many of
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these enzymes share common structural motifs involved in DNA binding and catalyze
hydrolysis using divalent metal cations as cofactors.
Members of the flap endonuclease family include FEN-1, EXO-1, GEN-1, and
XPG (reviewed in

308

). FEN-1 has 5’ to 3’ exonuclease and endonucleolytic activity,

preferentially acting on 5’ single-stranded DNA termini309,310. Purified human Exo1 also
has 5’ to 3’ exonucleolytic and flap endonuclease activity in vitro, preferentially at bluntended or 5’ recessed DNA311. XPG and GEN-1 are thought to act via endonucleolytic
activities at DNA bubbles and four-way junctions, respectively312,313, though in vitro 5’ to
3’ exonucleolytic activity has also been reported for XPG314.
Structural studies of archaeal and bacterial FEN nucleases309,315, and more
recently, human FEN-1316 and EXO-1317 have lent insight into the common mechanisms
by which these nucleases bind and cleave DNA while maintaining specificity for
different substrates.

Members of this family contain conserved N- and C-terminal

domains that contact DNA and are separated by a variable length intermediate (I) domain
thought to form a helical arch or clamp308. The catalytic site is located in the N-terminal
portion of the I-domain and consists of seven positionally conserved aspartates and
glutamates that coordinate metal ion cofactors317. A helix-two-turn-helix motif in the Cterminus of the protein binds duplex DNA upstream of the cleavage site, while the Nterminus binds to the downstream DNA segment317. These interactions bend DNA near
the cleavage site at a 90-100 degree angle, which can only be achieved in DNA with a
gap or flap316,317. This sharp bend exposes the scissile bond and causes fraying of two
nucleotides at the 5’ end, which provides a common intermediate for apparent endo- and
exonucleolytic actions316,317.

	
  

Elements specific to the individual nucleases confer

38

preferences for different structures while factors that interact with the C-terminal domain
of the nucleases have been proposed to further regulate nuclease activity317. For instance,
a positively charged groove near the active site of EXO1 accomodates the binding of 3’
overhangs and gapped structures317.
The XPF family members XPF/ERCC4 and Mus81 compose another class of
divalent metal cation dependent endonucleases. XPF consists of a catalytic domain (also
known as the ERCC4 domain) with the active site motif GDXnERKX3D, followed by a
DNA-binding domain containing two helix-hairpin-helix (HhH) motifs318. Mus81
contains a similar catalytic domain flanked by single HhH motifs319,320. The activities of
both XPF and Mus81 require their interactions with structurally related protein partners,
ERCC1 and Eme1, respectively, which contain similar ERCC4 and HhH motifs but lack
critical residues for catalytic activity321-323. XPF/ERCC1 cleaves the 5’ end of bubble
structures as well as within the duplex regions next to a 3’ or 5’ single-stranded
overhang324,325. RPA specifically stimulates the binding of XPF/ERCC1 to the doublestranded/single-stranded DNA junction next to a 5’ protruding end326,327. Mus81/Eme1
has been implicated in Holliday junction resolution and has in vitro activity at branched
duplex DNA, replication fork substrates, and synthetic HJ intermediates322,323,328.
Eukaryotic SLX1 typifies the UvrC family of endonucleases, which were first
identified as prokaryotic NER factors. An N-terminal GIY domain contains several
conserved residues important for catalysis, including a glutamate and several tyrosine or
histidine residues involved directly or indirectly in coordinating the active site metal
cation and an arginine that may stabilize the phosphate group at the scissile bond. While
UvrC contains a C-terminal helix-hairpin-helix motif for DNA binding, SLX1 orthologs
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contain a C-terminal cysteine-rich PHD zinc finger-like domain329. Like the XPF family
nucleases that require a partner for activity, the nucleolytic activity of yeast SLX1 is
stimulated by SLX4330. Mammalian SLX4 appears to interact with a number of other
nucleases and repair proteins including Mus81, Msh2-3 as well as the shelterin
component TRF2, suggestive of a telomeric role299,331,332. SLX1-SLX4 acts at branched
DNA containing a ds-ss junction, including 5’ flaps, 3’ and replication fork structures,
and symmetrically cleaves Holliday junctions299,331,332.
A final class of nucleases considered here is the β-CASP family of metallo- β lactamases, which includes the CPSF, Artemis, SNM1 and PSO2 (CASP) nucleases333.
This family is thusly named due to a common structural motif shared with the βlactamases expressed by bacteria to counteract antibiotics. This common metallo-βlactamase (MBL) fold consists of two anti-parallel β-sheets between two α helices, with
the metal-binding site on one edge334.

The MBL domain contains a characteristic

HxHxDH motif that comprises the active site of PSO2/SNM1 family members, with the
first histidine and aspartate being conserved in all MBL proteins333. A second C-terminal
domain found specifically in the β-CASP family contains additional conserved
carboxylates and a histidine involved in coordinating the zinc cation in the active site333.
While no structural information is yet available for DNA-processing β-CASP proteins,
structures of prokaryotic and eukaryotic RNA processing β-CASP family members have
suggested that the β-CASP domain forms a lid-like structure on the edge of the MBL that
limits substrate access to the active site335,336.
The in vitro activities of the β-CASP family members are diverse. Purified
Artemis alone acts as a 5’ to 3’ exonuclease337.
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However, when complexed with the

DNA-dependent protein kinase, DNA-PKcs, Artemis exhibits endonucleolytic activity
that cleaves 5’ and 3’ overhangs as well as hairpins337. Apollo also possesses 5’ to 3’
exonuclease activity on single stranded DNA as well as double stranded blunt and
recessed ends52. In addition, Apollo purified from insect cells has been found to exhibit
endonucleolytic activity on branched, bubble, and hairpin substrates in vitro338. The
exonucleolytic activity of Apollo has been reported to be modified by its binding with
TRF2217. Whether Apollo is modified or complexed with proteins other than TRF2 is not
known, but such in vivo interactions could also modulate its function.	
  

Involvement of nucleases in DNA replication and repair pathways
Okazaki fragment maturation
The removal of initiator RNA primers during Okazaki fragment maturation has
been proposed to occur via a number of possible mechanisms that involve the FEN1
and/or Dna2 nucleases as well as RNase H (reviewed in

339

). During replication, DNA

polymerase α/primase synthesizes RNA primers, initiates low-processivity, low-fidelity
synthesis, after which polymerase switching occurs whereby more processive
polymerases extend the newly-synthesized strand340-343. In vitro reconstitution
experiments had originally demonstrated the ability for DNA polymerase δ to act at both
strands at a replication fork344.

However, more recent genetic experiments in S.

cerevisiae investigating the strand-specific mutation rates caused by DNA polymerase
mutants with higher error rates have assigned DNA polymerase δ primarily to laggingstrand synthesis345, while polymerase ε replicates the leading-strand346. RNA primers
used in lagging strand synthesis can be digested by RNase H or via polymerase-
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dependent strand displacement and flap cleavage by DNA nucleases. The FEN1 nuclease
was isolated from a number of mammalian sources and found to be required for the
removal of initiator RNA and ligation of Okazaki fragments in several systems of in vitro
reconstituted replication347-350. While FEN1 can act within RNA via its endonucleolytic
activity351, eukaryotic RNase H has also been implicated in lagging strand synthesis352. In
S. cerevisiae, overexpression of RNase H partially suppresses the growth defect of Rad27
(Fen1 ortholog) mutants352.
Though the presence of RNase H and FEN1 are sufficient for Okazaki fragment
maturation using in vitro reconstituted systems, genetic studies have led to a model that
also involves DNA2, which is essential in S. cerevisiae353. DNA2p interacts physically
and genetically with Rad27p354. In addition, in vitro reconstituted systems using yeast
proteins have suggested that polymerase-dependent displacement of downstream Okazaki
fragments generates a flap of variable length355. While short 5’ flaps can be cleaved by
FEN1, stable binding of RPA to flaps of 30 nt or longer can inhibit the activity of FEN1,
while stimulating the nuclease activity of DNA2356. Thus, a revised model proposes that
while Okazaki fragment maturation largely involves short flaps that are cleaved by FEN1
(with or without RNase H), strand displacement synthesis nevertheless generates some
long flaps, which are lethal if unresolved, accounting for the essential role of DNA2.

Base excision repair
The base excision repair pathway responds to modified bases that do not induce
significant distortion of the DNA backbone (reviewed in	
   122,357). In brief, specific DNA
glycosylases recognize and remove various modifications to generate an abasic (AP) site.
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Subsequently, an AP endonuclease introduces an incision 5’ to the AP site358,359, and the
area can be excised by one of two mechanisms. Short-patch BER occurs through the
removal of the abasic sugar to leave a 1-nt gap that is filled by DNA polymerase beta in
conjunction with DNA ligase III-XRCC1360. On the other hand, long-patch repair occurs
when DNA synthesis mediated by DNA polymerase delta/epsilon and PCNA cause
strand-displacement, producing a 2-10 nt flap cleaved by FEN1361. In this case, DNA
ligase I seals the nick362. The choice of repair pathway appears to depend on the tissue
type and the mechanism by which the AP site is generated.

Nucleotide excision repair
Bulky adducts induced by UV damage or chemical agents are recognized and
resolved by nucleotide excision repair. NER involves a complex sequence of events
accomplished by over 30 proteins that assemble at the lesion, excise a 24-32 nt long
segment to generate a single-stranded gap, and finally re-synthesize DNA across the gap
using the undamaged strand as a template363. This mode of repair can occur via either a
transcription-coupled pathway in which the lesion is sensed by the stalling of RNA
polymerase II or a global genome pathway that depends on DNA binding proteins, RPA,
XPA, and XPC, which recognize damaged duplex DNA and initiates the recruitment of
other NER factors364-366. Two nucleases, XPG and XPF (heterodimerized with ERCC1),
make incisions 3’ and 5’ to the damaged site, respectively312,367.
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Mismatch repair
The mechanism of eukaryotic mismatch repair has mostly been elucidated
through biochemical reconstitution of mismatch or nick- directed repair, which requires
the MutS complex (predominantly MutSα composed of Msh2/6 or, in some cases, MutSβ
composed of Msh2/3), the MutL complex (Mlh1/Pms2 or Mlh1/Mlh3), PCNA, RFC, and
exonuclease 1368 (reviewed in

369

). The paradox that either a 5’ or 3’ nick can direct

excision by the 5’-3’ exonuclease 1370 was resolved by the identification of
endonucleolytic activity of MutL, which is thought to generate two nicks flanking the
mismatch371.

The intervening sequence is excised by exonuclease-1 and can be

resynthesized by DNA polymerase δ368. While Msh2-deficient mice have significantly
compromised mismatch repair372,373, the Exo1-deficient mouse exhibits only mild mutator
phenotypes suggesting the existence of Exo1-independent repair pathways374.

DSB repair
The non-homologous end-joining and homology directed repair pathways that
respond to DNA double strand breaks have been outlined previously, so here I will focus
on the nucleases associated with these pathways. The primary nucleolytic activity in the
NHEJ pathway is that of the 5’ to 3’ nuclease Artemis, which has mainly been studied in
the context of V(D)J recombination174,375,376. Artemis is required to cleave the hairpins
generated on coding ends following the initial cleavage by the lymphoid specific RAG1
and RAG2 endonucleases337. Artemis interacts with the catalytic subunit of the DNAdependent protein kinase, DNA-PKcs, which phosphorylates several C-terminal S/TQ
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sites in Artemis that modify its in vitro nucleolytic activity, though these modifications
do not appear to be required for in vivo activation377.
Two steps in homology-directed repair require the activity of nucleases: initiation
of 5’ end resection and HJ resolution. Resection at a double strand break has been
genetically dissected in yeast and appears to involve sequential steps performed by
several partly redundant nucleases. MRX acts in conjunction with Sae2 endonuclease to
initiate a cut, while two pathways dependent on either Exo1 or Sgs1/Dna2 mediate more
extensive resection378-380.

Deletion of Sae2 slows the rate of resection after DSB

induction by HO, though a subset of breaks still undergo efficient resection that is
dependent on Exo1378,379. Similarly, in the absence of either Rad50 or Mre11, ~20% of
DSBs do not initiate resection, while resection beyond 25 kb from the initial break site
still occurs at a majority of breaks378,379. Co-deletion of Exo1 and Sae2 impairs but does
not abolish resection and subsequent homology-directed repair, and the remaining
activity that allows resection has been attributed to the Sgs1 helicase acting with the
Dna2 nuclease378,379. Interestingly, 5’ resection has been reconstituted in vitro with Dna2,
Sgs1, and RPA381,382. In this in vitro reaction, RPA stimulates Sgs1 unwinding of a
duplex as well as the 5’ to 3’ nucleolytic activity of Dna2, while inhibiting the 3’ to 5’
nuclease activity of Dna2381,382.
In mammalian cells, extensive resection at a DSB has been attributed to Exo1 and
BLM380.

The induction of DSBs in replicating human cells by the topoisomerase

inhibitor camptothecin resulted in reduced cell survival and RPA foci formation when
both Exo1 and BLM were depleted, compared to depleting either factor alone380. Initial
resection by CtIP appears to promote the recruitment of Exo1 and further resection380.
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Resection by CtIP is modulated by a number of modifications including phosphorylation
by Cdk and acetylation by SIRT6383,384.
Following strand invasion and second end capture, the double Holliday junction
can either be dissolved by the BLM/Top3/Rmi complex or resolved by a number of
structure-specific endonucleases. Resolvase activity has been attributed to Mus81,
GEN1/YEN1, and SLX1-SLX4313,322,328,331,332,385. GEN1/YEN1 behaves similar to classical
bacterial resolvases that incise symmetrically on opposite sides of the four-way junction,
while Mus81 cleaves asymmetrically313,322,328. The differential contributions of the
different nucleases to dHJ resolution in vivo are not easily explained by their in vitro
activities. Depletion of SLX1-SLX4 or GEN1 in human cells compromises repair in
response to the interstrand crosslink inducing agent mitomycin C and camptothecin,
while depletion of Mus81 has little effect385. In BLM-deficient human cells that exhibit
increased sister-chromatid exchanges, it appears that Mus81 and SLX1-SLX4 have a
significant role in the resolving double Holliday junctions, while the role of GEN1/YEN1
appears to become important when either Mus81 or SLX1-SLX4 is depleted386. The
relative contribution of these nucleases in vivo may depend on other interacting factors
that are important for their recruitment to HJs.

Interstrand crosslink repair
The interstrand crosslink repair pathway responds to crosslinks that can occur
between complementary strands of DNA treated with various chemical agents, including
mitomycin C (MMC) and cisplatin. Compared to the other repair pathways described in
this section, ICL repair is less well-understood.
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Replication-coupled ICL repair is

thought to be the dominant pathway and its mechanism has been elucidated through in
vitro systems reconstituted with Xenopus egg extracts387. The recognition of interstrand
crosslinks during replication involves the NER factor ERCC1-XPF. Incisions are made
flanking the break site387. A multiprotein complex composed of members of the FANC
complementation group localizes to the site and is required for processing that results in a
one-ended DSB, which is presumably repaired by HDR387. ICL repair thus requires the
nucleases that perform incisions surrounding the lesions as well as nucleases involved in
HDR.

Recently, the novel nuclease FAN1 and the human orthologs of the yeast

Slx1/Slx4 complex have been implicated in ICL repair, though the steps at which they act
are not well elucidated388-391.

Known telomeric roles of nucleases
A number of mammalian nucleases have been documented to contribute to
telomeric function, though it has often been difficult to distinguish between global repair
functions and telomere-specific roles. Telomere-related phenotypes reported in cells
deficient for various repair factors can sometimes be nonspecific, such as in the case of
Artemis deficiency, where telomere fusions have been reported to occur at a very low
frequency. Nucleases that interact with shelterin may likely have important telomeric
functions. However, the absence of detectable telomeric localization of a candidate
nuclease does not preclude a telomeric role. Telomere end-processing may involve only
transient telomeric localization of nucleases and is not expected to occur synchronously
at all telomeres in a cell. Thus, cases in which compromised nuclease function has
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produced aberrant telomere phenotypes warrant a re-evaluation of the telomeric
overhang.
Nucleases known to interact with shelterin include Apollo/SNM1b, Mre11,
XPF/ERCC4, FEN1, and Mus81. The interaction between SLX4 and TRF2 may also
mediate the localization of additional nucleases to telomeres.

Human Apollo was

identified as a member of the TRF2/Rap1 complex by mass spectrometry51,52. Though the
inability to generate an adequate antibody has precluded the detection of endogenous
Apollo, exogenously expressed Apollo appears to colocalize with a subset of telomeres5153

. A C-terminal YxLxP motif in Apollo interacts with the TRFH domain of TRF244.

This interaction is abolished by mutating phenylalanine 120 of TRF2 or by deleting the
YxLxP motif of Apollo44. Depletion of Apollo by shRNA in human cells results in a
transient DNA damage response in S phase cells and the appearance of multiple
telomeric FISH signals at a low percentage (<5%) of chromosome ends in metaphase51.
These results suggested a role for Apollo in telomere replication. Recent evidence has
indicated that human TRF2/Apollo may have a role in the replication of interstitial
telomeric sequences, though no such role has been ascribed in mouse217.
The interaction of the MRN complex with TRF2 in human cells is also suggestive
of a role during telomere replication. The association of Nbs1 with telomeres appears
specific to S phase cells, while the other components of the complex, Mre11 and Rad50,
localize to telomeres throughout interphase49. Depleting MRN components transiently
reduces the overhang by ~20-30 nt in telomerase-positive human cells but not in
telomerase-negative settings, thus MRN was proposed to have a role in modulation
telomerase action at human telomeres262. In mouse cells, compromising MRN function
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does not lead to any telomere-specific phenotypes, suggesting that the complex is not
absolutely required for telomere function and that other factors may act redundantly194.
Only in the absence of TRF2 does the MRN complex appear to have a function in
promoting NHEJ in G1 and generating the overhang at leading ends in S phase194,195.
A telomeric role for FEN1 has been described, but the challenge is in dissociating
this function from its general role in lagging strand DNA replication. Depletion of FEN1
in human cells results in a low level of γ-H2AX detected in telomeric ChIP and loss of
lagging-end telomeres on metaphase54. FEN1 appears to contribute to the stability of the
telomeric replication fork while not being essential for general S phase progression54. On
the other hand, depleting FEN1 in mouse cells does not result in phenotypes associated
with fork instability, but results in a low level of fusions between newly-synthesized
lagging-end telomeres392. Though this role of FEN1 required its nuclease activity, its
depletion had no apparent effect on the telomeric overhang392.
The telomeric roles of other shelterin-associated nucleases make them less likely
candidates for physiologic overhang generation. XPF/ERCC1 has been proposed to
protect telomere from recombining with interstitial (TTAGGG) repeats50. Human cells
depleted for XPF or ERCC1-deficient mouse cells do not have reduced overhangs50.
However, XPF/ERCC1 is involved in the removal of 3’ overhangs and subsequent NHEJ
when TRF2 is inhibited in human cells50. In mouse, other nucleases can perform this
role393.
Mus81 interacts with TRF2 specifically in human telomerase-negative ALT cells,
and localizes to telomeres by ChIP, an association that could not be detected in non-ALT
immortalized human cell lines299. In this setting, the interaction between TRF2 and
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Mus81 was found to inhibit the in vitro nuclease activity299. These findings support a
function for Mus81 at telomeres specifically in ALT cells.
Finally, though Exonuclease 1 has not been documented to interact with shelterin
components, its deficiency ameliorates the organ dysfunction associated in late
generations of mice lacking the telomerase RNA component394. This was attributed to the
role of Exo1-mediated resection in the DNA damage response to dysfunctional telomeres,
rather than a direct function of Exo1 in altering telomere structure394. Nonetheless, subtle
effects of Exo1 deficiency on telomere structure or function may have been missed in the
gross characterizations performed in this study that focused largely on in vivo
phenotypes.

PART III: OBJECTIVES
The objective of this thesis was to elucidate the mechanism by which the singlestranded 3’ overhang at the telomere terminus is generated and regulated.

First, I

examined the chromatin structure of the telomere terminus through a combination of
conventional micrococcal nuclease digestion and a novel assay to determine the
chromatin organization adjacent to the telomeric overhang (Chapter 2 and

395

). These

assays were also used to determine whether terminal chromatin organization is altered at
deprotected telomeres. Next, I identified a role for the TRF2-associated nuclease Apollo
in the generation of overhangs at telomeres synthesized by leading strand DNA
replication in mouse cells (Chapter 3 and

396

). Through subsequent studies on the

mechanism by which POT1b limits overhang size at mouse telomeres, I determined that
POT1b inhibits 5’ resection by Apollo while promoting the function of the mammalian
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Ctc1/Stn1/Ten1 complex (Chapter 4). Finally, to identify additional nucleases that might
contribute to overhang generation, I tested the hypothesis that telomeres are transiently
recognized as sites of DNA damage and processed by the same factors that perform
resection at a DNA double strand break (Chapter 5). Through these studies, I uncovered
a role for Exonuclease 1 in the generation of transiently extended telomeric overhangs in
late S phase. However, the processing of telomeres by Exonuclease 1 did not appear to
recapitulate previously proposed models for resection at a DNA double strand break, and
the mechanism by which Exo1 is recruited to telomeres remains unknown.
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CHAPTER 2:
THE TERMINAL CHROMATIN ORGANIZATION
OF MAMMALIAN TELOMERES

	
  

52

INTRODUCTION
Whereas the telomeric overhangs in yeast and ciliates are protected by endbinding proteins arranged in non-nucleosomal complexes58-60 the results of electron
microscopy and micrococcal nuclease (MNase) digestion studies have demonstrated the
presence of nucleosomes at telomeres in a number of vertebrates12,15,56,57. The chromatin
organization of the telomere terminus could be one way by which changes in the state of
telomere protection are signaled to the DNA damage response machinery.
The cellular machinery that responds to DNA damage executes its functions
within the context of chromatin, and several studies have suggested that chromatin
remodeling and modifications contribute to the recognition and repair of DSBs.
Chromatin decondensation at DSBs has been suggested to occur in living cells subjected
to DNA damaging agents, and such conformational changes have been proposed to
activate the ATM kinase397,398. In addition, nucleosome loss has been observed at sites of
induced DSBs in several model systems. In yeast, the induction of a single DSB by HOendonuclease leads to histone displacement that depends on the DNA damage sensor
MRX and the chromatin remodeling complex, INO80399,400. In human cells, break sites
introduced by the I-PpoI nuclease exhibit nucleosome disruption that requires NBS1 and
ATM401. Furthermore, several steps in NHEJ or HDR are stimulated by one or more of
the three major ATP-dependent chromatin remodeling complexes, INO80, Swi/Snf, and
RSC399,402-406.
Given that telomere dysfunction activates the canonical response to DSBs,
exploring the role of chromatin remodeling at damaged telomeres may lend insight into
the mechanisms by which shelterin protects telomeres from being recognized as DNA
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damage.

Here, I investigated the terminal chromatin organization of native and

deprotected telomeres to determine whether the DNA damage signaling and repair
processes at damaged telomeres involve chromatin remodeling at the terminus.
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RESULTS
The telomere terminus has a nucleosomal organization similar to bulk telomeres
A standard method to examine nucleosomal organization involves the partial
digesting of chromatin in nuclei with micrococcal nuclease (MNase), after which
fractionation of the DNA on agarose gels results in a periodic ladder of fragments
corresponding

to

the

mononucleosomes,

dinucleosomes,

and

higher

order

oligonucleosomes407. Genomic loci of interest, such as telomeres, can be detected after
Southern blot and hybridization with a specific probe.
I devised a novel method for detecting the nucleosomal organization at the
telomere terminus based on the fact that mammalian telomeres end in a 30-500 nt singlestranded tract of TTAGGG repeats, termed the 3’ overhang5,6,260,408. Although the 3’
overhang is removed from telomeres undergoing NHEJ, the single-stranded TTAGGG
repeats are retained when TRF2 is deleted from DNA ligase IV-deficient cells193 and also
persist in POT1-deficient cells37. Therefore, the last nucleosome of the dysfunctional
telomeres in these settings is expected to be adjacent to the 3’ overhang, and an assay
detecting chromatin organization of the terminus can be used to determine whether
telomere deprotection induces changes in the terminal chromatin structure.
A concern with using the 3’ overhang as a marker for the last nucleosome is that
MNase is known to rapidly degrade single-stranded DNA409. Indeed, when agaroseembedded protein-free genomic DNA was digested with MNase, the single-stranded
overhang signal decreased rapidly and at a much faster rate than the total TTAGGG
signal representing the duplex telomeric repeats (Figure 2.1A). In contrast, the telomeric
overhang remains largely intact during the MNase treatment of nuclei from wild type
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cells, as well as in nuclei lacking POT1a and –b (Figure 2.1B), indicating that the singlestranded DNA is protected from the nuclease. As discussed below, this protection could
be due to strand-invasion of the 3’ overhang in the t-loop configuration and/or coating
with POT1a and -b.

Figure 2.1. The single-stranded telomeric overhang is protected in chromatin from MNase digestion.
In gel overhang assay of DNA fragments recovered from MNase digestion of (A) agarose-embedded
genomic DNA and (B) nuclei from POT1aS/F POT1bS/F cells infected with pWzl vector (left panel) or pWzlCre (right panel) at 5 days post-selection with hygromycin. MNase concentrations are given as U/mL.
Agarose plugs were digested overnight with MboI and fractionated on a 1% agarose gel in 0.5x TBE by
pulse field electrophoresis. Fragments in solution were treated with AluI/MboI and fractionated on a 0.7%
agarose gel. Gels were dried by vacuum suction and hybridized with [32P](CCCTAA)4. The gel was
denatured in situ and rehybridized with the same probe. The relative G-strand signal in the native gel was
normalized to the total telomeric signal detected in the denatured gel. The numbers below each lane
correspond to the ratio relative to the value in the first lane of that panel. n.a.: not applicable. The relative
overhang signal at [MNase] = 80 U/mL in (B) was not quantified because the duplex signal was at
background level making the ratio between ss overhang signal and duplex TTAGGG repeats unreliable.

	
  
The resistance of the telomeric overhang to MNase digestion of chromatin in
nuclei suggested that it should be possible to detect the most terminal nucleosome
abutting the 3’ overhang. However, the standard method of detecting DNA fragments
bearing a 3’ overhang – in-gel hybridization to native DNA – is not applicable to
fragments smaller than ~500 bp due to their loss during the gel-drying step required for
this protocol.

I therefore developed an alternative method of detecting the MNase

product representing the last nucleosome next to the single-stranded TTAGGG repeats
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(Figure 2.2A). Biotinylated oligonucleotides complementary to the 3’ overhang were
annealed to the DNA fragments recovered from MNase-treated nuclei; the last
nucleosomal fragments could then be precipitated with streptavidin beads. The DNA
fragments in the supernatant and precipitate were fractionated on an agarose gel,
transferred onto a nitrocellulose membrane, and the telomeric signal was detected with a
[32P](CCCTAA)4 probe.
To verify that this assay could efficiently isolate telomeric fragments containing a
G-rich overhang, I constructed a model telomeric fragment by annealing and ligating a
BglII/KpnI restriction fragment (dsTel) excised from a plasmid with 25 tandem
TTAGGG

repeats

(pSXneo.25T2AG3)410

to

a

single-stranded

(TTAGGG)12

oligonucleotide (ssTelG) containing a BglII protrusion at the 5’ end (Figure 2.2B). When
the products of the ligation reaction were detected by Southern blot for telomeric signal,
the major product was a 270 to 280 bp fragment that was absent when either dsTel or
ssTelG was excluded from the reaction (Figure 2.2C).

When this model telomeric

fragment was annealed to biotin-(CCCTAA)6 and isolated with streptavidin beads, nearly
all of the DNA was pulled down (Figure 2.2D). On the other hand, dsTel lacking the 3’
overhang remained in the supernatant, confirming that only the fragments containing a Grich overhang can be isolated by the assay.
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Figure 2.2. Assay to detect nucleosomes near the telomere terminus. (A) Scheme of the last nucleosome
assay. Nuclei are treated with MNase and the isolated DNA fragments are incubated with a biotinylated
oligonucleotide representing the C-rich telomeric DNA strand, biotin-(CCCTAA)6. Magnetic streptavidin
beads are used to pull down DNA fragments containing a telomeric [TTAGGG]n 3’ overhang. The
supernatant contains fragments of bulk nucleosomes while the pull down contains nucleosomal fragments
ending at the telomere terminus. Fragments were fractionated on a 1% agarose gel and subjected to
southern blot hybridization with a [32P](CCCTAA)4 probe. (B) Scheme for the construction of a model
telomeric fragment to test the last nucleosome assay. A BglII/KpnI fragment excised from
pSXneo.25(T2AG3) (dsTel) was annealed and ligated to a single stranded telomeric oligonucleotide (ssTel)
containing the complementary BglII recognition sequence at its 5’ end. (C) Southern blot detection of the
telomeric signal ligation products of dsTel and ssTel (lane 1), dsTel only (lane 2), or ssTel only (lane 3).
(D) Southern blot detection of the telomeric signal after annealing the DNA products from lanes 1 and 2 in
(C) with biotin-(CCCTAA)6 and separating the supernatant (sup) and pull-down (ppt) following incubation
with streptavidin beads. 2% of the supernatant was loaded next to 50% of the total pulldown. (E) Detection
of the telomeric signal associated with the last nucleosomes in wild type MEFs. The last nucleosomal assay
was performed as described, and the supernatant (2% of total fraction) containing the bulk nucleosomes
were loaded in the first eight lanes, while nucleosomal fragments containing the telomeric overhang (50%
of total pulldown) were loaded in the last eight lanes. MNase concentrations are given as U/ml. (F)
Detection of the telomeric signal pulled down by the last nucleosomal assay following ExoI treatment of
DNA from MNase-digested nuclei. DNA fragments isolated after MNase digestion were mixed and treated
with ExoI (300 U in 300 μl), removing the 3’ overhang. ExoI-treated and untreated samples were then
subjected to the last nucleosome assay. 2% of the supernatant (bulk nucleosomes) was loaded next to 50%
of the total pull down (last nucleosomes). Percent of total TTAGGG signal pulled down was calculated by
the equation: (2 x pulled down signal) / (2 x pulled down signal + 50 x supernatant signal).
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I tested this assay for nucleosomes associated with the 3’ overhang in wild type
cells. The pattern of MNase digestion at the terminus largely resembled that of bulk
telomeric chromatin (Figure 2.2E).
nucleosomes could be visualized.

Partially digested oligomers of up to 7-8

Quantitatively, after normalizing for the relative

volumes loaded, the signal intensity of the DNA associated with the last nucleosome
accounted for approximately 2 to 4% of the total telomeric signal at low MNase
concentrations (Figure 2.3B) when the median size of the MNase products is ~0.9 kb. A
maximal yield of ~3% is expected upon isolation of the terminal fragments from a 30 kb
telomere digested into fragments of 1 kb. The observed yield in the last nucleosome assay
is therefore within the expected range.
The results of additional control experiments confirmed the specificity of the
assay for the 3’ overhang. When DNA fragments recovered from MNase digestion were
treated with the E. coli 3’ to 5’ exonuclease ExoI prior to annealing with the biotinylated
oligonucleotide, the percentage of total telomeric signal pulled down by the assay
decreased by 50 to 70% (Figure 2.2F). Furthermore, when the assay was performed with
a biotin-(TTAGGG)6 oligonucleotide instead of the C-rich oligonucleotide, and the
telomeric signal was probed with [32P](TTAGGG)4, no telomeric signal was detected in
the pull down.
Finally, I applied the last nucleosome assay to a setting in which telomeres
become fused and are therefore expected to lose their 3’ overhang. For this control, I used
Cre-mediated deletion of TRF2 from DNA ligase IV proficient cells, focusing on a late
time point when ~30% of chromosome ends have undergone NHEJ193. TRF2 deletion
from these cells resulted in a 20 to 40% reduction in the percentage of total telomeric
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signal pulled down in the last nucleosome assay compared to the percentage for the
control (Figure 2.3A-B). The difference between Cre-infected cells and the controls
became less pronounced with increasing MNase concentration (Figure 2.3B), suggesting
that the optimal range for interpreting results from the last nucleosome assay was at
MNase concentrations less than 80 U/ml.

Figure 2.3. Telomere fusion reduces the signal in the last nucleosome assay. (A) MNase sensitivity of
bulk and last telomeric nucleosomes assessed by the last nucleosomal assay, performed as previously
described in TRF2F/-p53-/-Lig4+/+ cells not infected with Cre (top) or at 120 hrs following Cre-mediated
TRF2 deletion (bottom). MNase concentrations are given as U/ml. (B) Quantitation of the percentage of
total TTAGGG signal pulled down in (A).

Deletion of TRF2 does not disrupt the organization of telomeric chromatin or result
in overt nucleosome eviction
To explore the possibility of chromatin remodeling at telomeres in the setting of
ATM kinase activation, I first examined bulk telomeric nucleosomes following Cremediated deletion of TRF2 in TRF2F/-p53-/-Lig4-/- MEFs. Due to the absence of p53 and
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DNA ligase IV, these cells do not undergo cell cycle arrest nor do they accumulate
telomeric fusions, thus allowing the assessment of the nucleosomal organization of free
dysfunctional telomeres.

Nucleosomal chromatin was examined in this and other

experiments by digesting nuclei with MNase. Cells were harvested at 90 hr after Cre
infection, and immunoblots confirmed the loss of TRF2 and its interacting partner Rap1
(Figure 2.4A). Furthermore, as expected, the cells showed evidence of ATM kinase
signaling based on the phosphorylation of Chk2 (Figure 2.4A).
Nuclei from these cells lacking TRF2 were digested with MNase, and the
resulting DNA products were fractionated on agarose gels to visualize bulk and telomeric
chromatin fragments. The deletion of TRF2 resulted in no obvious change in the MNase
sensitivity of bulk nucleosomes, as seen by the results of ethidium bromide staining
(Figure 2.4B). In cells with and without TRF2, MNase digestion generated the typical
nucleosomal ladder with regular periodicity.

DNA fragments representing partial

digestion products of up to 7-8 nucleosomes were seen at low MNase concentrations. In
comparison to bulk nucleosomes, telomeric nucleosomes showed a more diffuse ladder of
oligonucleosomes (Figure 2.4C), as reported previously57. However, when wild type and
TRF2-deficient cells were compared, no obvious difference in the sensitivity of telomeric
chromatin to MNase was observed. The telomeric chromatin maintained the same
nucleosomal periodicity in the presence and absence of TRF2. Furthermore, in both
cases, the formation of partial products correlated similarly with the MNase
concentration, suggesting no difference in the rate of MNase digestion of the
dysfunctional telomeres.
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Figure 2.4. No disruption of telomeric chromatin after TRF2 depletion. (A) Immunoblot confirming
loss of TRF2 and Rap1, and phosphorylation of Chk2 at 90h after retroviral-mediated Hit&Run-Cre
expression in TRF2F/-p53-/-Lig4-/- MEFs. The non-specific band on the TRF2 blot served as a loading
control. (B) Bulk nucleosomes in cells with and without TRF2 detected by ethidium bromide staining of
DNA from nuclei digested with MNase and fractionated on a 1% agarose gel. (C) Telomeric nucleosomes
detected by Southern blot hybridization with a [32P](CCCTAA)4 probe. Roman numerals represent
oligonucleosomes formed by partial digestion. (D) Immunoblot for γ -H2AX, confirming activation of
DNA damage signaling after 6 h shift of TRF2ts cells from the permissive temperature (32°C) to the nonpermissive temperature (37°C). γ-tubulin is shown as a loading control. (E) Bulk nucleosomes in cells with
and without TRF2 detected by ethidium bromide staining of DNA from nuclei digested with MNase and
electrophoresed on a 1% agarose gel. (F) Telomeric nucleosomes detected by Southern blot hybridization
with a [32P](CCCTAA)4 probe. MNase concentrations are given as U/ml. Roman numerals represent
oligonucleosomes formed by partial digestion.

	
  

While Cre-mediated deletion of TRF2 requires several days before the
consequences of telomere dysfunction can be assayed, a recently characterized
temperature-sensitive allele of TRF2 allowed me to examine chromatin organization
within a shorter time frame after telomere deprotection197. The TRF2ts allele has a point
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mutation in the Myb/SANT DNA binding domain (I468A in mouse TRF2) that affects
the ability of TRF2 to stably associate with telomeric DNA at the non-permissive
temperature. A DNA ligase IV-deficient cell line carrying TRF2ts was generated by
expressing the mouse TRF2ts allele in TRF2F/-p53-/-Lig4-/- MEFs and removing the
endogenous TRF2 through Cre-mediated deletion197. These cells retain telomere
protection at 32°C, while incubation at 37°C dislodges TRF2ts from telomeres, leading to
a telomere damage response within hours. I compared the MNase sensitivity of telomeric
chromatin in TRF2ts cells growing at 32°C to that of cells shifted to 37°C for 3 or 6 h.
Immunoblotting confirmed that the temperature shift induced γ-H2AX at 6 h (Figure
2.4D). Consistent with the data obtained after Cre-mediated deletion of TRF2, the
MNase digestion patterns of telomeric chromatin remained unchanged within 3-6 h after
removal of TRF2ts from telomeres (Figure 2.4E-F). Thus, there is no overt alteration in
the nucleosomal structure of dysfunctional telomeres despite ongoing ATM kinase
signaling.
Since the 3’ overhang remains intact following deletion of TRF2 in cells deficient
for DNA ligase IV193, the assay for the last nucleosome could be used to examine whether
terminal nucleosomes are evicted following telomere deprotection in this setting. Thus, I
isolated the DNA fragments associated with the last nucleosome in TRF2F/-p53-/-Lig4-/MEFs infected with Cre. Whereas degradation of the overhang would decrease the yield
of the terminal DNA, thereby reducing the signal intensity of the ladder representing the
last nucleosomes, Iobserved no change in the signal intensity of last nucleosomal DNA
from cells infected with Cre compared to those that were uninfected (Figure 2.5A). Upon
longer exposure, the signal due to the last nucleosome appeared similar with and without
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TRF2 and quantification indicated a comparable percentage of total telomeric signal
pulled down by the assay in both cases (Figure 2.5B). Furthermore, no significant shift in
the last nucleosome was observed, further supporting the absence of nucleosome eviction
from telomere ends lacking TRF2.
I further assayed the MNase sensitivity of the last nucleosome following telomere
deprotection in the TRF2ts system. After 6 h of incubation at 37°C, there was no change
in the MNase digestion pattern in the last nucleosome compared to that in cells
maintained at the permissive temperature (Figure 2.5C). The relative telomeric signal
pulled down by the assay also remained roughly similar before and after removal of
TRF2 (Figure 2.5D).

Deletion of POT1a and –b leads to increased MNase susceptibility of the overhang,
but no overt nucleosome eviction
Next, I evaluated nucleosomal organization at telomeres deprotected by POT1
deletion to determine whether chromatin remodeling accompanies activation of the ATR
kinase. The introduction of Cre into POT1aSTOP/FLOXPOT1bSTOP/FLOX MEFs resulted in the
expected loss of both POT1a and POT1b proteins, as confirmed by immunoblots (Figure
2.6A). The loss of the POT1 proteins did not affect the MNase sensitivity of the bulk
nucleosomes (Figure 2.6B) or the telomeric nucleosomes (Figure 2.6B-C). Furthermore,
similar to the result with TRF2, deletion of both POT1 genes or either POT1a or POT1b
alone also did not lead to an obvious change in MNase digestion patterns (Figure 2.6DE).
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Figure 2.5. No eviction of terminal nucleosomes following TRF2 depletion. MNase sensitivity of bulk
and last telomeric nucleosomes assessed by the last nucleosomal assay in (A) TRF2F/-p53-/-Lig4-/- cells not
infected with Cre (left) or at 90 hrs following Cre-mediated TRF2 deletion (right) and (C) TRF2ts cells at
32°C (left) or after 6 hours of incubation at 37°C (right). MNase concentrations are given as U/ml. Roman
numerals represent oligonucleosomes formed by partial digestion. (B) and (D) Longer exposure of the
telomere blots for the last nucleosome assay in TRF2-deficient cells by Cre-mediated deletion or
temperature shift, respectively, with 4% of total supernatant and 100% of total pull down loaded onto the
gel. Quantitation of the percentage of total TTAGGG signal pulled down is provided below the blot.
Percent of total TTAGGG signal pulled down was calculated by the equation: (pulled down signal) /
(pulled down signal + 25 x supernatant signal).	
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I next determined whether the DNA damage response associated with POT1
deficiency involves nucleosome eviction from the chromosome end. Although POT1
DKO cells show a two- to three-fold excess of single-stranded overhang signal, the
amount of single-stranded telomeric signal in the fragments recovered after MNase
digestion was comparable to that from control cells following the same treatment (Figure
2.1B).

This suggested that MNase digestion of POT1 DKO nuclei led to some

degradation of the excess single-stranded DNA, although the last nucleosome assay could
still be used to detect chromatin organization at the telomere ends with intact overhangs.
I used the last nucleosome assay to compare the MNase digestion pattern of the
last nucleosomes in Cre-infected POT1aSTOP/FLOXPOT1bSTOP/FLOX cells to that in vectorinfected control cells. First, I found that the percentage of total telomeric signal pulled
down in POT1 DKO cells was significantly less than that in control cells, corroborating
the data showing that some of the overhangs were degraded (Figure 2.7A). However,
POT1 deletion did not significantly alter the MNase pattern of the detectable last
nucleosomes (Figure 2.7B). Partial digestion products representing 6 to 7 nucleosomes
from the chromosome end were seen in cells with and without POT1a and -b.
Furthermore, deletion of either POT1a or POT1b alone also did not affect the MNase
digestion pattern of the terminal nucleosomes (Figure 2.7C,E). In addition, deletion of
POT1b led to no change in the fraction of last nucleosomal fragments pulled down in the
assay (Figure 2.7D,F).

On the other hand, deletion of POT1a alone resulted in a

reduction in the percentage of total telomeric signal pulled down, suggesting some
degradation of the single-stranded overhang by MNase (Figure 2.7E-F).
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Figure 2.6. No disruption of telomeric chromatin after deletion of POT1a and POT1b. (A)
Immunoblot confirming deletion of POT1a and POT1b after retroviral infection of POT1aS/FPOT1bS/F cells
with pWzl-Cre followed by 5 days selection with hygromycin. γ-tubulin is shown as a loading control. (B)
Bulk nucleosomes in cells with and without POT1a and -b detected by ethidium bromide staining of DNA
from nuclei digested with MNase and fractionated on 1% agarose gels. (C) Telomeric nucleosomes
detected by Southern blot hybridization with a [32P](CCCTAA)4 probe. Roman numerals represent
oligonucleosomes formed by partial digestion. Southern blot detection of telomeric nucleosomes by
hybridization of a [32P](CCCTAA)4 probe to DNA fragments isolated and fractionated following MNase
digestion of nuclei in (D) POT1aS/F cells infected with pWzl vector or pWzl-Cre at 5 days post-selection
with hygromycin and (E) POT1bS/F cells infected with pWzl vector or pWzl-Cre at 5 days post-selection
with hygromycin. MNase concentrations are given as U/mL. Roman numerals represent oligonucleosomes
formed by partial digestion.
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TRF2 deletion in Ku-deficient cells does not affect nucleosome organization, while
deletion of POT1 and Ku leads to increased MNase susceptibility of the overhang.
Since nucleosome displacement appears particularly important in DSB repair by
homology directed repair399,400,402, I further explored the possibility that nucleosome
eviction occurs in the absence of factors that protect telomeres from HDR.
Recombination between sister telomeres is frequent in cells that lack both Ku70 and
TRF2198 and increased T-SCEs have been observed in cells triply deficient in Ku70, and
both POT1a and POT1b39. Therefore, I examined the MNase digestion pattern of bulk
telomeric chromatin as well as that of the last nucleosomes, in cells deficient in Ku70 and
either TRF2 or POT1a and -b. Ku70 deficiency alone led to a typical MNase digestion
pattern of the bulk and last nucleosomes (Figure 2.8A and C, left panels). Further
removal of TRF2 did not alter the MNase digestion pattern of either the bulk telomeric
chromatin or terminal nucleosomes (Figure 2.8A, right panel). Furthermore, there was no
change in the signal intensity of the MNase digestion ladder for the last nucleosomes,
indicating no degradation of the overhang (Figure 2.8B). On the other hand, deletion of
POT1a and -b in Ku deficient cells did not affect the MNase digestion pattern of the
telomeric nucleosomes but reduced the percentage of total telomeric signal that could be
isolated with the last nucleosome assay, suggesting an increased susceptibility of the
overhang to MNase (Figure 2.8C-D). The results seen in the absence of POT1 and Ku
appeared similar to those observed with POT1 deletion alone.
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Figure 2.7. No eviction of terminal nucleosomes following POT1a and POT1b deletion. MNase
sensitivity of bulk and last telomeric nucleosomes assessed by the last nucleosomal assay in (A) POT1aS/F
POT1bS/F cells infected with pWzl vector (left) or pWzl-Cre (right) at 5 days post-selection with
hygromycin. MNase concentrations are given as U/ml. MNase sensitivity of bulk and last telomeric
nucleosomes assessed by the last nucleosomal assay in (A) POT1aS/F cells infected with pWzl vector (left)
or pWzl-Cre (right) at 5 days post-selection with hygromycin and C) POT1bS/F cells infected with pWzl
vector (left) or pWzl-Cre (right) at 5 days post-selection with hygromycin. MNase concentrations are
given as U/mL. Roman numerals represent oligonucleosomes formed by partial digestion. (B) and (D)
Longer exposure of the telomere blots for the last nucleosome assay in POT1a and POT1b deleted cells,
respectively, with 4% of total supernatant and 100% of total pull down loaded onto the gel. Quantitation of
the percentage of total TTAGGG signal pulled down is provided below the blot. Roman numerals represent
oligonucleosomes formed by partial digestion. (B) Longer exposure of the telomere blots for the last
nucleosome assay in POT1-deleted cells, respectively, with 4% of total supernatant and 100% of total pull
down loaded onto the gel. Quantitation of the percentage of total TTAGGG signal pulled down is provided
below the blot. Percent of total TTAGGG signal pulled down was calculated by the equation: (pulled down
signal) / (pulled down signal + 25 x supernatant signal).
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SUMMARY OF FINDINGS
The results described in this chapter suggest that the telomeric terminus in
mammalian cells is organized in a protected chromatin state that resists digestion when
nuclei are treated with MNase. I found that MNase treatment left the single-stranded
overhang largely intact in wild type and TRF2-deficient cells but led to some degradation
following deletion of POT1a or POT1a and –b. The absence of the NHEJ factor Ku70 did
not affect the protection of the overhang from MNase. As MNase rapidly degrades the
single-stranded telomeric DNA in naked DNA, the results suggest that POT1 proteins, in
particular POT1a, block MNase from digesting the telomeric overhang in chromatin.
Nevertheless, even in POT1a-deficient cells, DNA fragments recovered after MNase
digestion retained a significant fraction of the overhang, suggesting an alternative mode
of protection, potentially involved other single-stranded DNA binding proteins, such as
replication protein A, or the strand invasion of the overhang into duplex telomeric DNA
as it occurs in the t-loop.
My results revealed that the organization of terminal nucleosomes in wild type
cells resembles that of bulk telomeric chromatin. The results of previous work have
shown that short telomeres yield a more diffuse MNase pattern than long telomeres,
which led to the proposal that telomere ends may exhibit an unusual chromatin
organization that would appear more prominently in cells with short telomeres57.
However, this previous study did not examine the terminal telomeric chromatin directly.
Alternative explanations for the altered chromatin of short telomeres may be a difference
in shelterin loading or a change in the histone modification state of shorter versus longer
telomeres61-63.
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Figure 2.8. No eviction of terminal nucleosomes in cells doubly deficient for Ku70 and TRF2 or
POT1a and -b. MNase sensitivity of bulk and last telomeric nucleosomes in (A) TRF2F/-Ku-/- cells without
Cre infection (left) or at 96 hr after Cre-mediated TRF2 deletion (right) and (C) POT1aS/FPOT1bS/FKu-/cells not infected with Cre (left) or at 96 hr after Cre (right). MNase concentrations are given as U/ml.
Roman numerals represent oligonucleosomes formed by partial digestion. (B) and (D) High exposure of the
telomere blots for the last nucleosome assay in TRF2/Ku-deficient and POT1/Ku-deficient cells,
respectively, with 4% of total supernatant and 100% of total pull down loaded onto the gel. Quantitation of
the percentage of total TTAGGG signal pulled down is provided below the blot.

The results of my studies on cells with deprotected telomeres suggest that a
number of DNA damage signaling and repair pathways can occur at damaged telomeres
without detectable changes in the organization of the bulk telomeric chromatin or overt
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nucleosome eviction. The absence of any observable change in the sensitivity of
telomeric chromatin to MNase following the conditional deletion of shelterin components
demonstrates that damaged telomeres retain their nucleosomal organization while
eliciting an ongoing DNA damage signal. Specifically, since no overt chromatin
remodeling occurs at either bulk or terminal telomeric nucleosomes at timepoints when
TIFs have previously been observed37,193, the maintenance of the DNA damage signal at
dysfunctional telomeres, as evident from the phosphorylation of H2AX and the
recruitment of 53BP1, does not appear to require persistent nucleosome eviction.
Importantly, my work contributes to an understanding of the mechanisms by
which the sensing of DNA damage and subsequent activation of ATM signaling occur at
dysfunctional telomeres. The Mre11/Rad50/Nbs1 complex has been implicated as a DNA
damage sensor that promotes ATM activity142, but the molecular event sensed by the
Mre11 complex remains undefined. It has been suggested that chromatin changes directly
activate ATM, based on the results of studies in which ATM activation occurred in the
presence of chromatin relaxation without DSBs397. In contrast, the absence of changes in
telomeric chromatin following the deletion of TRF2 excludes the requirement of
nucleosome eviction for DNA damage sensing and signaling by ATM at damaged
telomeres.
My results further suggest that signaling through the ATR pathway can also occur
without overt nucleosome eviction, since cells lacking POT1a and POT1b, which
accumulate ATR-dependent TIFs, maintain their nucleosomal organization at the
telomeres. In POT1a and –b DKO and POT1a knockout cells, MNase degraded some,
but not all, of the single-stranded overhang and hindered the isolation of the last
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nucleosomal DNA. Nonetheless, the assay retrieved a fraction of ends, whose chromatin
organization appeared unchanged following POT1 deletion. In cases where MNase
significantly degrades the single-stranded overhang, it remains a possibility that my assay
detects a subset of terminal nucleosomes that maintain protection and are not involved in
the DNA damage signaling or repair processes.
Finally, my results suggest that NHEJ and HDR at damaged telomeres do not
require nucleosome eviction, since the telomeric chromatin did not show obvious changes
in settings that make telomeres highly susceptible to these repair pathways.

It is

interesting that no chromatin rearrangements were observed under conditions where TSCEs occur, since nucleosome displacement has been posited to be particularly important
for HDR399,400,402.
What accounts for the finding that damaged telomeres do not appear to experience
nucleosome eviction whereas DSBs elsewhere in the genome undergo extensive
chromatin remodeling? One explanation may be that the kinetics of DNA damage
signaling and repair processes at damaged telomeres differ from those found in other
models of the response to DSBs. In my system, distinct steps in signaling by ATM or
ATR and in repair by NHEJ or HDR may indeed involve nucleosome displacement at
damaged telomeres, but may occur transiently or too early to be detected by these
methods. The results of my studies using the TRF2ts allele, which allows the assessment
of chromatin organization within a shorter time frame, argue against the likelihood of this
explanation, since I demonstrate the absence of nucleosome eviction as early as 3 to 6 h
after the removal of TRF2.

Alternatively, nucleosome rearrangement may not be

required at chromosome ends lacking TRF2 or POT1 because intrinsic properties of
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telomeric chromatin render it more accessible to DNA damage factors. For instance, the
shelterin component TRF1, which can bind telomeric DNA within a nucleosomal
context, has been shown to modulate nucleosome structure411. It is also interesting to
note that nucleosomes assembled on telomeric sequences under physiologic conditions
appear intrinsically more mobile than those assembled on average DNA412 and that the
telomeric core particles appear highly sensitive to nucleases. Perhaps these unusual
features of telomeric nucleosomes obviate the need for chromatin remodeling, permitting
access to DNA repair and signaling factors in the native telomeric chromatin state. Such a
model would be consistent with the view that numerous DNA repair factors are present at
telomeres, where they presumably act to promote the protective function of telomeres.
The finding that telomeric chromatin does not undergo remodeling in the presence
of a persistent and robust DNA damage signal has implications for how shelterin protects
the telomere. It has previously been proposed that shelterin may create an alternative
nucleosomal organization that prevents the end from being recognized as a DSB. My
findings argue against this possibility, as there appears to be no difference between the
organization of telomeric chromatin in protected and deprotected states. Nonetheless,
these results do not preclude contributions of chromatin remodeling and modifications to
shelterin function in other ways that remain to be elucidated.
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CHAPTER 3:
THE ROLE OF THE SHELTERIN-ASSOCIATED NUCLEASE APOLLO AT
TELOMERES SYNTHESIZED BY LEADING-STRAND DNA REPLICATION
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INTRODUCTION
In this chapter, I investigated the role of the TRF2-associated nuclease Apollo in
overhang generation. It had been previously proposed that TRF2 recruits a nuclease
required for overhang generation and protection of newly synthesized leading-end
telomeres194,195,204. Apollo was an attractive candidate based on previous work showing
that its depletion in human cells activates a DNA damage response at telomeres in S
phase51.
Apollo belongs to the mammalian SNM1/Pso2 family of nucleases, which also
includes SNM1A and Artemis/SNM1C.

SNM1A contributes to the repair of DNA

interstrand crosslinks (ICLs)413,414, lesions that block DNA replication and transcription
(reviewed in

415

). Similarly, knockdown of Apollo/SNM1B in human cells results in

hypersensitivity to ICL-inducing agents413,416. In contrast, Artemis/SNM1C functions as
an

endonuclease

to

remove

hairpins

from

coding

ends

during

V(D)J

recombination174,337,375 and has been suggested to contribute to HDR and NHEJ of a subset
of DSBs by removing structures that block repair reactions376,417,418. Apollo is the only
member of the SNM1/Pso2 family known to function as a shelterin accessory factor.
Here, the function of mouse Apollo was determined using Cre-mediated gene deletion,
complementation with Apollo mutants, and the TRF2-F120A mutant that cannot bind
Apollo.
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RESULTS
Conditional gene deletion of Apollo in mouse embryonic fibroblasts
A conditional gene deletion system was developed using gene targeting to modify
the mouse Apollo gene (Dclre1b, chr. 3), yielding a floxed allele (ApolloF) that contained
loxP Cre recombinase target sites flanking exons 2 and 3 (generated by S. Rooney, Figure
3.1A). Deletion of exons 2 and 3 is predicted to result in out-of-frame splicing of exon 1
to exon 4, interrupting the Apollo ORF at amino acid position 67. This strategy was
favored over conditional deletion of exon 1, which might affect the neighboring Ap4b1
gene (Figure 3.1A). ApolloF/F embryos (E13.5) derived from ApolloF/+ mouse intercrosses
were used to establish SV40 large T antigen (SV40-LT) immortalized MEFs. Transient
expression of Cre recombinase in these cells resulted in the expected deletion of the
Apollo gene and concomitant loss of the full-length Apollo mRNA whereas the Ap4b1
transcript was not affected (Figure 3.1B,C).
Cre treatment of ApolloF/F MEFs resulted in a slight proliferation defect that was
due to the absence of Apollo since it was largely rescued by expression of the wild type
protein (Figure 3.1D). The cell cycle profile of SV40-LT ApolloF/F MEFs showed an
elevated 4N peak due to a high basal level of tetraploid cells, which is a common
phenomenon in immortalized MEFs. Cre-mediated deletion of Apollo caused a slight
increase in tetraploid cells reflected in an increase in the 8N peak, but did not
significantly alter the cell cycle profile or S phase index, as measured by BrdU
incorporation (Figure 3.1E). Thus, deleting Apollo does not immediately block
proliferation of immortalized cells, allowing the evaluation of Apollo function in these
cells.
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Figure 3.1. Conditional gene deletion of mouse Apollo. (A) Targeting of the mouse Apollo locus. The
structure of the genomic locus, the targeting construct, the floxed allele and the deleted allele are shown.
loxP sites are represented as triangles; FRT sites surrounding the neo gene are shown as rectangles.
Approximate positions of the PCR primers for genomic analysis (F and R1 and R2) and RT-PCR mRNA
analysis (RTF and RTR) are shown. Restriction endonucleases and the probe used for analysis of genomic
DNA: B, BamHI, N, NsiI, Nh, NheI, P, PacI, S, ScaI. (B) Genotyping PCR for Apollo using DNA from
MEFs. (C) RT-PCR with two independent sets of primers for both Apollo and Ap4b1 using RNA purified
from cells treated with or without Cre. GAPDH was used as a control. (D) Growth curve of SV40LTimmortalized ApolloF/F MEFs expressing different Apollo alleles. Filled squares: vector (no cre). Open
squares: vector +Cre. Open circles: Apollo +Cre. Open diamonds: Apollo-ND +Cre. Open triangles:
ApolloΔTRF2 +Cre. (E) Cell cycle profile of SV40-LT ApolloF/F MEFs 120h after Cre. Cells were pulsed
for 30 minutes with BrdU, fixed, and stained with PI for DNA content and FITC-anti-BrdU to determine
%BrdU-positive cells.

Apollo mutants
An Apollo allele deficient for binding to telomeres (ApolloΔTRF2) was generated
to assess the telomere-specific functions of Apollo (M. van Overbeek, S. Rooney, Figure
3.2A-C). Despite a previous report documenting that Apollo is unstable when not bound
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to TRF2295, mouse ApolloΔTRF2 was expressed at the same level as the wild type protein
(Figure 3.2B). Deletion of the YLLTP TRF2 binding site abolished the interaction of
Apollo with TRF2 and generated a protein that was incapable of accumulating at
telomeres (Figure 3.2C-D).
Two nuclease-deficient alleles of Apollo were generated to evaluate whether the
function of Apollo depends on its nuclease activity. The Apollo-ND allele contained
mutations in the HxHxDH motif in the metallo β-lactamase domain as well as a highly
conserved histidine in the β-CASP domain (M. van Overbeek, S. Rooney, Figure 3.2AC). Both the HxHxDH motif and histidine 230 are conserved in Artemis and required for
the endonucleolytic activity of this closely-related SNM1 nuclease333,419,420. Consistent
with the preservation of the TRF2-interacting site in Apollo-ND, the nuclease-deficient
protein associated with TRF2 and localized to telomeres (Figure 3.2C-D). Based on IF
analysis (n>100 nuclei), both the wild type and Apollo-ND alleles were detectable at
approximately half the telomeres in the cells.

Since Apollo is not as abundant at

telomeres as the shelterin components, it is possible that both wild type Apollo and
Apollo-ND localize to all telomeres but escape detection because of their low abundance.
I generated an additional nuclease-deficient allele, ApolloΔ31-37, that removes the
HxHxDH motif in the metallo-β-lactamase domain and also contains the H230A
mutation. This mutant was expressed at similar levels as wild type Apollo and retained
its interaction with TRF2 (Figure 3.2E).
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Figure 3.2. Expression and localization of Apollo mutants. (A) Schematic of the mouse Apollo protein
indicating regions that are altered in Apollo rescue alleles. Amino acids in red indicate important residues
for nuclease activity and TRF2 interaction. (B) Immunoblotting analysis of ApolloF/F MEFs expressing the
indicated Apollo alleles in the absence of Cre and at 120h after Cre. Apollo is detected with the HA.11
antibody. (C) Immunofluorescence showing the localization of the indicated Apollo alleles (detected with
HA.11 Ab) in ApolloF/F MEFs at 72h after Cre infection. Telomeric loci are detected with Ab 644 to the
shelterin component TRF1. DNA is stained with DAPI. (D) Co-immunoprecipitation of Apollo and TRF2
alleles. 293T cells were transiently transfected with the indicated myc-tagged TRF2 alleles and FLAG[HA]2-tagged Apollo alleles and IPs were performed with the myc (9E10) antibody. Input (left) and IPs
(right) were analyzed by immunoblotting for tagged-Apollo (HA.11, top panels) and tagged-TRF2 (myc
9B11, bottom panels). (E) Co-immunoprecipitation of ApolloΔ31-37 and TRF2. 293T cells were cotransfected with myc-TRF2 and FLAG-[HA]2-tagged Apollo alleles. IPs were performed with the myc
(9E10) antibody. Input (left) and IPs (right) were analyzed by immunoblotting for tagged-Apollo (HA.11,
top panels) and tagged-TRF2 (myc 9B11, bottom panels).

	
  

82

The TRF2-F120A mutant
In an alternative approach to assess the role of Apollo at telomeres, I analyzed
MEFs expressing the mouse TRF2-F120A mutant (generated by S. Kabir) containing a
phenylalanine-to-alanine point mutation at amino acid 120, the conserved residue
required for the interaction between human TRF2 and Apollo44. Co-immunoprecipitation
of mouse Apollo and TRF2-F120A co-transfected in 293T cells confirmed that the
F120A mutation abolished the interaction between the proteins, as previously reported for
the human orthologs (Figure 3.2D).

Figure 3.3. The TRF2-F120A mutant localizes to telomeres and rescues the growth defect associated
with TRF2 deletion. (A) Immunoblot for TRF2 in TRF2F/-p53-/- MEFs expressing the indicated rescuing
alleles without Cre and at 144 hours after Hit&Run Cre. (B) IF showing localization of TRF2 alleles in
TRF2F/-p53-/- MEFs at 72h after Cre. TRF2 alleles are detected with the myc antibody 9B11. Telomeres are
detected with the TRF1 antibody #644. (C) Growth curve showing cumulative population doublings after
infection with Cre. Filled squares: vector (no Cre). Open squares: vector +Cre. Open circles: TRF2 +Cre.
Open triangles: TRF2-F120A +Cre.

	
  
TRF2-F120A or wild type TRF2 were introduced into TRF2F/-p53-/- MEFs and the
endogenous TRF2 was deleted with Cre. TRF2-F120A was overexpressed to the same
level as the exogenous wild type TRF2 (Figure 3.3A) and co-localized with TRF1 at
telomeres (Figure 3.3B). While cells lacking TRF2 exhibited a severe defect in
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proliferation, TRF2-F120A rescued this growth defect to a similar extent as wild type
TRF2 (Figure 3.3C). This result is consistent with the ability of TRF2-F120A to largely
suppress the ATM-mediated DNA damage response and frequent telomere fusions
associated with TRF2 deletion (discussed later).
	
  
TRF2-bound Apollo contributes to overhang generation at leading-end telomeres
To evaluate the role of Apollo in generating the proper terminal structure of
telomeres, I used native in-gel hybridization to detect the telomeric overhang in cells
lacking Apollo. At five days after Cre-mediated deletion of Apollo, I observed a 30-40%
reduction in the relative telomeric overhang signal (Figure 3.4A-B).

The overhang

phenotype was rescued by full-length wild type Apollo but not by ApolloΔTRF2 or
Apollo-ND (Figure 3.4A-B). Similar results were observed in cells expressing TRF2F120A in place of endogenous TRF2. When TRF2 is deleted in MEFs, the telomeric
overhang is lost due to extensive NHEJ-mediated chromosome fusions, which can be
visualized as a smear of high molecular weight signal in the denatured gel. Expression of
the TRF2-F120A mutant in TRF2-deficient cells suppressed the appearance of such
signals in the denatured gel.

However, the relative telomeric overhang signal was

approximately 30% less than in the presence of wild type TRF2 (Figure 3.4C-D). As will
be shown later, telomeric FISH on metaphase spreads further confirmed that TRF2F120A represses most of the telomere fusions resulting from TRF2 deletion (Figure
3.11C-E). Thus, the disproportionate loss in overhang signal cannot be ascribed to
processing by NHEJ; more likely, the diminished overhang signal in the TRF2-F120A
setting is due to the lack of recruitment of Apollo to telomeres.
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Figure 3.4. TRF2-bound Apollo maintains the telomeric overhang. (A) Representative telomeric
overhang analysis of ApolloF/F MEFs expressing the indicated rescuing alleles without Cre and 120 h after
pWzl-Cre infection. The single-stranded telomeric signal was determined by in-gel hybridization (left) of
an end-labeled 32P-(AACCCT)4 telomeric oligonucleotide to native MboI-digested genomic DNA. After
capture of the signal, the DNA was denatured in situ and the gel was rehybridized with the same probe to
determine the total telomeric DNA signal (right). The single-stranded telomeric signal between ~9-100kb in
each lane was normalized to the total telomeric DNA signal in the same region of that lane. (B)
Quantification of relative single-stranded telomeric overhang signal with ApolloF/F MEFs. Values represent
means for five independent experiments with SDs. (C) Representative telomeric overhang analysis of
TRF2F/-p53-/- MEFs expressing the indicated alleles without Cre and at 120h post Cre-infection, assayed as
in (A). (D) Quantification of relative single-stranded telomeric signal with TRF2F/-p53-/- MEFs. Values
represent means for three independent experiments with SDs. For each rescuing allele (or cells infected
with the empty vector) the normalized value was set at 100 for cells not treated with Cre and the post-Cre
values are given as a percentage of this value. p-values were determined using paired student t-test.

	
  
In the presence of telomerase, telomeric overhangs can be elongated transiently
due to the uncoupling of telomerase action, which occurs throughout S phase, and Cstrand fill-in, which is delayed until late S/G2260. To exclude the possibility that the
change in overhang signal was due to an effect of Apollo on telomerase, I generated
TRF2F/FmTR-/- MEFs in order to assess the phenotype of the TRF2-F120A mutant in a
telomerase-deficient setting. ApolloF/F mTR-/- MEFs could not be generated due to the
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proximity of the genes encoding Apollo and telomerase RNA on mouse chromosome 3.
Cre treatment of SV40-LT immortalized TRF2F/FmTR-/- MEFs expressing TRF2-F120A
resulted in a ~30% reduction in overhang signal (Figure 3.5A-D). This result indicates
that Apollo regulates the telomeric overhang in a manner independent of telomerase.

	
  
Figure 3.5. The overhang defect in cells expressing TRF2-F120A is independent of telomerase. (A)
Genotyping PCR for mTR status of MEFs generated from a TRF2F/FmTR+/- intercross. TRF2F/FmTR-/- MEFs
analyzed in the fourth lane were used in subsequent experiments. (B) Immunoblot for TRF2 in SV40-LT
TRF2F/FmTR-/- MEFs expressing the indicated TRF2 alleles, at 120 hours after Hit&Run Cre. (C)
Representative telomeric overhang analysis of SV40-LT TRF2F/FmTR-/- MEFs expressing the indicated
alleles before and after Cre. The relative single-stranded signal was determined with the first lane set to
100. (D) Quantification of the telomeric overhang signal. Values represent the mean of two independent
experiments. For each rescuing allele, the normalized value in the absence of Cre was set to 100.

I next analyzed the overhang signal in Apollo null cells in different phases of the
cell cycle using a method for isolating G1, S, and late S/G2 cells based on the FUCCI
(fluorescence ubiquitination-based cell-cycle indicator) system421 (Figure 3.6A-D).
FUCCI uses fluorescently-tagged Cdt1 (expressed in G1 and degraded in early S phase)
and Geminin (expressed in S/G2 and degraded in mitosis) to mark cells in different
phases of the cell cycle. With this approach, G1, S, and S/G2 populations are isolated by
FACS sorting, avoiding the disadvantages of synchronizing cells with drug treatments.

	
  

86

For the FUCCI-sorting method, I introduced red/orange-fluorescent Cdt1 and greenfluorescent Geminin into immortalized ApolloF/F MEFs and used FACS for both Cdt1 and
Geminin to select cells that had incorporated both constructs into their genomes. The
cells, which were in early S phase at the time of the FACS-sorting, were re-plated and
infected with Hit&Run Cre to delete Apollo. At 120 h after Cre, wild type and Apollodeficient cells were harvested and sorted again by FACS to isolate Cdt1+Gem- G1 and
Cdt1-Gem+ late S/G2 populations, which were immediately embedded in agarose plugs to
assess the telomeric overhang (Figure 3.6C). In addition, in order to collect cells in earlymid S phase, Cdt1+Gem- G1 cells were plated and harvested at different time points. All
cells were pulsed for 30 minutes with BrdU to evaluate their S phase index.
The cell cycle profile of the Cdt1+Gem- cells, analyzed immediately after sorting,
showed distinct 2N and 4N peaks with few cells containing intermediate DNA content
(Figure 3.6D). The low percentage of BrdU-positive cells confirmed that most cells were
not in S phase. Given the high incidence of tetraploid cells in the asynchronous ApolloF/F
MEFs (Figure 3.1E), the 4N peak of the Cdt1+Gem- G1 cells likely reflects tetraploid cells
in G1 rather than diploid G2 cells. Meanwhile, Cdt1+Gem+ cells analyzed upon sorting
showed a majority of cells with an intermediate DNA content between 2N and 4N or 4N
and 8N, while ~80% of cells incorporated BrdU (Figure 3.6D). Thus, these cells were
likely in early/mid S phase.

Finally, the cell cycle profiles of Cdt1-Gem+ cells

immediately after sorting showed a large number of cells nearing either a 4N or an 8N
DNA content and ~80% BrdU-positive cells (Figure 3.6D), confirming that these cells
were in late S/G2. The different sorted populations exhibited similar cell cycle profiles in
the presence and absence of Apollo.
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Figure 3.6. Apollo deficiency results in reduced telomeric overhangs in G1 and S phase. (A)
Schematic showing cell cycle expression of FUCCI markers. (B) Representative FACS sort of cells
expressing the FUCCI markers. Wild type MEFs transduced with mKO2-Cdt1 (red) and mAG-Geminin
(green) were excited with 561nm and 488nm lasers, and gates are shown for the three sorted populations:
Cdt1+Gem-, Cdt1+Gem+, and Cdt1-Gem+. (C) Schematic of the procedure for isolating cells in G1, early S,
and late S/G2 phases by FUCCI-FACS. SV40-LT ApolloF/F MEFs transduced with the FUCCI vectors were
selected by FACS for integration of both plasmids, replated, and infected with Hit&Run Cre. Cells were
harvest at the desired time after Cre, sorted for different populations, and embedded in agarose for
overhang analyses. (D) Cell cycle profiles of unsorted and sorted populations. Cells were pulsed with BrdU
for 30 minutes prior to sorting. After sorting, cells were immediately fixed, stained with FITC-anti-BrdU
and PI for DNA content, then analyzed by flow cytometry. (E) Representative telomeric overhang analysis
of G1 and late S/G2 ApolloF/F MEFs at 120 h after Cre. The relative single-stranded signal was normalized
to total TTAGGG signal and determined as a percentage of the signal in the lane containing G1 cells
without Cre (set at 100). (F) Quantification of relative single-stranded telomeric signal in G1 and late S/G2
as assayed in (E). The single-stranded telomeric signal was normalized to the total TTAGGG signal and
determined as a percentage of the signal in G1 cells without Cre (set at 100). Values are the mean of three
independent experiments and SDs. p-values were determined by paired student’s t-test. (G) In-gel
detection of relative overhang signal in early/mid S phase in SV40-LT ApolloF/F MEFs at 120 h post Cre.
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When the telomeric overhangs of cells in different cell cycle phases were
analyzed by in-gel hybridization, Apollo-deficient cells in G1 and late S/G2 showed a
40% reduction in telomeric overhang signal compared to wild type cells in the same
phase of the cell cycle. Interestingly, the telomeric overhangs in both wild type and
Apollo-deficient cells were increased in late S phase compared to G1 (Figure 3.6E-G).
This Apollo-independent increase in overhang signal during progression from G1/early S
to late S phase could arise due to extension of the G-rich overhang by telomerase (which
in mammalian cells is uncoupled from complementary strand synthesis) and/or resection
of the C-rich strand by other nucleases. As will be shown later (Chapter 5), this increase
in overhang signal occurs in telomerase-deficient MEFs, suggesting that this step in
telomere end-processing is telomerase-independent.
In order to determine whether Apollo acts differentially at leading- and laggingend telomeres, I adapted an approach for separating newly synthesized telomeres of
human cells7 to analyze the overhangs at leading- and lagging-end telomeres in MEFs.
This approach is based on sequence differences between the complementary strands of
telomeric DNA.

For every 6 bp of telomeric sequence, the G- and C-rich strands

respectively contain two and one thymidine that can be replaced with the heavier BrdU.
Incorporating BrdU into replicating telomeres yields leading-end telomeres (containing
the newly-synthesized G-rich strand) that are heavier than lagging-end telomeres
(containing the newly-synthesized C-rich strand), permitting their separation by CsCl
density gradient equilibrium centrifugation (Figure 3.7A). For this procedure, MEFs
were grown in the presence of 100 µM BrdU for one round of replication (16 hours).
Genomic DNA was isolated and digested with MboI and AluI to retain telomeric
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restriction fragments. The DNA was fractionated by CsCl density gradient equilibrium
centrifugation and the telomeric signal in each fraction was determined by slot blot with a
32

P-labeled G-rich telomeric probe. When the telomeric signal intensities were plotted as

a function of the CsCl density calculated based on the measured refractive index of each
fraction, distinct peaks of telomeric signal appeared, corresponding to the unreplicated,
lagging-end, leading-end, and doubly replicated telomeres.

Between three to five

fractions spanning each peak were pooled, and the telomeric overhangs were detected by
native in-gel hybridization.
To confirm the density of unreplicated and doubly substituted telomeric DNA,
DNA was also isolated from cells that were not treated with BrdU (Figure 3.7C) or cells
that had been incubated with BrdU for 48 hours. (Figure 3.7D). CsCl density gradient
equilibrium centrifugation of unlabeled telomeres followed by slot blot detection of the
telomeric signal in each collected fraction resulted in the appearance of a single peak of
telomeric signal at 1.74 g/ml. Meanwhile, the same protocol performed on telomeres that
had undergone two rounds of replication yielded a major peak at 1.87 g/ml, two minor
peaks at 1.78 and 1.82 g/ml, corresponding to those telomeres that had only completed
one round of replication, and no peak at 1.74 g/ml, since presumably all cells had
replicated within the 48 hours of the BrdU pulse.
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Figure 3.7. Separation of newly synthesized leading- and lagging-end telomeres. (A) Schematic of the
separation of newly synthesized telomeres, as described in the text. (B) Representative slot blot of
telomeric signal in each fraction collected from CsCl density gradient equilibrium centrifugation of
telomeric DNA labeled with BrdU for one round of replication. The density of each fraction corresponding
to peaks in telomeric signal was calculated based on the measured refractive index. (C) Slot blot of
telomeric signal in fractions collected from CsCl gradient using telomeric DNA not labeled with BrdU. (D)
Slot blot of telomeric signal in fractions collected from CsCl gradient using telomeric DNA isolated from
cells incubated for >2 PDs with BrdU.

	
  
In-gel hybridization was used to detect the relative overhang signal at newly
synthesized leading- and lagging-end telomeres in the presence and absence of Apollo.
In wild type MEFs, the relative overhang signal at leading-end telomeres was either
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approximately equal to or slightly greater than that at lagging-end telomeres (3.8C-D).
This is in contrast to published studies on absolute overhang length in telomerasenegative human cells, which is greater at lagging-end telomeres compared to leading-end
telomeres. In human cells, expression of telomerase reduces the difference in overhang
length between leading- and lagging-end telomeres, though the lagging-end overhangs
still remain longer7. Evaluation of the relative overhang signal at leading- and laggingend telomeres in telomerase-negative MEFs revealed no reproducible differences
compared to telomerase-positive MEFs (see Chapter 4). This result may be indicative of
differences in telomere-end processing between MEFs and human fibroblasts, and should
be kept in mind when making interspecies comparisons.
When this method was used to separate the newly synthesized leading- and
lagging-end telomeres from Apollo-deficient cells, slot blot detection of the telomeric
signal in each fraction showed similar peaks of intensity corresponding to the leading-,
lagging-end, and unreplicated telomeres (Figure 3.8A-B).

No aberrant intermediate

peaks of telomeric signal intensity were observed, suggesting that telomeres lacking
Apollo were able to complete replication. Detection of the telomeric overhang signal by
in-gel hybridization revealed that the overhangs at leading-end telomeres were reduced
by ~50% while lagging-end overhangs were unaffected (Figure 8C-D). On the native
gel, the single stranded overhang of telomeres lacking Apollo appeared as a smeared
signal, which may be indicative of secondary structures that occur as leading end
telomeres lacking an overhang are recognized and processed as DNA damage. The
severity of the overhang defect at leading end telomeres in the absence of any defect in
lagging-end overhangs is consistent with the 25-35% reduction in overhang signal
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detected in bulk DNA isolated from Apollo-deficient cells. Thus, Apollo contributes to
the size of overhangs generated specifically at newly synthesized leading-end telomeres.

Figure 3.8. Apollo contributes to overhang generation at newly synthesized leading-end telomeres.
(A) Representative slot blot of telomeric signal in each fraction collected from CsCl density gradient
equilibrium centrifugation of telomeric DNA from ApolloF/F MEFs labeled with BrdU for one round of
replication. The fractions pooled for overhang analyses are shown. (C) Representative overhang analysis of
bulk telomeres (prior to CsCl density gradient equilibrium centrifugation), and separated leading, and
lagging-end telomeres from ApolloF/F MEFs in the absence of Cre and 120 hours post-Cre. (D)
Quantification of relative overhang signal as detected in (C). Values represent the mean of two independent
experiments.
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Apollo protects a subset of telomeres from activating the ATM kinase in S phase
The effect of Apollo deletion on the repression of DNA damage signaling at
telomeres was next investigated to determine whether an overhang defect can
compromise end protection. Following deletion of Apollo, approximately one-third of
cells exhibited Telomere dysfunction-Induced Foci (TIFs;

192

) at a subset (~10%) of the

telomeres (Figure 3.9A,E). The TIF response was accompanied by phosphorylation of
Chk2, a target of the ATM kinase (Figure 3.9B). Consistent with the Chk2
phosphorylation, the TIF response was ablated when cells were treated with an shRNA to
the ATM kinase but unaffected by knockdown of ATR (M. van Overbeek, Figure 3.9CG). Thus, deletion of Apollo elicits ATM kinase signaling at a subset of the telomeres in
a fraction of the cells.
Whereas wild type Apollo effectively repressed TIF formation and Chk2
phosphorylation in Cre-treated ApolloF/F MEFs, ApolloΔTRF2 was unable to prevent the
DNA damage response associated with Apollo loss (Figure 3.9A-B,E). In addition,
Apollo-ND failed to prevent activation of ATM signaling at telomeres. Both mutant
forms of Apollo induced a level of Chk2 phosphorylation similar to that in the absence of
Apollo (Figure 3.9B). Therefore, repression of ATM signaling at telomeres appears to
require an Apollo that is both nuclease-proficient and localizes to telomeres.
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Figure 3.9. Apollo is required to repress telomeric ATM signaling. (A) TIF assay on ApolloF/F MEFs
expressing the indicated Apollo alleles to detect telomeric DNA damage signaling before (left) and after
(right) deletion of the endogenous Apollo with Cre. Telomeres are detected using a FISH probe (green).
DNA damage sites are marked with 53BP1 (red). DNA is counterstained with DAPI (blue). Circled TIFs in
the enlarged images highlight the prevalence of TIF occurrence at two closely positioned telomeres or in
cells with paired telomeres, indicative of DNA damage signaling during or after telomere replication. (B)
Immunoblotting for the phosphorylation state of Chk2 at 6 days after Cre treatment. (C) Immunoblot
showing depletion of ATM (Mat3-Sigma) 6 days after shRNA treatment and 3 days after the start of
puromycin selection in ApolloF/F MEFs expressing the indicated Apollo alleles. Apollo-ND* is identical to
Apollo-ND, except without the mutation of H230. (D) Effect of ATM kinase knockdown on the TIF
response in Apollo deficient cells. TIF analysis as in (A) but with cells expressing an shRNA to the ATM
kinase. (E) Quantification of TIF responses as assayed in (A) and (D). TIFs were scored on the basis of colocalization of 53BP1 foci with 5 or more telomeres per cell. Values for alleles +Cre indicate the mean of 3
independent experiments (> 100 nuclei per experiment), and SDs. * indicates the use of the Apollo-ND*
allele in the ATM shRNA experiment. (F) Immunoblot showing depletion of ATR (FRP-Santa Cruz) 6
days after shRNA treatment and 3 days after start of puromycin selection in SV40-LT ApolloF/F MEFs
expressing the indicated Apollo alleles. (G) TIFs after ATR shRNA. The % of cells with ≥5 TIFs is noted
below the images. Apollo-ND* is identical to Apollo-ND, except without the mutation of H230. (H)
Immunoblot for TRF2 and Chk2 in TRF2F/-p53-/- MEFs expressing the indicated TRF2 alleles without Cre
and at 144 hours after Hit&Run Cre. (I) TIF assay on TRF2F/-p53-/- MEFs expressing the indicated TRF2
alleles to detect telomeric DNA damage signaling before (left) and after (right) deletion of the endogenous
TRF2 with Cre. Telomeres are detected using a FISH probe (green). DNA damage sites are marked with
53BP1 (red). DNA is counterstained with DAPI (blue). (J) Quantification of TIF response as assayed in
(I). TIFs were scored on the basis of co-localization of 53BP1 foci with 5 or more telomeres per cell.
Values indicate the mean of 3 independent experiments (>100 nuclei per experiment) and SDs. p-values
were determined based on paired student’s t-test.
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I also examined the ability of TRF2-F120A to suppress the ATM-mediated DNA
damage response induced in the absence of TRF2. Whereas TRF2 deletion resulted in
80-90% cells with TIFs at most telomeres, expression of the TRF2-F120A mutant
reduced the percentage of TIF-positive cells by approximately 2-fold and the remaining
TIF-positive cells had fewer TIFs/cell (Figure 3.9I-J). Expression of TRF2-F120A also
diminished the level of Chk2 phosphorylation elicited by TRF2 deletion (Figure 9H).
Notably, however, the fraction of cells with ≥ 5 TIFs in the presence of TRF2-F120A
remained significantly greater than when TRF2-deficient cells were complemented with
wild type TRF2 (Figure 3.9I-J). As was observed for Apollo deletion, 30-40% of the cells
were TIF positive (Figure 3.9I-J). Furthermore, like cells lacking Apollo, the TRF2F120A cells showed a low level of Chk2 phosphorylation (Figure 3.9H).

Thus,

disrupting the Apollo binding site of TRF2 elicits a DNA damage response that
resembles the phenotype of Apollo deletion.
Since the TIF response was observed in approximately one third of the Apollodeficient cells, and these cells often contained paired TTAGGG repeat FISH signals
indicative of recent replication (Figure 3.9A), I investigated the cell cycle dependence of
this DNA damage response.

Using the FUCCI sorting method, I isolated Apollo-

deficient cells in G1 and late S/G2 phase, which were plated on coverslips, and fixed for
immunofluorescence either 1.5 h or 6-8 h later. Prior to fixation, cells were treated with a
30 min pulse of BrdU in order to evaluate their S phase index. At 1.5 h after plating, the
cell cycle profile of MEFs that were Cdt1+Gem- at the time of sorting was almost identical
to cells analyzed immediately upon sorting (Figure 3.10A). In addition, only ~10% of
cells were positive for BrdU incorporation, indicating that these cells remained in G1
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phase. On the other hand, by 6-8 h after plating, a significant fraction of cells that were
in G1 upon sorting had progressed into early/mid S phase based on their DNA content,
with ~40% having incorporated BrdU (Figure 3.10A). Finally, when cells sorted based
on Cdt1-Gem+ staining were analyzed at 1.5 h after plating, cell cycle profiles showed a
large number of cells nearing a 4N or an 8N DNA content while ~70% of the cells were
BrdU-positive, indicating that the majority of these cells remained in late S/G2.
Immunofluorescence detection of DNA damage markers in cells at different cell
cycle phases revealed that the TIFs seen in the absence of Apollo occurred in early/mid S
phase (Figure 3.10B). Whereas the percentage of TIF positive G1 or late S/G2 cells did
not increase, Apollo-deficient cells in mid-S phase had a strikingly higher TIF response
than the controls (Figure 3.10C). Thus, the absence of Apollo results in a telomeric DNA
damage signal in early/mid S phase.

TRF2-bound Apollo prevents fusion of leading-end telomeres
In addition to activating ATM at a subset of telomeres, Apollo deletion was
associated with aberrant DNA repair at telomeres. Apollo-deficient MEFs showed a
distinctive telomere fusion phenotype on metaphase spreads (M. van Overbeek, Figure
3.11A). Although the telomere fusions were 5-10 times less frequent compared to when
TRF2 is deleted, the fusion phenotype of Apollo-deficient cells was highly significant.
Strikingly, the telomere fusions observed between 84-120 hours after introduction of Cre
were nearly all of the chromatid-type, indicating a post-replicative fusion event (M. van
Overbeek, Figure 3.11B). Later time points included chromosome-type fusions that were
most likely due to duplication of chromatid-type fusions after their segregation into
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daughter cells. These secondary chromosome-type fusions were not likely to reflect the
function of Apollo, and their incidence was affected by the proliferation rate of the cells.
Therefore, later time-points after Apollo deletion were not analyzed.

Figure 3.10. Cell cycle dependence of telomere dysfunction in the absence of Apollo. (A) Cell cycle
profile and S phase index for different FUCCI-sorted population at 1.5 h or 6-8 h after plating on coverslips
for immunofluorescence. Cells were pulsed for 30 min with BrdU before harvesting and fixing for cell
cycle analysis. Cells were stained with FITC-anti-BrdU and propidium iodide (PI) for DNA content, and
analyzed by flow cytometry. (B) TIF assay of G1, early/mid S, and late S/G2 ApolloF/F MEFs at 72 h post
Cre. G1 and late S/G2 cells were obtained by sorting Cdt1+Gem- and Cdt1-Gem+ populations and plating
cells for 1.5 h prior to fixation. Early/mid S phase cells were obtained by plating Cdt1+Gem- sorted (G1)
cells on coverslips for 6-8 h prior to fixation. Telomeres are detected using a FISH probe (green). DNA
damage sites are marked with 53BP1 (red). DNA is counterstained with DAPI (blue). (C) Quantification of
the TIF response in G1, early/mid S, and late S phase as assayed in (B). Values are the mean of three
independent experiments (>60 nuclei per experiment) and SDs. p-values were determined using paired
student’s t-test.
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Leading-strand and lagging-strand DNA synthesis generates two distinct types of
telomeres that could be vulnerable to post-replicative fusions. To determine whether
Apollo was important for the protection of both types of telomeres, Chromosome
Orientation Fluorescent in situ Hybridization (CO-FISH;

422

) was used to distinguish

between telomere ends generated by leading- and lagging-strand DNA synthesis (referred
to as leading-end and lagging-end telomeres). CO-FISH analysis of the Apollo null cells
showed that the fusions exclusively involved telomeres generated by leading-strand DNA
synthesis (shown in red) (Figure 11C-E). Thus, Apollo has a specific role in protecting
leading-end telomeres, resulting in chromatid-type fusions when Apollo is absent. The
absence of sister fusions suggests that the lagging-end telomeres remain protected in
Apollo-deficient cells. This is consistent with the contribution of Apollo to overhang
generation specifically at leading end telomeres.
The function of Apollo in protecting leading-end telomeres required its
localization at telomeres. The ApolloΔTRF2 mutant was unable to prevent leading-end
telomere fusions (Figure 3.11C-E). Similarly, expression of TRF2-F120A resulted in a
significant level of leading-end telomere fusions observed by CO-FISH while this mutant
was fully capable of repressing the chromosome-type fusions associated with TRF2
deletion (Figure 3.11C-E). Just as the overhang defect was not due to an inability for
telomerase to act at telomeres, the fusions were independent of telomerase, since the cells
showed the same induction of leading-end telomere fusions observed when TRF2-F120A
replaced the endogenous TRF2 in telomerase-positive cells (Figure 3.11D-E).
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Figure 3.11. TRF2-bound Apollo prevents leading-end telomere fusions. (A) Telomere fusions in
metaphase spreads from Apollo-deficient cells. Metaphase spreads were obtained from ApolloF/F MEFs
before or after introduction of Cre and processed for telomeric FISH (FITC, green). DNA was stained with
DAPI (false-colored in red). Arrowheads highlight chromatid-type fusion events. (B) Quantification of
chromatid-type fusion events after deletion of Apollo. (C) CO-FISH analysis of leading and lagging end
telomeres. Metaphases harvested from ApolloF/F MEFs or TRF2F/-p53-/- MEFs expressing the indicated
rescuing alleles were incubated with BrdU/BrdC and treated with ExoIII and UV to remove the newlysynthesized DNA strand. The undigested parental telomeric DNA strands were detected with TAMRA(TTAGGG)3 (red) and FITC-(CCCTAA)3 (green). DNA is stained with DAPI (blue). The telomere
replicated by leading-strand DNA synthesis is highlighted in red, and the telomere replicated by laggingstrand DNA synthesis is highlighted in green. (D) Quantification of leading-end telomere fusions from
metaphase analyses shown in (C) at 120 hours post Cre. Values represent means of three or more
experiments (chromosome number >1000 per experiment) and SDs. (E) Quantification of other telomere
fusions events (lagging-to-lagging, lagging-to-leading chromatid-type fusions, and chromosome-type
fusions). Values represent means of three or more experiments (>1000 chromosomes per experiment) and
SDs.
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Furthermore, the nuclease domain of Apollo was involved in protecting the
leading-end telomeres. Cells expressing Apollo-ND instead of wild type Apollo
generated a statistically significant level of leading-end telomere fusions after deletion of
endogenous Apollo (Figure 3.11D). A more severe phenotype was observed with the
second nuclease domain mutant (ApolloΔ31-37, removing the HxHxDH motif in the
metallo β-lactamase domain and also containing the H230A mutation), which was
expressed at similar levels as wild type Apollo and retained its interaction with TRF2
(Figure 3.2E) but was incapable of repressing leading-end telomere fusions (Figure
3.11D).
Although both nuclease-deficient mutants of Apollo appear to be null alleles with
regard to overhang maintenance and repression of ATM signaling, it is noteworthy that
Apollo-ND, containing point mutations of the HxHxDH motif in the metallo β-lactamase
domain, has a reduced but still significant ability to repress the leading-end telomere
fusions. In contrast, the second nuclease-deficient allele of Apollo, lacking the HxHxDH
motif, completely fails to protect leading-end telomeres from fusions. One explanation
for this discrepancy is that the Apollo-ND allele has residual nuclease activity that is
sufficient to protect leading-end telomeres during the short time period in S/G2 when
they are vulnerable to fusion. This residual nuclease activity would have to be very minor
because there is no overt difference in the overhang signal compared to Apollo deletion.
Another possibility is that the Apollo protein itself protects the leading-end telomeres
from fusion. Such protection could conceivably involve the nuclease domain in a manner
that is destroyed by deletion of amino acids 31-37 but preserved in Apollo-ND despite
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the point mutations. It will therefore be of interest to study the nuclease and end-binding
activities of TRF2-Apollo complexes in vitro.
It is worth noting that when the different Apollo alleles were overexpressed in
293T cells, wild type Apollo and Apollo-ND appeared to migrate as two forms that were
both pulled down by TRF2 while only the faster migrating form was observed for
ApolloΔTRF2 and ApolloΔ31-37 (3.2D-E). This has not observed in any other cell lines,
so the modification that results in the slower migrating form of Apollo might be specific
to the case of overexpressing Apollo in 293T cells. Nonetheless, it is interesting that the
absence of the slower migrating form of Apollo correlates with the inability to suppress
the telomere fusion phenotype associated with Apollo loss. It remains an open question
whether Apollo is post-translationally modified, in the absence or presence of DNA
damage, and whether such a modification contributes to the protection of leading end
telomeres from fusions independent of the role of Apollo in overhang generation.

NHEJ between leading-end telomeres lacking Apollo are independent of Ligase IV
The leading-end associations that occur in the absence of Apollo were presumed
to be NHEJ events and have since been reported by others to depend on Ku423. To further
investigate the genetic requirements for the leading-end fusions that occur following
deletion of Apollo, I analyzed the appearance of fusions in the absence of ligase IV,
which is responsible for sealing the nicks between ends joined by classical NHEJ. First, I
evaluated TRF2F/-p53-/-Lig4-/- MEFs expressing TRF2-F120A following Cre-mediated
deletion of endogenous TRF2. The extensive chromosome type fusions that occur after
TRF2 deletion were almost completely abrogated in the absence of ligase IV, though a
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low level of leading-leading and other telomere fusions remained (Figure 3.12B). Wild
type TRF2 suppressed these residual fusions, while interestingly, a significant level of
leading-end fusions persisted in the presence of TRF2-F120A, while other telomere
fusions appeared at the same level as wild type (Figure 3.12A-B). In an alternative
approach, I generated SV40LT-immortalized ApolloF/FLig4-/- MEFs. Cells lacking both
Apollo and ligase IV still showed a 20-30% reduction in the telomeric overhang signal
and leading end fusions at a frequency similar to that observed in the presence of ligase
IV (Figure 3.12C).

Figure 3.12. Leading-end fusions occurring in the absence of Apollo are independent of Ligase IV.
(A) Representative CO-FISH analysis of leading and lagging end telomeres on metaphases harvested from
TRF2F/-p53-/-Lig4-/- MEFs expressing TRF2-F120A. Cells were incubated with BrdU and BrdC for 16 hours
and treated with colcemid prior to harvest. Metaphase spreads were prepared, treated with ExoIII and UV
to remove the newly-synthesized strand. The undigested parental telomeric DNA strands were detected
with TAMRA-(TTAGGG)3 (red) and FITC-(CCCTAA)3 (green). DNA is stained with DAPI (blue). The
leading-end telomere is highlighted in red, and the lagging-end telomere is highlighted in green. (B)
Quantification of leading-end telomere fusions from metaphase analyses shown in (A). (C) Representative
CO-FISH analysis of leading and lagging end telomeres on metaphases harvested from ApolloF/FLig4-/MEFs at 120 hours after Hit&Run Cre. (D) In-gel overhang analysis of ApolloF/FLig4-/- before and after Cre.
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Though further investigation is required regarding the mechanism of end-joining
that occurs in the absence of Apollo, it appears that these events do not strictly require
ligase IV. Whether they depend on Ku requires further validation using ApolloF/FKu-/MEFs (or TRF2/Ku DKO cells complemented with TRF2-F120A), since the study
attributing Ku to the joining of Apollo-deficient telomeres used cells derived from mice
containing a null (rather than conditional) allele of Apollo423.
Studies of cells lacking classical end-joining factors have provided evidence for
the existence of alternative end-joining pathways. Though Ku and ligase IV are required
for V(D)J recombination172,173,176 and contribute to class-switch recombination424, recent
studies have shown that in the absence of Ku or XRCC4/ligase IV, or in the absence of
both factors, CSR can still occur at a reduced frequency425,426. Furthermore, when DNA
DSBs are induced at specific sites on different chromosomes in mouse cells deficient for
classical NHEJ factors, A-EJ gives rise to chromosome translocations427.

Whereas

classical end-joining primarily involves direct joining of non-homologous ends, A-EJ
pathways have largely been reported to use microhomology, though A-EJ in the absence
of microhomology has also been documented425,427.
The aberrant repair pathway activated in the absence of Apollo, which joins
unprotected leading-end telomeres in S phase, appears distinct from the NHEJ between
telomeres lacking TRF2, which occurs in G1 and largely depends on ligase IV. It would
be interesting to identify the factors involved in NHEJ of leading-end telomeres lacking
Apollo and investigate how and why this repair pathway differs from that activated in the
absence of TRF2.
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Expression of TRF2-F120A does not slow the rate of telomere shortening in
telomerase-deficient cells
Since the length of the telomeric overhang correlates with the rate of telomere
shortening in the absence of telomerase248, I investigated whether Apollo-mediated
resection contributes to telomere shortening by monitoring telomere length in telomerasedeficient cells deficient for Apollo function. As the loss of Apollo from telomeres
activates only a transient and mild DNA damage response, I attempted to monitor the
long-term consequences of Apollo deficiency using the TRF2-F120A mutant, which
appeared to be less detrimental to cell proliferation than complete loss of Apollo.
Therefore, I propagated TRF2F/FmTR-/- MEFs expressing exogenously introduced wild
type TRF2 or TRF2-F120A in the absence of endogenous TRF2 for up to 60 population
doublings in culture.
Growth curves of cells expressing either the wild type or mutant TRF2 were
almost identical (Figure 3.13A), indicating that the proliferation of MEFs expressing
TRF2-F120A was not hindered by the transient ATM-dependent DNA damage response
elicited by leading-end telomeres lacking Apollo. The apparent absence of a proliferation
defect in the presence of TRF2-F120A could in fact be due to overgrowth of cells that do
not express the TRF2-F120A mutant at high levels or of cells from which endogenous
TRF2 was not efficiently deleted. Immunoblot detection of TRF2 showed that at 30 PDs,
exogenously introduced wild type and mutant TRF2 continued to be expressed at high
levels, though this masked the detection of endogenous TRF2 (Figure 3.13B).
Nonetheless, overhang analyses of cells expressing TRF2-F120A showed persistently
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reduced overhang signals compared to wild type, suggesting that the defect in overhang
generation was maintained throughout the propagation of the cells (Figure 3.13C).

Figure 3.13. Loss of Apollo does not slow the rate of telomere shortening in telomerase-deficient cells.
(A) Growth curve of TRF2F/FmTR-/- MEFs expressing wild type TRF2 and TRF2-F120A in long-term
culture after Cre-mediated deletion of endogenous TRF2. (B) Immunoblot detection of endogenous and
exogenous TRF2 alleles in long-term cultures at 5 and 30 days after Cre. (C) Telomere length analysis of
cells expressing TRF2-F120A harvested at several time points during long-term passaging to >50
population doublings. Native in-gel detection of the telomeric overhang is shown on the left, while the
denatured gel is shown on the right.

	
  
Telomere length was assayed by fractionating DNA on pulsed-field gels and
detecting the telomeric signal in the denatured gel by in-gel hybridization with a
telomeric probe. The rate of telomere shortening in telomerase-deficient cells expressing
TRF2-F120A was not significantly slower than that observed in the presence of wild type
TRF2 (Figure 3.13C). In fact, the presence of TRF2-F120A slightly accelerated telomere
shortening and resulted in the appearance of smeared telomeric signals of lower
molecular weight that were not observed in the presence of wild type TRF2.
These experiments suggest that the loss of Apollo from telomeres does not slow
the rate of telomere shortening in telomerase-deficient cells.

However, the current

experiments do not adequately address the contribution of resection to the rate of
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telomere shortening, since the dynamics of bulk telomere length in cells lacking Apollo
could reflect the DNA damage responses, albeit transient, that are activated when
overhang generation is compromised.

The proper assessment of whether inhibiting

Apollo-mediated resection can slow telomere shortening requires a setting in which
nuclease activity is compromised without abolishing the ability to initiate overhang
generation, in order to monitor the rate of telomere shortening in cells with short
telomeric overhangs that do not activate any DNA damage response.
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SUMMARY OF FINDINGS
These data reveal that TRF2-bound Apollo functions at replicating telomeres,
promoting the maintenance of the telomeric overhang, repressing S phase specific ATM
signaling, and protecting leading-end telomeres from fusion. These results provide the
basis for a model in which TRF2 recruits the Apollo nuclease to process leading-end
telomeres immediately after their replication. If this processing does not occur or is
delayed, the leading-end telomeres would remain blunt, making them vulnerable to endjoining reactions and exposing the telomere end in a manner that activates the
MRN/ATM pathway. These findings establish that, as was generally assumed,
maintenance of the telomeric overhang is important for the protection of mammalian
telomeres.
As Apollo has been implicated in ICL repair413,416, the appearance of S-phase TIFs
in the absence of Apollo could alternatively be explained by an inability to repair lesions
encountered during telomere replication. This explanation is not favored because the
major phenotypes observed in the absence of Apollo are not associated with aphidicolininduced replication stress or deletion of the shelterin component TRF1. Replication fork
stalling prior to collapse is often associated with accumulation of single-stranded DNA
and activation of the ATR kinase, which is not observed in Apollo null cells.
Furthermore, deletion of Apollo in mouse cells does not induce the fragile telomere
phenotype associated with telomere replication problems215. In addition, CsCl density
gradient equilibrium centrifugation of BrdU-labeled telomeres from Apollo-deficient
cells revealed no aberrant incorporation of BrdU that would be suggestive of replication
defects. Although contributions of telomeric Apollo in repairing lesions encountered by
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the replication machinery have not been formally excluded, the major phenotypes
observed at telomeres lacking Apollo are inconsistent with the prevention of replication
stress being a primary function of Apollo at telomeres.
It has been previously proposed that the F120 site in TRF2 not only provides a
docking site for Apollo but also recruits additional shelterin accessory factors, such as
Nbs1, XPF, PARP1, ATM, and ATR28,44. There would be no competition for this docking
site because TRF2 is very abundant at telomeres, whereas most shelterin accessory
factors are not36. The versatility of the F120 docking site was supported by the
identification of two proteins, PNUTS and MCPH1, which can bind to TRF2 using the
YxLxP motif428. However, the current data now cast doubt on the importance of the F120
docking site beyond the interaction with Apollo. The phenotype of the TRF2-F120A
mutant is mild, showing the limited DNA damage response phenotype and telomere
fusions associated with Apollo loss but no additional telomere dysfunction. Although it is
possible that the other F120 interacting factors are dispensable for telomere protection
(for instance, due to redundancy), further testing of the concept of the common F120
docking site is warranted.
The role of Apollo at replicating telomeres is distinct from previously
characterized functions of the core components of shelterin. The predominance of
leading-end telomere fusions in the Apollo knockout cells contrasts with both the TRF2
and POT1a/b knockout phenotypes. Although TRF2 deletion induces occasional
chromatid-type fusions, most of the fusions in TRF2 null cells occur in G1 and manifest
as chromosome-type fusions in the subsequent metaphase193,197. POT1a/b deletion results
in sporadic chromosome-type fusions and post-replicative fusions involving sister
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telomeres37. Neither chromosome-type fusions nor sister fusions are observed in Apollo
null cells. Thus, whereas TRF2 and POT1a/b function at both leading- and lagging-end
telomeres, Apollo acts specifically in the protection of leading-end telomeres.
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CHAPTER 4:
THE MECHANISM BY WHICH THE SINGLE-STRANDED TELOMERIC
BINDING PROTEIN POT1B REGULATES TERMINAL STRUCTURE
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INTRODUCTION
Mouse shelterin contains two single-stranded telomeric DNA binding proteins,
POT1a and POT1b, which serve distinct roles in telomere protection. POT1a represses
ATR signaling at telomeres, while POT1b restricts the accumulation of excessive
terminal single-stranded overhangs37. Deletion of POT1b results in a two- to four- fold
increase in the terminal single stranded overhang, and subsequently accelerated telomere
shortening37,187. POT1b-deficient mice are alive, but develop characteristics of the human
disease, dyskeratosis congenita, which are exacerbated in the case of heterozygosity for
the RNA component of telomerase187. POT1b has been proposed to limit degradation of
the telomeric C-rich strand, but the mechanism by which POT1b serves this protective
role was unknown.
Here, I evaluated the genetic requirements of the aberrant overhang phenotype
that occurs in the absence of POT1b. My work revealed that POT1b limits overhang size
at both newly synthesized telomeres in S phase by inhibiting Apollo and promoting the
function of the Ctc1/Stn1/Ten1 (CST) complex. POT1b was found to interact physically
with the CST complex through unique residues that are not conserved in POT1a (H.
Takai). Based on these findings, a POT1b mutant unable to bind CST was generated and
used to explore the telomere-specific functions of the CST complex as well as the aspects
of POT1b function that specifically involve its interaction with CST.

	
  

113

RESULTS
POT1b suppresses aberrant processing of newly synthesized telomeres in S phase
To begin to elucidate the mechanism by which POT1b protects telomeres from
aberrant degradation, I investigated whether the function of POT1b is required in noncycling cells. POT1b was posited to either block the action of nucleases that do not
normally act at telomeres or to regulate physiologic telomere processing events. Endprocessing events that normally occur at telomeres, such as the generation of singlestranded overhangs at newly synthesized leading-end telomeres, are thought to be
associated with telomere replication in S phase. Thus, if POT1b negatively regulates
physiologic end-processing, the overhang phenotype associated with POT1b deficiency
might be predicted to occur only when POT1b is removed from telomeres in S phase.
The technical difficulties associated with arresting immortalized MEFs in G0/G1
and efficiently transducing Cre recombinase into quiescent cells were bypassed with the
use of primary POT1bF/F ROSA-Cre-ERT2 MEFs generated by crossing POT1bF/F mice187
with mice carrying an allele of Cre recombinase fused to a tamoxifen-responsive estrogen
receptor targeted to the ubiquitously expressed ROSA26 locus429 (Figure 4.1A). Addition
of tamoxifen to these cells results in the translocation of Cre-ER from the cytoplasm to
the nuclease and subsequent deletion of POT1b. Asynchronous cells treated for 12 hours
with 100 nM tamoxifen showed a 5-fold reduction in POT1b protein levels within 48
hours (Figure 4.1B). The reduced POT1b protein level resulted in a reproducible 2-fold
increase in the telomeric overhang signal at 120 hours following tamoxifen treatment
(Figure 4.1D-E). This phenotype is weaker than that observed when POT1b is deleted in
SV40LT-immortalized MEFs using retroviral transduction of Cre recombinase, which
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generally results in a 3-4 fold increase in the telomeric overhang signal. However, since
primary MEFs are more readily arrested in G0 than immortalized MEFs, this was the
optimal system to determine whether POT1b affects the telomere terminus in quiescent
cells.

Figure 4.1. POT1b is not required in G0 to suppress accumulation of overhangs. (A) Scheme to assess
the effect of deleting POT1b in non-cycling POT1bF/F ROSA-Cre-ERT2 MEFs. (B) Immunoblot detection of
POT1b and POT1a in asynchronous POT1bF/F ROSA-Cre-ERT2 MEFs at successive timepoints after 12hour incubation with 100 nM tamoxifen. (C) Cell cycle profile of cells at the time of preparation for
overhang analysis. (D) In-gel overhang assay of asynchronous, G0-arrested, and released POT1bF/F ROSACre-ERT2 MEFs with and without tamoxifen treatment. (E) Quanfication of overhang analysis shown in (D).
Values represent the mean of two experiments with two independent POT1bF/F ROSA-Cre-ERT2 MEF lines
and s.e.m.

	
  
Primary POT1bF/FROSA-Cre-ERT2 MEFs were arrested in G0 by contact
inhibition and gradual serum withdrawal over several days. Following treatment with
tamoxifen, the cells were either maintained under contact inhibition in serum-free media
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or passaged in serum-rich media and allowed to progress through S phase (Figure 4.1A).
After five days, at a time when POT1b protein levels had reached a minimum, cell cycle
profiles were analyzed, and the telomeric overhang was assayed by in-gel hybridization.
Flow cytometry showed that the contact-inhibited cells were mostly arrested with a 2N
DNA content, and few cells had an intermediate DNA content between 2N and 4N
indicative of ongoing replication (Figure 4.1C). Upon release into serum-rich media, the
percentage of cells with 2N content was reduced though these cells did not proliferate
well and showed a broad 4N peak, possibly indicative of G2/M arrest. The deletion of
POT1b in arrested cells resulted in no increase in the telomeric overhang, whereas
POT1b-deficient cells that were released accumulated increased overhang signals similar
to asynchronous cells (Fig 4.1D-E). Similar results were obtained with two independent
POT1bF/F ROSA-Cre-ERT2 cell lines. Thus, POT1b does not appear to be required in G0 to
protect telomeres from aberrant degradation but instead suppresses aberrant processing in
S phase.
Next, to evaluate the cell cycle dynamics of the aberrant overhangs in POT1bdeficient cells, I assessed the telomeric overhang in different phases of the cell cycle in
the steady state after POT1b had been deleted using the FUCCI-FACS system (described
in Chapter 3). The FUCCI vectors (mAG-Geminin, mKO2-Cdt1) were transduced into
POT1bF/- MEFs and following Cre-mediated deletion of POT1b, cells were sorted in G1
and late S/G2 by FACS. Overhang analysis by in-gel hybridization showed that the
excessive overhangs due to POT1b deletion were not restricted to a specific cell cycle
phase (Figure 4.2A-B). Instead, similarly elevated overhang signals were observed in
both G1 and S phase. Wild type cells undergo a two-fold increase in the telomeric
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overhang in late S phase compared to G1, and this extended overhang is presumably
filled in by C-strand synthesis as cells progress through mitosis. POT1b-deficient cells,
on the other hand, appeared to lack any dynamic changes in overhang signal, which could
reflect a defect in fill-in synthesis of the C-rich strand.

Figure 4.2. Aberrant overhangs in POT1b-deficient cells are not restricted to a specific cell cycle
phase. (A) In-gel overhang analysis of POT1bF/F cells in G1 and late S at 120 hours post-Cre, isolated by
FUCCI-FACS as previously described. The relative overhang signal normalized to the total telomeric
signal was determined with the lane containing wild type cells in G1 set to 1. (B) Quantification of
overhang analyses shown in (A). Values represent the mean of three independent experiments and standard
deviations. (C) Overhang analyses of synchronized POT1b-deficient cells treated for the duration of S
phase with nocodazole or roscovitine. Cells in G1, early S, and late S phase were sorted by FUCCI-FACS.
Early S phase cells were plated and treated with drugs for 4-6 hours prior to harvesting.

	
  
As seen in Figure 4.2A-B, the overhang signal of unsorted asynchronous POT1bdeficient cells was on average greater than in either the G1 or late S phase cells,
prompting a more careful investigation of whether the overhang phenotype associated
with POT1b loss was more severe during a specific cell cycle phase other than G1 or late
S. I evaluated the effect of different drug treatments on the aberrant overhangs in
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POT1b-deficient cells. POT1b-deficient cells in early S phase were sorted by FUCCI for
the Cdt1+Gem+ population. These cells were plated and treated with nocodazole for 8
hours to arrest the cells in mitosis, or with roscovitine for 4 hours, to inhibit Cdk and
arrest the cells in S phase. Nocodazole treatment had very little effect on the overhang
signal, indicating that the accumulation of excessive overhangs in the absence of POT1b
is not affected by mitotic arrest (Figure 4.2C). Meanwhile, roscovitine treatment did not
reduce the level of overhang signal, suggesting that the excess overhangs are not the
result of nucleases whose activity depends on Cdk phosphorylation (Figure 4.2C). This is
in contrast to the Cdk-dependent C-strand degradation that occurs in S. cerevisiae cdc131 mutant430. In fact, Cdk inhibition resulted in a slight increase in the overhangs,
suggesting that prolonged S phase arrest could result in further accumulation of excess
overhangs.

Though POT1b-deficient cells do not exhibit overt signs of checkpoint

activation, they may nevertheless progress slowly through G2, which may account for the
slightly elevated overhang signal in asynchronous populations compared to G1 and late S
cells (Figure 4.2A-B).
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Figure 4.3. POT1b limits overhang size at both newly synthesized telomeres. (A) and (B)
Representative slot blot of telomeric signal in each fraction collected from CsCl density gradient
equilibrium centrifugation of telomeric DNA from POT1bF/- MEFs without Cre (A) and 120 hours after Cre
(B) labeled with BrdU for one round of replication. The fractions pooled for overhang analyses are shown.
(C) Representative overhang analysis of the separated leading, and lagging-end telomeres from POT1bF/MEFs in the absence of Cre and 120 hours post-Cre. (D) Quantification of relative overhang signal as
detected in (C). Values represent the mean of three independent experiments and standard deviations.
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Next, to determine whether POT1b is differentially required at telomeres
synthesized by leading- and lagging-strand DNA replication, I labeled POT1b-null cells
with BrdU for one round of replication and used CsCl density gradient equilibrium
centrifugation to separate the newly synthesized telomeres (as described in Chapter 3).
Slot blot detection of the telomeric signal in each fraction collected from the CsCl
gradient showed peaks of intensity in fractions corresponding to the leading-end, laggingend, and unreplicated telomeres. Similar separation of the newly-synthesized telomeres
was achieved for both wild type and POT1b-deficient cells (Figure 4.3A-B). In-gel
hybridization to detect the telomeric overhangs in pooled fractions isolated from the CsCl
gradient revealed that POT1b deletion induced a ~2 fold increase in leading-end
overhangs and a ~3 fold increase in the lagging-end overhangs (Figure 4.3C-D). Thus,
POT1b appears to be required to limit overhang length at both newly-synthesized
telomeres.

As expected based on previous work indicating that POT1b function is

independent of telomerase187, the effect of POT1b deletion on the overhangs of both
newly synthesized telomeres was similar in telomerase-deficient cells (see Figure 15 for
example).

DSB resection factors do not contribute to the excessive overhangs associated with
POT1b deficiency
In order to identify factor(s) responsible for the excessive overhangs associated
with POT1b deletion, I investigated whether the aberrant overhang phenotype could be
rescued by co-depletion of a number of candidate nucleases and/or helicases. To evaluate
whether POT1b deletion results in aberrant processing of telomeres by the
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nucleases/helicases that act in response to a DSB, I assessed the telomeric overhang of
POT1b-deficient MEFs after Nbs1, Exo1, or various RecQ helicases were depleted
individually as well as in MEFs lacking POT1b, Nbs1 and Exo1. Among many tested
candidates that appeared to have no role in the aberrant resection associated with POT1b
loss, those whose depletion was confirmed included Nbs1, Exo1, BLM, and RecQL5.
These negative results are summarized below.
Deletion of POT1b and Nbs1 in SV40LT-immortalized POT1bF/FNbs1F/- cells
(generated by N. Dimitrova) with hygromycin-selectable pWzl-Cre resulted in a
significant growth defect that was also observed with deletion of Nbs1 alone. Initial
overhang analyses using this approach suggested that Nbs1 deficiency did not abrogate
the overhang increase that occurs when POT1b is deleted. Since the growth defect could
affect the ability for cells to accumulate excess overhangs, I repeated this experiment
using non-selectable Hit&Run Cre, which resulted in a less severe growth defect in
POT1b/Nbs1 DKO cells (Figure 4.4B-C). I assayed the overhang at 3 and 5 days after
the introduction of Cre, timepoints during which POT1b/Nbs1 DKO and POT1b KO cells
were still growing at similar rates. Co-deletion of Nbs1 and POT1b had no effect on the
aberrant overhang signal that appears in the absence of POT1b (Figure 4.4A).
To address the possibility that MRN/CtIP and Exo1 act in a redundant manner, I
generated POT1bF/FNbsF/FExo1-/- MEFs. Deletion of POT1b in the absence of both Nbs1
and Exo1 still resulted in an increase in the telomeric overhang signal at 96 hours postCre that was comparable to the increased overhang signal following deletion of POT1b
and Nbs1, in littermate MEFs that were assessed in parallel (Fig. 4.4D).
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Figure 4.4. The aberrant overhang phenotype that occurs following POT1b deletion does not depend
on Nbs1 and/or Exo1. (A) In-gel overhang assay on POT1bF/FNbs1F/+, POT1bF/FNbs1F/- and
POT1bF/+Nbs1F/- MEFs at 84 hours after Hit&Run Cre. (B) Immunoblot detection of POT1b and Nbs1 in
the indicated MEFs. (C) Growth curve of POT1bF/FNbs1F/+, POT1bF/FNbs1F/- and POT1bF/+Nbs1F/- MEFs in
the absence and presence of Cre. (D) In-gel overhang assay on primary POT1bF/F Nbs1F/F Exo1-/- and
POT1bF/F Nbs1F/F Exo1+/+ littermate MEFs at 96 hours after Hit&Run Cre.

	
  
In addition, depleting either the BLM or RecQL5 helicase by shRNA also had no
effect on the overhang phenotype associated with POT1b deletion (Figure 4.5A-C).
Based on these results, it appeared unlikely that POT1b represses aberrant resection by
factors involved in DSB resection. These results in themselves did not rule out the
possibility that these factors might act redundantly in POT1b-deficient cells – however,
subsequent experiments identifying factors that are indeed regulated by POT1b provided
support that these negative results are valid.
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Figure 4.5. The aberrant overhang phenotype that occurs following POT1b deletion does not depend
on BLM or RecQL5. A) In-gel overhang assay on POT1bF/- MEFs following depletion of BLM with three
different retroviral shRNAs (puromycin-selectable) and at 96 hours after pWzl-Cre (hygromycinselectable). (B) In-gel overhang assay on POT1bF/- MEFs following depletion of RecQL5 with two
different lentiviral shRNAs (puromycin-selectable) and at 96 hours after pWzl-Cre (hygromycin-selectable).
(C) Immunoblot detection of RecQL5 showing depletion with shRNAs.

	
  
POT1b inhibits the Apollo nuclease at leading- and lagging-end telomeres
Based on the previously identified role of the Apollo nuclease in the generation of
overhangs at leading-end telomeres, I tested whether POT1b inhibits Apollo by
generating SV40LT-immortalized POT1bF/FApolloF/F MEFs from which both POT1b and
Apollo could be deleted by Cre recombinase (Figure 4.6A). Following Cre-mediated
deletion of Apollo and POT1b, cells showed a mild proliferation defect similar to that
observed in the absence of Apollo only (Figure 4.6B). This growth defect was partially
rescued by the introduction of wild type Apollo but not by the introduction of the
ApolloΔTRF2 allele (refer to Chapter 3) lacking the ability to localize to telomeres due to
mutations in the TRF2-interacting YxLxP motif (Figure 4.6C-D). When the telomeric
overhang signal was detected by in-gel hybridization, co-deletion of Apollo and POT1b
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resulted in a ~1.5 fold increase in the telomeric overhang signal, which was
approximately half that observed in the absence of POT1b alone (Figure 4.6E-F).

Figure 4.6. Accumulation of excess overhangs upon POT1b deletion partially depends upon Apollo.
(A) Immunoblot detection of POT1b at 120 h after Cre in SV40LT-immortalized ApolloF/F, POT1bF/F, and
ApolloF/FPOT1bF/F MEFs. (B) Growth curve of SV40LT-immortalized ApolloF/F and ApolloF/FPOT1bF/F
MEFs after treatment with Hit&Run Cre. (C) Immunoblot detection of FLAG-[HA]2-tagged Apollo alleles
expressed in SV40LT-immortalized ApolloF/FPOT1bF/F MEFs. HA.11 antibody was used to detect
exogenously-introduced Apollo. (D) Growth curve of SV40LT-immortalized ApolloF/FPOT1bF/F MEFs
expressing Apollo alleles in the absence and presence of hygromycin-selectable pWzl-Cre. (E) In-gel
overhang analysis of indicated MEFs without and at 120 h after Hit&Run Cre. (F) Quantification of
overhang assay as shown in (E). Values indicate the mean and sd of three independent experiments. (G)
Quantifiation of CO-FISH analysis to detect telomere fusions in ApolloF/FPOT1bF/F MEFs after Cre.
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Though the bulk overhang signal in the absence of both Apollo and POT1b was
increased compared to that of wild type cells, a mild telomere dysfunction phenotype was
observed, as might be expected based on the proliferation defect. Metaphase spreads of
cells lacking Apollo and POT1b revealed a significant incidence of chromatid-type
fusions between telomeres, at a similar level as that observed in the absence of Apollo
alone (Figure 4.6G). CO-FISH analysis revealed that the fusions occurred largely
between leading-end telomeres (Figure 4.6G). Thus, despite no apparent reduction in the
relative overhang signal of bulk telomeres in Apollo/POT1b DKO cells, the appearance
of leading-end fusions suggested that at least a subset of these telomeres become
deprotected in the absence of both Apollo and POT1b.
These results suggested that POT1b might limit overhang size by inhibiting
Apollo at both newly-synthesized telomeres. Alternatively, co-deletion of Apollo and
POT1b could result in a reduction in overhang size at leading-end telomeres while
accumulating excessive overhangs at lagging-end telomeres to the same extent as in the
absence of POT1b alone. The latter scenario is plausible due the specific role of Apollo in
overhang generation at leading-end telomeres, and since cells lacking both Apollo and
POT1b exhibited some of the telomere dysfunction phenotypes associated with the loss
of Apollo alone. To distinguish between these possibilities, I used the CsCl density
gradient approach to isolate the leading- and lagging-end telomeres in cells lacking
Apollo and POT1b. If POT1b inhibits Apollo at both newly synthesized telomeres, the
overhang signal at both leading- and lagging-end telomeres lacking Apollo and POT1b
would be less than that in the absence of POT1b alone. Meanwhile, if the excess
overhangs at lagging-end telomeres lacking POT1b are generated independently of
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Apollo, cells deficient for both Apollo and POT1b would have reduced overhangs at
leading-end telomeres while the overhang signal at lagging-end telomeres would remain
similar to that observed as in the absence of POT1b alone.
Separation of newly synthesized telomeres by the CsCl density gradient approach
revealed that cells lacking both Apollo and POT1b had a reduced overhang signal at
leading-end telomeres compared to wild type cells, though this defect was less severe
than in cells lacking Apollo only (Figure 4.7A-E, refer to Figure 3.8 for Apollo KO data).
The finding that the co-deletion of POT1b and Apollo does not result in an increase in the
overhang signal at leading-end telomeres, as observed in the absence of POT1b alone
(Figure 4.7C-E, refer to Figure 4.3 for POT1b KO data), suggests that POT1b inhibits
Apollo at newly-synthesized leading-end telomeres. In Apollo-deficient cells, a subset of
leading-end telomeres activate a DNA damage response and engage in fusions due to
compromised overhang generation. At the remaining leading-end telomeres that still
possess overhangs in the absence of Apollo, POT1b is dispensable for limiting overhang
size.
Following deletion of Apollo and POT1b, the overhang signal at lagging-end
telomeres was elevated by approximately 1.5 fold compared to wild type (Figure 4.7CD). This phenotype was much milder than that observed in the absence of POT1b alone,
which induces a ~3 fold increase in the lagging-end telomeric overhang signal (Figure
4.7E, refer to Figure 4.3 for POT1b KO data). Thus, POT1b limits overhang size at both
newly-synthesized telomeres through the inhibition of Apollo.

Since co-deletion of

Apollo and POT1b does not completely abolish the accumulation of excessive singlestranded overhang signals at lagging-end telomeres (4.7C-E, also see Figure 4.6E-F,
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4.8A,C), POT1b is likely to limit overhang size through additional mechanisms besides
the inhibition of Apollo.

	
  
Figure 4.7. POT1b inhibits Apollo at both newly synthesized telomeres. (A) and (B) Representative slot
blot of telomeric signal in each fraction collected from CsCl density gradient equilibrium centrifugation of
telomeric DNA from ApolloF/FPOT1bF/F MEFs without Cre (A) and 120 hours after Cre (B) labeled with
BrdU for one round of replication. (C) Representative overhang analysis of the separated leading- and
lagging-end telomeres from ApolloF/FPOT1bF/F MEFs in the absence of Cre and 120 hours post-Cre. (D)
Quantitation of relative overhang signal as detected in (C). Values for the leading- and lagging- end
telomeres represent the mean of two independent experiments. (E) Relative overhang size in different
genetic backgrounds (refer to Figs. 3.8 and 4.3 for data on Apollo KO and POT1b KO).
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Figure 4.8. The excess telomeric overhang signal that persists in the absence of POT1b and Apollo
does not depend on Nbs1 or Exo1. A) In-gel overhang assay on MEFs of the indicated genotypes at 96
hours after Hit&Run Cre. (B) Immunoblot detection of Nbs1 and POT1b in MEFs assayed in (A). (C) Ingel overhang assay on MEFs of the indicated genotypes at 96 hours after Hit&Run Cre.

	
  
To determine if other nucleases such as MRN/CtIP or Exo1 contribute to the
residual accumulation of excess overhangs that occurs in the absence of POT1b and
Apollo, the telomeric overhang was analyzed in ApolloF/FNbs1F/FPOT1bF/F and
ApolloF/FExo1-/-POT1bF/F MEFs treated with Cre. Co-deletion of Nbs1 in addition to
Apollo and POT1b resulted in a similar level of excess overhang accumulation as in the
absence of Apollo and POT1b (Figure 4.8A-B). As will be discussed in the next chapter,
Exo1 contributes to the transient elongation of the telomeric overhang that occurs in wild
type cells during late S phase; however, co-deletion of Exo1, Apollo, and POT1b did not
abolish the accumulation of excess overhang signal observed in Apollo/POT1b DKO
cells (Figure 4.8C). Thus, as suggested by previous work, POT1b does not protect
telomeres from excessive degradation by Exo1187. Together, these results argue against a
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role for POT1b in protecting telomeres from aberrant degradation by nucleases involved
in DNA DSB resection. This is consistent with the fact that the absence of POT1b does
not elicit any DNA damage signal that might be expected to activate nucleases involved
in DSB resection37.

POT1b promotes the activity of Stn1 at leading and lagging end telomeres
Since there was no evidence that POT1b inhibited resection by other candidate
nuclease(s)/helicase(s), I tested whether POT1b has a role in promoting the telomeric
function of the mammalian Ctc1/Stn1/Ten1 (CST) complex, which has recently been
implicated in limiting overhang size in human cells288,289. Ctc1 and Stn1, also known as
AAF144 and AAF42, respectively, were originally identified as accessory factors of
polymerase alpha/primase that stimulate its activity in vitro and share structural
similarities with RPA32 and RPA70290. Along with a third OB-fold containing protein,
Ten1, this RPA-like complex binds single-stranded DNA in a sequence-independent
manner and has been reported to localize to replication foci as well as telomeres288,290.
Based on its localization to a subset of telomeres, as well as sequence homology between
mammalian and yeast Stn1 and Ten1, this complex has been proposed to be the
mammalian counterpart of yeast Cdc13/Stn1/Ten1 (CST)288,289.
Corroborating previous studies on the effects of Stn1 depletion in human cells,
depleting Stn1 in wild type MEFs resulted in a 2-fold increase in the single-stranded
telomeric signal (Figure 4.9A-C). This single-stranded signal was completely susceptible
to digestion by the E. coli 3’-5’ exonuclease ExoI, indicating that the signal was due to
terminal and not internal single-stranded telomeric DNA that might arise from
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uncoupling of the replication fork and exposure of the lagging strand template (Figure
4.10A). Stn1 depletion did not affect the levels of POT1a or b (Figure 4.9A) and did not
lead to the appearance of telomere dysfunction induced foci (TIFs) (see Figure 4.16C).
In addition, the effect of Stn1 depletion on the telomeric overhang was independent of
telomerase (Figure 4.10A-B).

	
  
Figure 4.9. POT1b is epistatic to Stn1. A) Immunoblot detection of Stn1, POT1b, and POT1a in POT1bF/MEFs at 96 hours following lentiviral shRNA to Stn1 and 120 hours after Cre. (B) In-gel overhang assay
on MEFs of the indicated genotypes at 96 hours following lentiviral shRNA to Stn1 and 120 hours after
Hit&Run Cre. For each MEF line, the relative ssTTAGGG signal is given with the first lane set to 100. (C)
Quantification of overhang analyses as shown in (B).

	
  
On the other hand, depleting Stn1 in POT1b KO cells had very little additional
effect on the already elevated overhang signal (Figure 4.9B-C). A similar epistatic
relationship was observed when Stn1 was depleted in cells lacking both POT1b and
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Apollo (Figure 4.9B-C). This suggested that Stn1 requires POT1b for its role in limiting
overhang size at telomeres.

Figure 4.10. Stn1 depletion results in elevated telomeric overhangs in G1 and S phase. (A) In-gel
overhang analysis of SV40LT-immortalized mTR-/- MEFs at 96 hours after retroviral shRNA to shStn1 in
G1 and late S, isolated by FUCCI-FACS as previously described. (B) Quantification of overhang analyses
shown in (A). Values represent the mean of three independent experiments and standard deviations.

	
  
An unexpected outcome occurred when Stn1 was depleted in TPP1-deficient
cells. Since TPP1 is required for the telomeric localization of POT1b29,188, the overhang
phenotype associated with TPP1 deletion was expected to be epistatic to Stn1 depletion.
However, Stn1 depletion in the absence of TPP1 resulted in a statistically significant
increase in the already elevated telomeric overhang signal (Figure 4.9C). This result
suggests that Stn1 may have a POT1b-independent role at telomeres in certain contexts,
such as with the loss of TPP1. In contrast to deleting POT1b alone, TPP1 deletion also
leads to the removal of POT1a, eliciting an ATR-dependent DNA damage signal and
increased single-stranded telomeric signals greater than that observed with POT1b
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deletion alone188.

The capacity in which Stn1 may act at telomeres lacking

TPP1/POT1a/POT1b remains a question for future investigation.
To further evaluate the role of Stn1 in limiting overhang size, Stn1 was depleted
in telomerase-deficient cells expressing the FUCCI markers and cells G1 or late S phase
cells were isolated by FACS. Stn1-depleted cells had increased overhangs in both G1
and S phase when compared to wild type cells in the same cell cycle phase (Figure
4.10A-B). These results suggest that following Stn1 depletion, not only are overhangs
aberrantly increased in S phase, but fill-in synthesis of the C-rich strand is insufficient to
restore overhang length to wild type levels in G1.
Next, I asked whether Stn1 acts differentially at leading and lagging end
telomeres. Stn1-depleted cells incorporated BrdU into the leading and lagging end
telomeres at similar ratios as wild type cells (Figure 4.11A-B), indicating that Stn1
depletion does not cause significant problems in semi-conservative replication of
telomeres and that the newly synthesized telomeres in Stn1-depleted cells could be
effectively separated by CsCl density gradient equilibrium centrifugation. Analyses of
the overhangs at leading- and lagging-end telomeres following Stn1 depletion revealed a
2-fold increase in the overhangs at both newly synthesized telomeres (Figure 4.11C-D).
Thus, Stn1 limits terminal overhang size at telomeres synthesized by both leading- and
lagging-strand DNA replication. Based on its identification as an accessory factor DNA
polymerase α/primase, Stn1, in complex with Ctc1 and Ten1, may promote fill-in
synthesis of the telomeric C-rich strand.
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Figure 4.11. Stn1 limits overhang size at both newly synthesized telomeres. (A) and (B) Representative
slot blot of telomeric signal in each fraction collected from CsCl density gradient equilibrium
centrifugation of BrdU-labeled telomeric DNA from wild type MEFs at 96 hours following lentiviral
transduction of vector (A) or shRNA targeting Stn1 (B). The fractions pooled for overhang analyses are
shown. (C) Representative overhang analysis of the separated leading- and lagging-end telomeres from
MEFs at 96 h following Stn1 depletion. (D) Quantification of relative overhang signal as detected in (C).
Values represent the mean of two independent experiments.

	
  
POT1b, but not POT1a, interacts with CST
Since POT1b and CST appeared to function in the same pathway, a natural
question was whether POT1b interacts physically with components of CST. Experiments
performed by H. Takai (de Lange lab) showed that when myc-POT1b and FLAG-tagged
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versions of all three components of mouse CST (Ctc1, Stn1, and Ten1) were cotransfected in 293T cells, co-immunoprecipitation with the myc antibody pulled down
Ctc1 and Stn1. A low level of CST could also be pulled down with TPP1, but not with
POT1a or any other component of mouse shelterin (Figure 4.12C). Myc-POT1b could
also be detected in the reciprocal co-IP using the FLAG antibody (Figure 4.12E, right
panel).
Previous studies have mapped the domain required for POT1b function using a
domain-swapping approach in which chimeric constructs of POT1a, POT1b, and human
POT1 were generated by interchanging the N-terminal OB-folds, C-terminal TPP1binding domain, and an internal region spanning amino acids 300-35039 (Figure 4.12A).
These studies revealed that the C-terminal domain of POT1b was required to prevent the
accumulation of single stranded telomeric DNA39. In relation to their ability to suppress
the aberrant overhang phenotype associated with POT1b deletion, the regions spanning
amino acids 300-350 of POT1b and human POT1 were functionally equivalent, while the
domain C-terminal to aa 350 could not be replaced by the same region in POT1a or
human POT139.
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Figure 4.12. POT1b, but not POT1a, interacts with Ctc1/Stn1/Ten1. (A) Domain organization of mouse
POT1b. Below are listed the domain requirements for suppression of aberrant overhang accumulation, as
revealed from domain-swapping experiments using chimeric constructs of POT1a, POT1b, and hPOT1. (B)
Sequence alignment of regions in the C-terminal domain of human POT1, mouse POT1a, and mouse
POT1b. Shown in blue are residues conserved among all three POT1s. Residues conserved between
hPOT1 and mPOT1b but not POT1a are shown in green and marked below with asterisks (*). Residues
conserved in hPOT1 and mPOT1a but not POT1b are shown in red and marked below with arrowheads (^).
Residues that were changed to generate POT1b mutants are indicated with gray boxes. (C) Coimmunoprecipitation of POT1b and Ctc1/Stn1/Ten1 (C/S/T). 293T cells were transiently co-transfected
with myc-tagged mPOT1a or mPOT1b, and FLAG-tagged mCtc1, mStn1, and mTen1, in the absence or
presence of myc-mTPP1. IPs were performed with the myc (9E10) antibody. Input (left) and IPs (right)
were analyzed by immunoblotting for myc (top) and FLAG (bottom). (D) List of POT1b mutants tested for
their ability to interact with CST in 293T co-IP. (E) Co-immunoprecipitation of POT1b mutants with C/S/T.
In the left two panels, co-IP was performed as in (C). In the right panel, IPs were performed with the
FLAG antibody and inputs and IPs were analyzed by immunoblotting for myc (top) and FLAG (bottom).
(Experiments by H. Takai)
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Sequence alignment of human POT1, mouse POT1a, and mouse POT1b identified
a number of residues in the C-terminal domain that were conserved between human
POT1 and POT1b but not found in POT1a as well as residues conserved between human
POT1 and POT1a but not found in POT1b (Figure 4.12B). Based on these sequence
differences, a number of POT1b mutants were generated in which the residues in POT1b
were mutated to the corresponding amino acids in POT1a (Figure 4.12D). Though most
of the mutations did not affect the ability of POT1b to pull down Ctc1 and Stn1 by coimmunoprecipitation in 293T cells, two POT1b mutants showed a diminished interaction
with CST by 293T co-IP (Figure 4.12E). The first mutant, named POT1b-LV, contained
two point mutations, L329P/V333E, of residues conserved between human POT1 and
mouse POT1b in the region that was previously identified to be interchangeable between
human POT1 and mouse POT1b. The second, named POT1b-DII, was generated by
mutating the three residues at the C-terminus of POT1 to the corresponding amino acids
in POT1a. Notably, D638 and I640 are conserved in both human POT1 and mouse
POT1b, while I639 is found only in mouse POT1b (Figure 4.12B).

Though these

mutations comprised the interaction between POT1b and CST, a residual amount of
POT1b-LV and POT1b-DII could still be detected in co-IPs with FLAG-CST (Figure
4.12E). However, the POT1b-LVDII mutant, containing mutations in all five residues,
completely abolished the interaction between POT1b and CST detected by 293T co-IP
(Figure 4.12E). Mutating the same residues in POT1a to the corresponding amino acids
in POT1b was not sufficient to provide POT1a with the ability to interact with CST in
293T co-IPs431.
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Figure 4.13. A POT1b mutant unable to interact with CST still interacts with TPP1 and localizes to
telomeres. (A) Co-immunoprecipitation of POT1b mutants and TPP1. 293T cells were transiently
transfected with the indicated myc-tagged POT1b alleles, and FLAG-tagged TPP1. IPs were performed
with the myc (9E10) antibody. Input (left) and IPs (right) were analyzed by immunoblotting for myc (top)
and FLAG (bottom). (B) Immunoblot detection of POT1b mutants expressed in POT1bF/- MEFs after Cremediated deletion of endogenous POT1b. (C) Immunofluorescence detection of the indicated POT1b
alleles using the myc antibody. Telomeres are detected with the TRF1 antibody. (D) Telomeric DNA ChIP
for POT1b mutants. ChIP was performed with myc and control (rabbit preimmune) antibodies on POT1bF/MEFs expressing different POT1b alleles after Cre-mediated deletion of endogenous POT1b.
Quantification of the % of TTAGGG repeats recovered in the IPs is shown the bar graph below.
(Experiments by H. Takai)

	
  
Consistent with the preservation of most of the C-terminal TPP1-binding domain
in POT1b-LVDII, 293T co-immunoprecipitation experiments showed that this mutant
maintained its ability to interact with TPP1 (Figure 4.13A). When POT1b-LVDII was
introduced into POT1bF/- MEFs from which endogenous POT1b was deleted by Cre
recombinase, the mutant protein was detectable at telomeres by immunofluorescence for
the myc tag as well as telomeric ChIP (Figure 4.13B-D). While POT1b-LVDII localized
to telomeres to a similar extent as wild type POT1b, its expression reduced the telomeric
localization of Stn1 as detected by immunofluorescence431. Thus, the POT1b-LVDII
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mutant could be used not only to explore the functions of POT1b related to its interaction
with CST but also to query the telomere-specific functions of CST.

Figure 4.14. The POT1b mutant unable to interact with CST mimics depletion of Stn1. (A)
Representative in-gel overhang analysis of POT1bF/- MEFs expressing the indicated POT1b alleles at 120 h
after Hit&Run Cre. (B) Representative in-gel overhang analysis of ApolloF/FPOT1bF/F MEFs expressing the
indicated POT1b alleles at 120 h after Hit&Run Cre. (C) Quantitation of overhang analysis in (A). Values
indicate the mean and sd of three independent experiments. (D) Quantitation of overhang analysis in (B).
Values indicate the mean and sd of three independent experiments. (Experiments by H. Takai)

	
  
In collaboration with H. Takai, I investigated the telomeric overhang signal in
POT1bF/- MEFs expressing either wild type or mutant alleles of POT1b after the deletion
of endogenous POT1b with Cre. Whereas wild type POT1b completely abolishes the
excess overhangs associated with POT1b deletion, POT1b-LVDII mutant was unable to
fully rescue this phenotype (Figure 4.14A, C). In the presence of POT1b-LVDII, the
telomeric overhang signal remained elevated by ~2 fold compared to wild type, similar to
the case when Stn1 was depleted by shRNA.

The partial rescue of the overhang

phenotype associated with POT1b deletion by the POT1b-LVDII mutant suggested that
this mutant might be functional in its ability to suppress aberrant resection by Apollo
while being unable to promote the telomeric function of CST.
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Indeed, when ApolloF/FPOT1bF/F cells expressing either vector or POT1b-LVDII
were treated with Cre, the resultant increase in overhang signal was identical (Figure
4.14B,D). Thus, POT1b-LVDII appears to be a dissociation-of-function mutant that
inhibits Apollo while being unable to promote CST function. In the absence of both
Apollo and POT1b, the accumulation of excess overhangs is due entirely to the loss of
CST function at telomeres. Overhang analyses of POT1b-deficient cells complemented
with the POT1b-LV and POT1b-DII mutants further confirmed that the level to which the
mutants suppressed the aberrant overhang phenotype of POT1b KO cells correlated with
the ability of the mutants to interact with CST. That is, the POT1b-LV and POT1b-DII
mutants, which still retained some ability to interact with CST, suppressed the excessive
overhangs in POT1b null cells to a greater extent than POT1b-LVDII (Figure 4.14A-D).
Next, I analyzed the overhangs of the leading- and lagging-end telomeres in cells
expressing the POT1b-LVDII mutant, to corroborate the functions attributed to Stn1.
Indeed, similar to what had been observed upon Stn1 depletion, POT1b-deficient cells
complemented with POT1b-LVDII had increased overhangs at both the leading- and
lagging-end telomeres compared to cells complemented with wild type POT1b (Figure
4.15A-F). With respect to the overhang phenotype at leading-end telomeres, POT1bLVDII completely mimicked deletion of POT1b (Figure 4.15D-F). At the lagging-end
telomeres, POT1b-LVDII partially rescued the excessive overhang signal that occurred in
the absence of POT1b. These results suggest that overhang size at leading-end telomeres
is limited by POT1b primarily through the recruitment of CST.

At lagging-end

telomeres, on the other hand, both the inhibition of Apollo and recruitment of CST are
important for limiting excessive overhang accumulation.
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Figure 4.15. The POT1b mutant unable to interact with CST mimics the depletion of Stn1 at at both
newly synthesized telomeres. (A), (B), (C) Representative slot blots of telomeric signal in each fraction
collected from CsCl density gradient equilibrium centrifugation of BrdU-labeled telomeric DNA from
POT1bF/- MEFs expressing vector (A), wild type POT1b (B), or POT1b-LVDII (C) at 120 hours after Cre.
(D) Overhang analysis of bulk telomeres, and the separated leading- and lagging-end telomeres from
telomerase-proficient MEFs. (E) Overhang analysis of bulk telomeres, and the separated leading- and
lagging-end telomeres from telomerase-deficient MEFs. (F) Compilation of results shown in (D) and (E).
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Similar results were observed in the presence and absence of telomerase,
providing further support that the function of CST at both newly-synthesized telomeres is
independent of telomerase (Figure 4.15D-F). In addition, detection of the total telomeric
signal on denatured gels revealed a subtle difference in telomere length between
telomerase-deficient MEFs expressing POT1b-LVDII and those expressing wild type
POT1b. In the presence of wild type POT1b, telomeres were slightly longer than in cells
lacking POT1b or expressing the POT1b-LVDII mutant.

Since the cells in this

experiment were analyzed a few weeks after endogenous POT1b had been replaced with
the exogenous alleles, the observed telomere length differences might reflect the ability
of wild type POT1b to rescue the accelerated telomere shortening associated with loss of
POT1b, whereas the POT1b mutant unable to interact with CST appears unable to
complement this function. More extensive analyses are required to explore the role of
CST in telomere length homeostasis. The recruitment of CST to telomeres may be
important for limiting the extent of telomere shortening that occurs in the absence of
telomerase.

Additional roles of CST in telomere replication
Since Ctc1 and Stn1 were originally identified as accessory factors to DNA
polymerase α290, I further investigated whether they have additional roles in telomere
replication other than at the terminus.

Challenging telomere replication with the

polymerase inhibitor aphidicolin or by depleting TRF1 induces the appearance of
multiple telomeric signals and/or a decondensed appearance of telomeric signals detected
at individual chromatid ends by telomeric FISH on metaphase spreads215,216. These have
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been referred to as fragile telomeres, since the phenotype resembles the appearance of
common fragile sites after treatment with aphidicolin. Stn1 depletion resulted in the
appearance of fragile telomeres (~10%) on metaphase spreads in the absence of an
apparent DNA damage response at telomeres (Figure 4.16A-C).
To investigate whether Stn1 acts in the same pathway as TRF1, I depleted Stn1 in
SV40LT-immortalized TRF1F/FROSA-Cre-ERT2 MEFs from which TRF1 could be rapidly
and efficiently deleted with tamoxifen (generated by A. Sfeir).

At 24 hours after

tamoxifen treatment of cells infected with a mock shRNA, ~60% of cells were TIFpositive, and ~30% of telomeres showed a fragile phenotype, as detected by telomeric
FISH on metaphase spreads (Figure 4.16A-C). When Stn1 and TRF1 were co-depleted,
the frequency of fragile telomeres increased, beyond what was observed in the absence of
either factor alone (Figure 4.16B), while the percentage of TIF-positive cells remained
similar to that in the absence of TRF1 (Figure 4.16C).

The percentage of fragile

telomeres upon depletion of both Stn1 and TRF1 was additive, while qualitatively, the
telomeres appeared even more fragmented than in the absence of TRF1 alone (Figure
4.16A-B).
The severity of the fragile telomere phenotype did not correlate with the amount
of single-stranded telomeric signal detectable by in-gel hybridization (Figure 4.16D). In
cells lacking both Stn1 and TRF1, the single-stranded telomeric signal was not
significantly elevated compared to that observed when Stn1 alone was depleted. The
telomeric signal in the denatured gel also did not reveal overt telomere shortening that
might be associated with chromosome breakage within the telomeres.
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Figure 4.16. Depletion of Stn1 induces a fragile telomere phenotype that is additive with TRF1
deletion. (A) Telomeric FISH on metaphase spreads from SV40-LT TRF1F/FROSA-Cre-ERT2 MEFs at 96
hours after shRNA depletion of Stn1 and 24 hours after treatment with tamoxifen. (B) Quantification of
fragile telomeres detected in (A). The numbers above the columns indicate the number of telomeres (long
arm only) scored for each condition in one experiment. (C) Quantification of TIF assay for the
colocalization of 53BP1 with telomeres detected by FISH. (D) In-gel overhang assay for cells harvested at
the same timepoint as in (A).

	
  
These results suggest that Stn1 and TRF1 facilitate telomere replication through
separate pathways.

The phenotypes observed upon Stn1 depletion resemble those

associated with aphidicolin treatment. Since Stn1 was identified as an accessory factor
for DNA polymerase α, CST may be required to promote the activity of lagging-strand
DNA polymerases during telomere replication. It remains to be seen whether the role of
Stn1 in replication is also dependent on its interaction with POT1b. Fragile telomeres
have not been reported in cells lacking TPP1/POT1b, suggesting that other mechanisms
might be involved in the recruitment of CST during semi-conservative replication of
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telomeres. It remains possible that the role of CST at the telomere terminus is distinct
from its function at internal sites of replication.
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SUMMARY OF FINDINGS
Here, I have elucidated the mechanism by which POT1b prevents aberrant
degradation of the telomeric C-rich strand (Figure 4.17). POT1b functions at the termini
of both newly synthesized telomeres during S phase to inhibit the nucleolytic activity of
Apollo while promoting the activities of the Ctc1/Stn1/Ten1 complex.

Figure 4.17. The mechanism by which POT1b protects telomeres from aberrant degradation of the
C-rich strand. (A) The replication fork as its reaches the telomere terminus. Throughout S phase, POT1b
loaded on the terminal overhang inhibits aberrant degradation by Apollo. (B) Apollo is required to
generate the 3’ overhang at leading-end telomeres. POT1b loading onto newly generated overhangs inhibits
Apollo and promotes the recruitment of CST, which limits overhang size by facilitating fill-in synthesis of
the C-rich strand. (C) POT1b inhibits Apollo and promotes CST function at the newly synthesized laggingend telomere.
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At newly-synthesized leading-end telomeres, Apollo initiates 5’ resection,
generating an overhang that binds POT1b, which in turn inhibits further degradation by
Apollo. POT1b also binds the single-stranded overhangs present throughout S phase at
unreplicated telomeres and newly-synthesized lagging-end telomeres, inhibiting aberrant
degradation of these ends by Apollo. The results further indicate that POT1b recruits the
mammalian CST complex to both newly-synthesized telomeres. Since Ctc1 and Stn1 are
accessory factors of DNA polymerase α/primase, the function of CST at telomeres may
be to complete fill-in synthesis of the C-rich strand, which is necessary not only
following extension of the G-rich strand by telomerase but also to counteract 5’ end
resection by Apollo (and other nucleases that act during S phase). CST also facilitates
the semi-conservative replication of telomeres and suppresses the appearance of fragile
telomeres, though it is not known whether this role requires its interaction with POT1b.
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CHAPTER 5:
THE TELOMERIC ROLE OF NUCLEASES THAT PERFORM
5’ END RESECTION AT DNA DOUBLE STRAND BREAKS
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INTRODUCTION
The aim of the research described in this section was to test the hypothesis that
newly-synthesized telomeres are recognized transiently as sites of DNA damage and
processed by the same factors that perform 5’ end resection at a DNA double strand
break. In S. cerevisiae, the model for DNA DSB resection involves initial processing by
the Mre11/Rad50/Xrs2 complex in cooperation with the Sae2 nuclease, after which
extensive resection occurs by either the Exo1 nuclease or the Dna2 nuclease in
conjunction with the Sgs1 helicase378,379. In human cells, the RecQ helicase BLM has
been found to be the helicase that acts in parallel with Exo1380. Here, I tested whether
any of the mammalian orthologs of MRX, Sae2, Exo1, and Sgs1 contribute to the
dynamics of the telomeric overhang in wild type cells. I further determined whether
Exo1 and/or Nbs1 have additional functions at leading-end telomeres when overhang
generation is compromised due to the absence of Apollo.
While Exonuclease 1 had previously been reported to have no contribution to
telomeric structure, my experiments reveal that Exo1 contributes to an end-processing
step that occurs on both newly synthesized telomeres, generating transiently elongated
overhangs in late S/G2 phase. Exo1 acts at telomeres independently of Apollo, while
other factors involved in resection at a DNA DSB do not appear to cooperate with Exo1.
The physiologic role of this step is unclear, as it does not appear important for telomere
end protection or telomere length homeostasis.
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RESULTS
Exo1 contributes to 5’ end resection of telomeres in late S phase
Since Exo1 has been proposed to have a major role in 5’ end resection at DSBs378380

, I evaluated the telomeric overhang in Exo1-deficient MEFs despite previous reports

suggesting that Exo1 does not contribute to overhang maintenance187,394. Exo1-/- mice are
homozygous for a mutant Exo1 allele containing a hygromycin resistance cassette
inserted into exon 6, which results in alternative splicing that fuses exon 5 in-frame to
exon 7, deleting amino acids 61-84 of the nuclease domain374. Exo1-deficient mice are
sterile, develop lymphomas at a higher rate, and show reduced survival374. Consistent
with the proposed role of Exo1 in mismatch repair, cells derived from Exo1-/- mice are
impaired in the ability to repair base:base and single-base insertion/deletion mismatches
in 5’ and 3’ nick-directed repair in vitro as well as increased microsatellite instability and
a 30-fold increase in the mutation rate at the Hprt locus374.
In asynchronous SV40LT-immortalized Exo1-/- MEFs, the telomeric overhang
was reduced by 30-40% compared to that in wild type littermate MEFs (Figure 5.1A), in
the absence of overt differences in cell cycle profile. To rule out the possibility that Exo1
loss compromises the ability of telomerase to extend the G-rich strand, I analyzed the
telomeric overhang in SV40LT-immortalized Exo1-/-mTR-/- MEFs generated from
intercrosses of Exo1+/-mTR+/- mice (Figure 5.1B). The overhang defect observed in the
absence of Exo1 was independent of telomerase, consistent with a role of Exo1 in
nucleolytic degradation of the telomeric C-rich strand (Figure 5.1B-C).
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Figure 5.1. Exo1 contributes to telomerase-independent overhang dynamics. (A) Genotyping PCR of
Exo1 and mTR status in MEFs generated from intercrosses between Exo1+/-mTR+/- mice. (B) Representative
in-gel overhang assay for MEFs genotyped in (A). The relative ssTTAGGG signal in the native gel was
normalized to total TTAGGG signal in the denatured gel and lane 1 was set to 100. (C) Quantification of
overhang assay shown in (B). Values shown are the means and sds from three independent experiments.
(D) In-gel overhang assay on MEFs of the indicated genotypes introducing vector control or N-terminal
myc-tagged Exo1 carrying the puromycin resistance marker at 3 days after selection. (E) In-gel overhang
assay on MEFs of the indicated genotypes at 96 hours after retroviral shRNA targeting Exo1 (puroresistant) at 3 days after selection.

	
  
To determine whether the overhang defect is specifically due to the loss of Exo1,
I introduced N-terminal myc-tagged mouse Exo1 into Exo1-deficient MEFs. Though
immunoblots for the myc tag showed a low level of Exo1 expression, the overhang signal
in Exo1-deficient cells was unaffected (Figure 5.1D).
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The inability to rescue the

overhang defect associated with Exo1 deficiency with wild type Exo1 could be due to a
dominant negative effect of the nuclease-deficient form of Exo1 (expressed in Exo1-/MEFs) or due to haploinsufficiency, whereby exogenously introduced Exo1 is not
expressed at a high enough level to achieve wild type function.

In an alternative

approach to evaluate the role of Exo1 in overhang generation, Exo1 was depleted in wild
type MEFs by shRNA, which resulted in a similar 30% reduction in the telomeric
overhang signal in the absence of changes in cell cycle profile (Figure 5.1E).
Introduction of this shRNA into Exo1-/- MEFs had no effect on the telomeric overhang,
suggesting that the overhang defect observed in both Exo1-/- MEFs and following Exo1
depletion by shRNA was likely due to the deficiency of the Exo1 nuclease (Figure 5.1E)
Using FUCCI-FACS, I isolated Exo1-deficient cells in G1 and late S/G2 and
compared the overhang signal during different cell cycle phases. As shown previously in
wild type MEFs (Chapter 3 and

213

) and human cell lines250, a 2-fold increase in the

telomeric overhang signal occurs in late S/G2 compared to G1 (Figure 5.2A). This
transient increase in the single-stranded telomeric signal is due to the terminal overhang
rather than internal single-stranded regions that might become exposed during
replication, since the overhang signal is abolished when agarose-embedded DNA from
late S phase cells is treated with the E. coli 3’ to 5’ exonuclease ExoI prior to preparation
for the in-gel hybridization assay (Figure 5.2A). Since this change in overhang signal is
observed in the absence of telomerase, it is likely due to 5’ end resection of telomeres in
late S phase, followed by fill-in synthesis of the C-rich strand as cells progress from G2
to M.

In telomerase-proficient cells, Exo1 deficiency did not have a statistically

significant effect on the overhang signal in G1 but specifically reduced the overhang
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signal in late S/G2 (Figure 5.2B). In cells deficient for both telomerase and Exo1, the
overhangs in G1 cells were ~10-20% reduced compared to telomerase-deficient cells, and
the relative overhang signal remained nearly constant between G1 and late S phase
(Figure 5.3C). These results are in contrast to those observed in the absence of Apollo,
which induces a 40-50% reduction of the overhang signal in both G1 and late S when
compared to wild type cells in the same cell cycle stages (refer to Figure 3.6E-F).

	
  
Figure 5.2. Exo1 contributes to transient overhang elongation in late S phase. (A) Representative
telomeric overhang analysis of G1 and late S/G2 Exo1+/+mTR-/- MEFs and Exo1-/-mTR-/- isolated by FUCCIFACS (described in Chapter 3). The relative single-stranded signal was normalized to total TTAGGG
signal and determined as a percentage of the signal in the lane containing wild type G1 cells (set at 100).
(B) Quantification of relative single-stranded telomeric signal in telomerase-proficient wild type and Exo1-/cells in G1 and late S/G2. (C) Quantification of relative single-stranded telomeric signal in G1 and late
S/G2 as assayed in (A).
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I next determined whether Exo1 acts at both newly-synthesized telomeres using
CsCl density gradient equilibrium centrifugation of BrdU-labeled telomeres to isolate the
leading- and lagging-end telomeres (described in Chapter 3). Slot blots detecting the
telomeric signal in each fraction collected from the CsCl gradient confirmed that
similarly effective separation of the leading- and lagging-end telomeres could be
achieved with BrdU-labeled DNA isolated from both wild type and Exo1-deficient cells
(Figure 5.3A-B).

Exo1 deficiency resulted in a 20-30% reduction in the telomeric

overhang signal at both newly synthesized telomeres (Figure 5.3C-D).

Thus, Exo1

contributes to the processing of both newly-synthesized telomeres in S phase.
When the CsCl gradient fractions corresponding to unreplicated telomeres were
pooled and analyzed by in-gel hybridization, there was no difference in the telomeric
overhang signal in the presence or absence of Exo1 (Figure 5.3C-D). This alternative
method of detecting the overhangs at unreplicated telomeres did not corroborate the small
reduction in the G1 overhang signal observed in Exo1-/-mTR-/- cells compared to
Exo1+/+mTR-/- cells, when FUCCI-FACS was used to isolate non-cycling cells. To reach a
more definitive conclusion as to whether Exo1 deficiency affects overhang size in G1, an
additional set of littermate Exo1-/-mTR-/- and Exo1+/+mTR-/- MEFs may need to be
generated and assessed.
	
  

	
  

155

Figure 5.3. Exo1 contributes to overhang dynamics of both newly synthesized telomeres. (A) and (B)
Representative slot blots of telomeric signal in each fraction collected from CsCl density gradient
equilibrium centrifugation of telomeric DNA from Exo1+/+mTR-/- (A) and Exo1-/-mTR-/- (B) MEFs labeled
with BrdU for one round of replication. The fractions pooled for overhang analyses are shown. (C)
Representative overhang analysis of bulk telomeres (prior to CsCl density gradient equilibrium
centrifugation), and separated leading-, lagging-end and unreplicated telomeres from Exo1+/+mTR-/- and
Exo1-/-mTR-/- MEFs (D) Quantification of relative overhang signal as detected in (C). Values represent the
mean of two independent experiments.
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Exo1 is not required for telomere protection and is not responsible for the rate of
telomere shortening in telomerase-deficient cells
Telomeres with blunt ends or short overhangs are expected to activate the ATM
kinase signaling pathway and undergo aberrant repair as exemplified by the case of
Apollo deficiency, where leading-end telomeres with short or nonexistent overhangs
activate ATM and engage in end-joining reactions. However, no telomere dysfunction
was observed in Exo1-deficient cells, as Exo1 deficiency did not give rise to telomere
dysfunction-induced foci, downstream signs of ATM signaling such as Chk2
phosphorylation, or telomere fusions (Figure 5.4A-B). This was not due to a defect in
ATM kinase signaling in the absence of Exo1, because irradiating Exo1-deficient cells
still resulted in robust Chk2 phosphorylation (Figure 5.4A). These results are consistent
with Exo1 acting in a late step in telomere end processing after sufficient overhangs have
been generated to suppress ATM signaling and aberrant end-joining.
Consistent with Exo1 contributing to a transient step in telomere end-processing
that does not significantly alter the overhang size in G1, Exo1 deficiency did not affect
telomere length homeostasis. Cells lacking both Exo1 and mTR exhibited a rate of
telomere shortening that was not significantly different from that of cells lacking
telomerase only (Figure 5.4C-D), suggesting that Exo1-mediated processing is not
responsible for the rate of telomere shortening in telomerase-deficient cells.

This

corroborates the previously published finding that late generation telomerase- and Exo1deficient mice do not have longer telomeres than late generation telomerase-deficient
mice394. Furthermore, Exo1 deficiency had no appreciable effect on telomere length in the
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presence of telomerase, suggesting that the telomere end-processing step mediated by
Exo1 is not required for telomerase to act at telomeres.

	
  
Figure 5.4. Exo1 is not required for telomere end protection. (A) Immunoblot detection of Chk2
phosphorylation status of wild type and Exo1-deficient MEFs. (B) Quantification of FISH analysis of
Exo1-deficient MEFs. (C) Growth curve of SV40-LT immortalized Exo1+/+mTR-/- and Exo1-/-mTR-/- MEFs
passaged in parallel for 120 days in culture. (D) In-gel detection of native and denatured telomeric signal in
DNA from Exo1+/+mTR-/- and Exo1-/-mTR-/- MEFs harvested after the indicated population doublings,
according to the growth curve shown in (C).

	
  
Stn1 depletion in Exo1-deficient cells still results in extended overhangs
After telomeric overhangs are transiently elongated in S phase, they must be
restored to the size found in G1 cells either by fill-in synthesis of the C-rich strand or
nucleolytic cleavage of the overhang. If C-strand fill-in synthesis occurs following Exo1mediated end processing, then defects in C-strand fill-in might be expected to produce a
less severe overhang phenotype in the absence of Exo1. Thus, I asked whether the
accumulation of excessive overhangs associated with Stn1 depletion can be mitigated by
Exo1 deficiency.
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Stn1 depletion in Exo1-deficient MEFs resulted in an increase in the telomeric
overhang signal, though this signal was reproducibly less than that observed when Stn1
was knocked down in wild type MEFs (Figure 5.5A-B). These results suggest that Exo1mediated processing is not the only mechanism by which telomeres acquire long
overhangs that require fill-in synthesis of the complementary strand. In the absence of
Exo1, Apollo is likely to still generate long overhangs at leading-end telomeres whose
length must be limited by Stn1. Meanwhile, lagging-end telomeres are likely to still
require the function of Stn1 for complete synthesis of the C-rich strand even in the
absence of additional processing by Exo1. Further experiments should be performed to
examine the effect of depleting Stn1 in cells lacking both Apollo and Exo1.

	
  
Figure 5.5. Overhang accumulation upon Stn1 depletion in Exo1-deficient cells. A) Representative
overhang assay of Exo1+/+ and Exo1-/- MEFs at 96 hr after lentiviral transduction of vector or shRNA
targeting Stn1. (B) Quantification of overhang analyses as assayed in (A). Values represent the mean and
sds of three independent experiments.

	
  
The DNA damage response to deprotected telomeres lacking TPP1/POT1 is not
modulated by Exo1 deficiency
Exo1 deficiency has been reported to ameliorate the organ dysfunction observed
in telomerase-deficient mice at late generations when their telomeres become critically
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short394. In this setting, the absence of Exo1 did not rescue telomere shortening but
reduced the accumulation of DNA damage foci394. Thus, it was proposed that Exo1mediated resection contributes to the DNA damage responses activated in the setting of
telomere dysfunction.
I therefore asked whether Exo1 deficiency mitigates the DNA damage response
observed in the absence of POT1a/b, where excessive single stranded telomeric
overhangs bind RPA and activate the ATR kinase pathway37,190,213. To address this
question, I depleted TPP1 by shRNA in wild type and Exo1-deficient cells and compared
the overhang signal and appearance of TIFs in both settings. As expected based on the
previous finding that Exo1 is not responsible for the accumulation of excessive single
stranded telomeric overhangs in the absence of POT1b187, the aberrant increase in
overhang signal induced by TPP1 depletion was not abolished in Exo1-deficient cells
(Figure 5.6A-B). Nevertheless, the relative overhang signal observed when TPP1 was
depleted in Exo1-deficient cells was less than that in wild type cells in which TPP1 was
depleted (Figure 5.6A-B). This is likely because Exo1 deficiency abolishes the transient
increase in telomeric overhang signal normally observed in S phase cells.

This

observation suggested that in cells depleted for both Exo1 and TPP1, the total amount of
single-stranded overhangs exposed to recognition by the DNA damage response,
particularly in S phase, might be less than that in the setting of TPP1 deficiency alone.
Immunofluorescence for the DNA damage factor 53BP1 at telomeres (detected by
FISH) showed that Exo1 deficiency did not significantly reduce the percentage of cells
with ≥5 TIFs compared to cells depleted for TPP1 alone (Figure 5.6C). However, Exo1
deficiency did result in a ~10% reduction in the percentage of cells with ≥10 TIFs (Figure
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5.6C). Exo1 deficiency and the associated reduction in telomeric overhang signal may
thus have a slight effect on the DNA damage response induced by TPP1 depletion by
reducing the fraction of telomeres that are recognized as DNA damage.
Since the depletion of TPP1 by shRNA induces a milder phenotype than that
observed when either TPP1 or POT1a and POT1b are deleted in MEFs, I investigated the
contribution of Exo1 to telomere dysfunction by an alternative approach in which Exo1
was depleted with shRNA in POT1aF/FPOT1bF/F or TPP1F/F MEFs following Cre
treatment.

Similar to what was observed in the previous experiment, the aberrant

overhang phenotype induced by deleting POT1a and –b or TPP1 was not abolished by the
depletion of Exo1 (Figure 5.6D). In addition, Exo1 knockdown in cells deficient for
POT1a and POT1b did not abolish the accumulation of 53BP1 to telomeres, though a
~10% reduction in the fraction of cells with >10 TIFs was observed (Figure 5.6E). It
remains to be determined whether this small effect of Exo1 depletion on the DNA
damage response to POT1a/b deletion is statistically significant, though the fact that
similar trends were observed in the setting of either TPP1 depletion in Exo1-deficient
cells or Exo1 depletion in POT1a/b DKO cells suggests that this may be a reproducible
result.
The current studies suggest a minor (if any) contribution of Exo1 to the telomere
dysfunction observed in the absence of TPP1 or POT1a/b. These results are in contrast to
the previous study where the DNA damage response observed in late generation
telomerase knockout mice was significantly reduced by Exo1 deficiency394. Since cells
deficient for both POT1a and POT1b or TPP1 accumulate excessive overhangs
independently of Exo1, depleting Exo1 in this setting may be insufficient to counteract
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the large amount of exposed single-stranded overhangs that accumulate and activate the
ATR signaling pathway. It will be of interest to determine whether the depletion of Exo1
can suppress the appearance of TIFs in cells deficient for POT1a only, which do not
accumulate excess telomeric overhangs37.

	
  
Figure 5.6. Exo1 depletion does not modulate the DNA damage response that occurs in the absence of
TPP1/POT1a/b. (A) Representative overhang assay of Exo1+/+ and Exo1-/- MEFs at 96 hr after retroviral
introduction of vector or shRNA to TPP1. (B) Quantification of overhang analyses as assayed in (A).
Values represent the mean and SDs of three independent experiments. (C) Quantification of TIFs defined
as colocalization of 53BP1 detected by immunofluorescence to telomeres detected by FISH, in cells of the
indicated genotype. (D) Representative overhang assay of POT1aF/FPOT1bF/F and TPP1F/F MEFs infected
with vector control or retroviral shRNA targeting Exo1 (selected for 3 days with puromycin) at 96 hr after
Hit&Run Cre. (E) Quantification of TIFs defined as colocalization of 53BP1 detected by
immunofluorescence to telomeres detected by FISH, in cells of the indicated genotype.
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The telomere processing step mediated by Exo1 is unaffected by the depletion of
other factors involved in DSB resection
I next investigated whether the action of Exo1 at telomeres resembles the process
of 5’ end resection at a DNA DSB by testing whether other nucleases and helicases
involved in DSB resection contribute to the telomere end-processing step mediated by
Exo1. As previously shown in Chapter 4, depletion of CtIP, Nbs1, or BLM alone had no
effect on the telomeric overhang signal in wild type MEFs (Figure 5.7A-F). Furthermore,
depletion of CtIP in Exo1-deficient cells resulted in no further reduction in the telomeric
overhang signal (Figure 5.7A-B). Co-deletion of Exo1 and Nbs1 or Exo1 and BLM also
did not exacerbate the overhang defect observed in the absence of Exo1 (Figure 5.7C-F).
Thus, neither the MRN complex nor BLM appear to contribute to the transient overhang
elongation that occurs in late S phase, in either wild type or Exo1-deficient MEFs. This
is in contrast to DSB repair in S. cerevisiae where resection is severely impaired in
sae2Δexo1Δ and sgs1Δexo1Δ mutants378,379 and also in human cells where the codepletion of Exo1 and BLM reduces RPA foci formation in response to camptothecin
compared to the depletion of either factor alone380. It has been shown in S. cerevisiae that
in the absence of Ku, Exo1-mediated resection no longer depends on Sae2, though the
Sgs1-mediated pathway still also functions in this setting432. The apparent differences in
the action of Exo1 at telomeres and DNA DSBs could be due to differences in the factors
that bind at wild type telomeres as opposed to DSBs.
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Figure 5.7. Exo1-mediated processing is not affected by depletion of CtIP, Nbs1, or BLM. (A)
Immunoblot for CtIP in Exo1+/+ and Exo1-/- MEFs transduced with retroviral vector or shRNA. γ-tubulin is
shown as a loading control. (B) Overhang assay of cells in (A). Relative ss TTAGGG signal in each lane of
the native gel was normalized to the total TTAGGG signal in the same lane of the denatured gel, with the
value in lane 1 set to 100. (C) Immunoblot for Nbs1 in Exo1+/+Nbs1F/F and Exo1-/-Nbs1F/F MEFs without
Cre and 120 hours after Hit&Run Cre. POT1b is shown as a loading control. (D) Overhang assay of cells
in (C). Relative ss TTAGGG signal in each lane of the native gel was normalized to the total TTAGGG
signal in the same lane of the denatured gel, with the value in lane 1 set to 100. (E) Immunoblot for BLM
in Exo1+/+BLMF/F and Exo1-/-BLMF/F MEFs without Cre and 120 hours after Hit&Run Cre. γ-tubulin is
shown as a loading control. (F) Overhang assay of cells in (E). Relative single-stranded TTAGGG signal in
each lane of the native gel was normalized to the total TTAGGG signal in the same lane of the denatured
gel, with the value in lane 1 set to 100.

	
  
To further examine telomere processing in S phase, I performed a number of drug
treatments on cells proceeding synchronously through S phase. Using FUCCI-FACS, I
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isolated Cdt1+Gem+ cells, which were confirmed to be in early S phase and progressed to
late S/G2 within 6 hours after plating (Figure 5.8A). Plated cells were treated with the
Cdk inhibitor, roscovitine, for 4 hours. The cell cycle profiles of roscovitine-treated cells
showed that both G1 and S phase cells were arrested after 4 hours of drug treatment,
indicating that Cdk activity was indeed inhibited. However, roscovitine treatment did not
abolish the late S phase increase in telomeric overhang (Figure 5.8B), suggesting that the
processing does not depend on factors such as CtIP that have been reported to require
Cdk phosphorylation for activity383. A recent report has suggested that SIRT6-mediated
acetylation of CtIP is also required for its nucleolytic activity, which can be inhibited by
nicotinamide, a non-specific SIRT inhibitor384. When G1 or early S phase cells were
plated and treated with nicotinamide for 4-16 h, no change in the overhang signal was
observed (Figure 5.8C). Together these results suggest that resection by CtIP does not
likely contribute to the telomere end-processing step that leads to transiently elongated
overhangs in late S phase, though a functional assay is required to show that CtIP
function is indeed impaired by these drug treatments.

Exo1 acts at newly-synthesized telomeres in the absence of Apollo
I next asked whether the action of Exo1 depends on earlier steps in end
processing. Since Apollo contributes to overhang generation at leading-end telomeres, I
generated ApolloF/FExo1-/- MEFs to determine whether Exo1 activity at leading-end
telomeres requires initial processing by Apollo. Co-deletion of Apollo and Exo1 by Cre
treatment resulted in an additive effect on the telomeric overhang. Whereas a deficiency
in either Apollo or Exo1 alone resulted in a 30-40% reduction in the overhang signal, the
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absence of both nucleases reduced the overhang signal by approximately 70% (Figure
5.9A-B). Thus, the action of Exo1 at telomeres appears to be independent of Apollo.

	
  
Figure 5.8. Late S phase processing of telomere ends is unaffected by roscovitine or nicotinamide
treatment. (A) Cell cycle profile of cells sorted by FUCCI-FACS in G1 or early S and plated for 1.5 hours
prior to addition of DMSO or 50 µM roscovitine for 4 hours. Cells were fixed with 70% ethanol, stained
with PI for DNA content, and analyzed by flow cytometry. (B) Overhang assay of cells treated as in (A).
(C) Overhang assay of cells sorted by FUCCI-FACS in G1 or early S and plated for 1.5 hours prior to
addition of DMSO or 10mM nicotinamide for the indicated amount of time.

Overhang analyses of Apollo/Exo1 DKO cells by FUCCI-FACS were also
consistent with the conclusion that Apollo and Exo1 act independently of each other.
When Apollo was deleted from Exo1-deficient cells, the telomeric overhangs in G1 and S
phase were reduced by ~40% compared to those of wild type cells in the same cell cycle
phases. Furthermore, in the absence of both Apollo and Exo1, no increase in overhang
signal was observed as cells progress from G1 to S phase (Figure 5.9C-D), whereas both
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wild type and Apollo-deficient cells displayed a 2-fold increase in overhang signal in late
S phase.

	
  
Figure 5.9. In the absence of Apollo, Exo1 contributes to extensive resection in S phase. (A)
Representative overhang assay of SV40-LT immortalized ApolloF/F Exo1+/+ and two independent ApolloF/F
Exo1-/- MEF lines at 120 hr after Hit&Run Cre. (B) Quantification of overhang analyses as assayed in (A).
Values represent the mean and sds of three independent experiments. (C) Representative telomeric
overhang analysis of G1 and late S/G2 ApolloF/F Exo1-/- in the absence and 120 hour post Cre, isolated by
FUCCI-FACS. The relative single-stranded signal was normalized to total TTAGGG signal and determined
as a percentage of the signal in the lane containing wild type G1 cells (set at 100). (D) Quantification of
relative single-stranded telomeric signal in G1 and late S/G2 as assayed in (A). The single-stranded
telomeric signal was normalized to total TTAGGG signal and determined as a percentage of the signal in
wild type G1 cells (set at 100). Values are the mean of three independent experiments and SDs.

	
  
When CsCl density gradient equilibrium centrifugation was used to separate the
leading- and lagging-end telomeres, Cre treatment of ApolloF/F Exo1-/- MEFs resulted in a
~60% reduction in the overhang at leading-end telomeres with no effect on lagging-end
overhangs. In this experiment, the deletion of Apollo in Exo1-deficient cells appeared to
cause a more severe overhang defect at leading-end telomeres than when Apollo was
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deleted in Exo1-proficient cells. This result requires validation, since it may suggest that
Exo1 has an even greater role in the 5’ resection of leading-end telomeres in the absence
of Apollo than in wild type cells. Nonetheless, these results permit the conclusion that
Apollo and Exo1 act independently and differentially at newly synthesized leading- and
lagging-end telomeres.

Figure 5.10. Exo1 acts at both newly-synthesized telomeres independently of Apollo. (A) and (B)
Representative slot blots of telomeric signal in each fraction collected from CsCl density gradient
equilibrium centrifugation of telomeric DNA from ApolloF/FExo1-/- MEFs in the absence of Cre (A) and at
120 hours after Hit&Run Cre (B), after labeling with BrdU for one round of replication. The fractions
pooled for overhang analyses are shown. (C) Representative overhang analysis of leading- and lagging-end
telomeres from ApolloF/F and ApolloF/FExo1-/- MEFs before and after Cre, separated in (A) and (B).
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In the absence of Apollo, Exo1 and MRN contribute differentially to the processing
and protection of leading-end telomeres
Though Exo1-mediated processing of telomeres in wild type cells appears to be
distinct from the canonical pathway of DSB resection, in a setting such as Apollo
deficiency, where the absence of a telomeric overhang elicits a DNA damage response,
factors involved in DSB resection may indeed be recruited and act as a alternative
method of generating overhangs at leading-end telomeres. This backup mechanism of
overhang generation could explain why the DNA damage response observed in Apollodeficient cells occurs only transiently in S phase. Since Exo1 appeared to act at leadingend telomeres even in the absence of Apollo, I asked whether Exo1 facilitates end
protection at leading-end telomeres in Apollo-deficient cells.

To investigate this

possibility, I evaluated whether Exo1 deficiency exacerbates the telomere dysfunction
phenotypes associated with the loss of Apollo. As shown previously in Chapter 3, the loss
of Apollo results in a transient ATM-dependent DNA damage response at a subset of
telomeres in S phase and the appearance of chromatid-type fusions between leading-end
telomeres on metaphase spreads. In the absence of both Apollo and Exo1, the fraction of
TIF-positive cells and the phosphorylation status of the ATM target Chk2 were
comparable to what was observed in the absence of Apollo alone (Figure 5.10B-C).
Exo1 deficiency also did not increase the total incidence of telomere fusion events,
though there appeared to be a slight reduction in leading-leading chromatid-type fusions
and a corresponding increase in fusions of other types (Figure 5.10D). Careful analyses
revealed that these other fusions were mainly of the chromosome-type, which may have
arisen as secondary events after chromatid-type fusions were segregated into daughter
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cells and duplicated. Since there was no increased incidence in sister fusions, laggingend telomeres appeared to remain largely protected. Consistent with the finding that
Exo1 loss does not exacerbate the DNA damage response occurring at leading-end
telomeres lacking Apollo, cells deficient for both Apollo and Exo1 also exhibited a
similar doubling rate as cells lacking Apollo only (Figure 5.10A). Thus, in the absence of
Apollo, though Exo1 mediates transient elongation of telomeric overhangs in late S
phase, this process does not appear to be necessary for end protection.

	
  
Figure 5.11. Exo1 deficiency does not exacerbate the DNA damage response associated with loss of
Apollo. (A) Growth curve of ApolloF/F and ApolloF/FExo1-/- in the absence and presence of Hit&Run Cre.
Open circles: ApolloF/F, open triangles: ApolloF/FExo1-/-, closed circles: ApolloF/F + Cre, closed triangles:
ApolloF/FExo1-/- + Cre. (B) Quantification of TIFs defined as the co-localization of 53BP1 detected by
indirect immunofluorescence to telomeres detected by FISH. (C) Immunoblot detection of Chk2
phosphorylation status. (D) Quantification of CO-FISH analysis detecting telomere fusions in ApolloF/F and
ApolloF/FExo1-/- MEFs at 120 hours after Hit&Run Cre.

	
  
Based on these results, it appeared that, in the absence of Apollo, nucleases other
than Exo1 were responsible for initiating resection at leading-end telomeres; thus, I next
investigated the contribution of MRN/CtIP. As previously shown (refer to Figure 5.7),
neither deleting Nbs1 nor depleting CtIP with two different shRNAs resulted in a defect
in the telomeric overhang or a preponderance of leading-end fusions, suggesting that
MRN/CtIP is not strictly required for overhang generation in wild type cells.
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Nonetheless, MRN/CtIP might contribute to overhang generation at leading-ends in the
absence of Apollo. Favoring this hypothesis is the observation that the level of leading
end fusions in TRF2/Nbs1 DKO cells is higher than that observed in the absence of
Apollo194,195.
I determined whether the overhang phenotype and leading-end fusions observed
in the absence of Apollo are exacerbated by co-deletion of Nbs1 by analyzing
ApolloF/FNbs1F/F MEFs following Cre treatment. Deletion of both Apollo and Nbs1
resulted in a significant growth defect (Figure 5.12A). Experiments were performed in
parallel to compare the overhang in Apollo KO vs. Apollo/Nbs1 DKO cells at 96 hours
after Cre-mediated deletion. The overhang defect in the absence of both Apollo and
Nbs1 was not significantly worse than in the absence of Apollo alone (Figure 5.12B).
Depletion of CtIP in Apollo KO cells also resulted in no further reduction in overhang
signal compared to Apollo null cells, though this result could be due to incomplete
depletion of CtIP (Figure 5.12E). These experiments suggest that MRN/CtIP contribute
negligibly to overhang size in the absence of Apollo.
Nonetheless, Nbs1 did appear to have a role in protecting leading-end telomeres
in the absence of Apollo. Co-deletion of Apollo and Nbs1 resulted in approximately
twice as many leading-end fusions as observed in the absence of Apollo alone. This level
of leading-end fusion is comparable to that observed in TRF2/Nbs1 DKO cells. In
analyzing the metaphases of Apollo/Nbs1 DKO cells, it appeared that roughly half of the
leading-end fusions appeared as two telomeric signals juxtaposed next to each other
rather than a single telomeric signal. Whether these two observed types of fusions reflect
different repair pathways is not known. It is possible that the juxtaposed telomeric
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signals represent a distinct class of associations between leading-end telomeres that occur
only when both Apollo and Nbs1 are absent.

	
  
Figure 5.12. In Apollo-deficient cells, Nbs1 suppresses NHEJ of leading-end telomeres. Growth curve
of SV40-LT immortalized ApolloF/F and ApolloF/F Nbs1F/F MEFs the absence and presence of Hit&Run Cre.
Closed triangles: ApolloF/F, closed circles: ApolloF/F Nbs1F/F, open triangles: ApolloF/F + Cre, open circles:
ApolloF/F Nbs1F/F + Cre. (B) Overhang assay of ApolloF/F and two independent ApolloF/FNbs1F/F MEF lines
without Cre and 96 hours after Hit&Run Cre. (C) Representative CO-FISH detection of newly synthesized
telomeres on metaphase spreads. ^ indicates leading-end fusions. * indicates juxtaposed leading-end signals.
(D) Quantification of CO-FISH analysis detecting telomere fusions in ApolloF/F and ApolloF/F Exo1-/- MEFs
at 120 hours after Hit&Run Cre. (E) Overhang assay of ApolloF/F at 96 hours after lentiviral transduction
with empty vector or two different shRNAs to CtIP, without Cre or 120 hours after Hit&Run Cre.

	
  
One explanation for these results could be that in the absence of Apollo, MRN
can accelerate the rate of overhang generation by other nucleases (such as Exo1) that
otherwise act at a slow rate. Thus, in the absence of MRN/CtIP, the bulk overhang size
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observed by in-gel hybridization is not changed but the slow rate of overhang generation
results in a longer time interval during which leading-ends are vulnerable to fusion. If
Exo1 is the nuclease responsible for this slow resection that occurs in the absence of
Apollo and Exo1, depleting Exo1 in Apollo/Nbs1 DKO cells would be expected to
further increase the leading-end fusions. The ATM-dependent DNA damage response
activated at leading-ends lacking Apollo may thus recruit/activate nucleases and
helicases, that act redundantly and have differential roles in protecting leading-ends from
fusing.
Alternatively, the MRN complex could inhibit end-joining of Apollo-deficient
telomeres in a manner that is independent of its ability to promote 5’ end resection. It has
been shown that in DNA-PKcs-deficient cells, MRN promotes alternative end-joining
between coding ends that require hairpin-opening activity, while suppressing alternative
NHEJ between signal ends. Based on the previous finding that the leading-end telomere
fusions occurring in Apollo-deficient cells do not depend on ligase IV (Chapter 3), an
alternative hypothesis is that the binding of these ends by the MRN complex inhibits the
apparent A-EJ pathway that occurs in the absence of Apollo.
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SUMMARY OF FINDINGS
The major findings of this chapter are summarized in Table 5.1. Here, I uncover a
role for Exo1 in the transient elongation of telomeric overhangs in late S phase. The
physiologic function of this processing step is unclear, though Exo1-mediated telomere
processing does not appear to contribute to telomere end protection or the ability for
telomerase to act at telomeres.

Furthermore, the telomere dysfunction phenotype

observed upon TPP1/POT1 deletion, whereby extensive telomeric overhangs activate an
ATR-dependent DNA damage response, appeared to be largely independent of Exo1.
The behavior of Exo1 at telomeres does not appear to recapitulate its activity in DNA
DSB resection, since the effects of Exo1 depletion are not exacerbated by deficiencies in
Nbs1, CtIP, or BLM. Exo1 acts at telomeres in Apollo-deficient cells, but its absence
does not exacerbate the telomere dysfunction phenotypes associated with Apollo loss,
suggesting that Exo1 is not required for initiating end resection at leading-end telomeres
that lack Apollo. On the other hand, cells lacking both Apollo and Nbs1 show an
increase in leading-end fusions compared to cells lacking Apollo only. This could reflect
a role of the MRN complex in initiating resection at a fraction of ends in Apollo-deficient
cells, though it has not been excluded that MRN might repress leading-end fusions by an
alternative mechanism.
How Exo1 is recruited to telomeres remains an unanswered question. These
studies suggest that a transient DNA damage response activated during telomere
replication is unlikely to be the mode by which Exo1 localizes to telomeres in S phase.
Investigations into the contributions of mismatch repair pathway components to telomeric
overhang dynamics may shed light on whether Exo1 is recruited to telomeres through
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interactions with mismatch repair proteins. Investigations into whether Exo1 interacts
with shelterin proteins are also warranted.
Table 5.1. Relative overhang size and telomere fusions observed in different genetic backgrounds.

Underlined values were set to 100, to which all numbers in the same column were normalized.
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CHAPTER 6:
DISCUSSION
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A model for the generation and maintenance of terminal telomere structure
The work described in this thesis delineates a model, based on genetic
experiments in mouse cells, for the generation and maintenance of the terminal structure
of mammalian telomeres (Figure 1).

As replication reaches the telomere terminus,

leading-strand DNA synthesis results in a blunt duplex or 5’ single-stranded end that is
degraded by the nuclease Apollo to generate a single-stranded 3’ overhang. Apollo is
dispensable for overhang generation at telomeres generated by lagging-strand DNA
synthesis, which presumably contain constitutive overhangs throughout DNA replication.
In the absence of Apollo, unprocessed leading-end telomeres activate a transient ATMdependent DNA damage response in S phase and engage in fusions. This DNA damage
response is not observed at all leading-end telomeres nor does it persist in G1 cells, likely
due to additional pathways by which overhangs can be generated at leading-ends in the
absence of Apollo. One such backup pathway appears to involve the Mre11/Rad50/Nbs1
complex, which has no apparent role in wild type cells but protects a subset of leadingend telomeres from fusing in the absence of Apollo.
In late S phase, telomeric overhangs undergo further transient elongation that
depends on Exonuclease 1. Exo1 acts at both leading- and lagging-end telomeres in a
step that appears to be independent of other nucleases involved in 5’ end resection at a
DNA DSB. Exo1 contributes to telomere end processing in the absence of Apollo, but
has no apparent contribution to end protection in wild type or Apollo-deficient cells. The
transient elongation of telomeric overhangs by Exo1 is thus not likely required for the
initiation of 5’ resection at telomeres in the presence or absence of Apollo. The loss of

	
  

177

Exo1 also does not affect the rate of telomere shortening in telomerase-deficient cells.
Thus, the physiologic role of Exo1-mediated processing remains unclear.
At mouse telomeres, the single-stranded telomeric DNA binding protein, POT1b,
regulates overhang size by inhibiting Apollo while facilitating the activities of the
Ctc1/Stn1/Ten1 (CST) complex, composed of accessory factors of DNA polymerase
alpha/primase.

Loading of POT1b onto newly synthesized leading-end telomeres

depends on Apollo, while the single-stranded overhang present on the template strand for
lagging-strand DNA synthesis can presumably bind POT1b throughout S phase. In the
absence of POT1b, both leading- and lagging-end telomeres accumulate significantly
increased single-stranded overhangs that depend partially on Apollo. POT1b also limits
overhang length by facilitating CST at both newly-synthesized telomeres.

Specific

residues in POT1b that are not conserved in POT1a mediate a physical interaction with
members of the CST complex. A POT1b mutant that can interact with TPP1 and localize
to telomeres while no longer interacting with CST is unable to fully suppress the
excessive accumulation of single stranded telomeric overhangs, though this apparent
dissociation-of-function mutant inhibits aberrant nucleolytic degradation by Apollo.
	
  

	
  

178

Figure 6.1. A unified model for the generation and maintenance of the terminal structure of
mammalian telomeres. (A) The replication fork as it reaches the telomere terminus. Throughout S phase,
POT1b loaded on the terminal overhang inhibits aberrant degradation by Apollo. (B) and (C) show the
different telomere end-processing steps that occur at newly-synthesized leading- and lagging-end telomeres.
1) Apollo is required to generate the 3’ overhang at leading-end telomeres. In the absence of Apollo, Nbs1
has a role in initiating 5’ end resection and protecting leading-end telomeres from fusing. 2) POT1b loading
onto overhangs inhibits Apollo. 3) Exo1 acts at both newly synthesized telomeres leading to transient
elongation of the telomeric overhang. 4) POT1b promotes the recruitment of CST, which limits overhang
size by facilitating fill-in synthesis of the C-rich strand.
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Differential processing of leading- and lagging-end telomeres
My work highlights significant differences in the genetic requirements for
telomere end processing at leading- and lagging-end telomeres in mammalian cells. In S.
cerevisiae, chromatin immunoprecipitation studies have detected the single-stranded
DNA binding protein Cdc13 and the Est1 and Est2 subunits of telomerase at both
daughter telomeres, while deficiencies in the Mre11/Rad50/Xrs2 complex specifically
compromise their ability to localize to newly synthesized leading-end telomeres433.
However, these differences have not been linked directly to differences in overhang
generation at leading- and lagging-end telomeres.

In human cells, differences in

overhang dynamics at leading- and lagging-end telomeres have been described7, though
the factors responsible for such differences were not identified.
The work attributing the nucleolytic activity of Apollo to overhang generation
specifically at leading-end telomeres validates the long-held hypothesis that nucleases are
required to generate the appropriate terminal structure at the end of leading strand DNA
replication, which results in ends that are blunt or have a 5’ single-stranded overhang.
The only nuclease so far implicated in the protection of lagging-end telomeres is
FEN154,392. Nonetheless, it is likely that some nucleolytic processing is required for
degradation of the terminal RNA primer. While such processing may not be critical for
the protection of lagging ends from activating DNA damage responses, the finding that
POT1b and CST have roles at both leading- and lagging-end telomeres suggest that
regulatory mechanisms are nonetheless important to ensure the proper terminal structure
at both newly-synthesized telomeres.
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The differences in processing between leading- and lagging-end telomeres may be
due to the different problems faced by the two newly-synthesized telomeres. Newlysynthesized leading-end telomeres must solve the unique problem of generating a singlestranded overhang in order to achieve end protection. On the other hand, lagging-end
telomeres may not have a problem maintaining end protection per se but face the
difficulties inherent in ensuring complete duplication of the template and the protection
of newly-synthesized Okazaki fragments from aberrant degradation. Both newlysynthesized telomeres require a mechanism for fill-in synthesis of the C-rich strand, a
process important not only after the extension of G-rich strands by telomerase but also to
limit the extent of degradation by nucleases in S phase.
In the absence of POT1b, significant degradation occurs at the 5’ end of newlysynthesized lagging-strand telomeres, inducing an increase in overhang size greater than
what is observed at leading-end telomeres.

This appears to be due to excessive

degradation by Apollo since the POT1b mutant unable to bind CST partially rescues the
overhang phenotype at lagging-end telomeres in POT1b-deficient cells but has no effect
on the excessive overhangs that occur in Apollo/POT1b DKO cells. One explanation for
why lagging-end overhangs become even longer than leading-end overhangs in the
absence of POT1b could be due to the constitutive presence of a 3’ overhang at laggingend telomeres. In the absence of POT1b, if Apollo performs an equal extent of 5’
exonucleolytic degradation of the C-rich strands of newly synthesized lagging- and
leading-end telomeres, the lagging-end telomere would naturally accumulate longer 3’
overhangs.
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Recruitment and activation of telomeric nucleases
A primary mode by which nucleases localize to telomeres involves shelterin.
TRF2 recruits Apollo to telomeres and mutations of the interaction sites in either TRF2 or
Apollo abolishes the function of Apollo in overhang generation44,51,53. The absence of an
antibody to detect endogenous Apollo has made it difficult to investigate the temporal
and physical regulation of its recruitment. Theoretically, the activity of Apollo at newly
synthesized leading-end telomeres could be due either to its specific recruitment to these
sites or due to differential regulation of Apollo activity at leading- and lagging-end
telomeres.

The finding that POT1b inhibits aberrant degradation of lagging-end

telomeres by Apollo suggests that Apollo is likely recruited to both newly-synthesized
telomeres. The overhangs present at lagging-end telomeres throughout S phase likely
provide a constitutive binding site for POT1b. On the other hand, the absence of a singlestranded 3’ overhang immediately upon completion of leading-strand DNA synthesis
may provide a window for the nucleolytic activity of Apollo until sufficient amounts of
single-stranded telomeric DNA have accumulated to bind POT1b.
My investigations ruling out telomeric contributions of nucleases and helicases
involved in DNA DSB resection suggests that the transient activation of a canonical
DNA damage response is not likely the instigating event that normally promotes 5’ end
resection at telomeres.

Besides Exonuclease 1, other nucleases involved in DSB

resection do not appear to act at telomeres except in cases of telomere deprotection. For
instance, in the absence of Apollo, the recognition of newly synthesized leading-end
telomeres as DNA damage by the MRN complex appears to provide an alternate route by
which to initiate overhang generation.
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recruiting nucleases to telomeres under normal circumstances, while the DNA damage
response provides a backup mechanism to resume end protection in settings where
overhang generation is compromised. While a major function of shelterin is to protect
telomeres from activating cell cycle checkpoints and aberrant repair pathways that
promote genome instability, the transient localization of DNA damage factors to
telomeres might be beneficial in cases when telomere function is compromised due to
loss of the overhang.
How Apollo is activated at the end of leading strand DNA synthesis is unknown.
It may simply be that the exposure of a blunt or single-stranded 5’ end at the terminus of
leading-strand DNA replication provides the preferred substrate for Apollo at leading-end
telomeres. Since leading-strand DNA replication uses the telomeric C-rich strand as the
template, the C-rich strand would not be expected to have discontinuities that expose a 5’
end to nucleolytic activities. At the recessed 5’ ends of unreplicated telomeres and
newly-synthesized lagging-end telomeres, Apollo would be inhibited by the binding of
POT1b to the adjacent single-stranded DNA.
Another

(not

mutually

exclusive)

possibility

is

that

post-translational

modifications of Apollo occur as the replication fork reaches the telomere terminus,
promoting its nucleolytic activity. Though modifications of Apollo that modulate its
nuclease activity have not been identified, the examples of Artemis and CtIP provide
precedents for this mode of regulation.

DNA-PK binding and phosphorylation of

Artemis modulate its nucleolytic activities337, while the phosphorylation and acetylation
of CtIP by Cdk and SIRT6383,384, respectively, promotes its activity in 5’ end resection of
DNA DSBs. Though not tested in this work, previous studies have suggested DNA-PK
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activity is required in mouse cells to protect a subset of leading-end telomeres from
fusions422,434. The finding that the Cdk inhibitor roscovitine does not compromise
overhang generation or cause any defects in overhang dynamics suggests that Cdk
activity is not required for the activities of Apollo and Exo1 at telomeres.

Regulation of nuclease activity by POT1b
The studies on POT1b indicate that the nucleolytic activity of Apollo must be
well regulated during S phase to prevent extensive degradation.

The possible

mechanisms by which POT1b inhibits resection include physical blockade of the 5’ end,
direct inhibition of nuclease activity, or recruitment of factors that counteract the action
of Apollo. The ability to replace the N-terminal OB folds of POT1b with the equivalent
domains in POT1a or human POT1 without eliciting an aberrant overhang phenotype
suggests that there are no functional differences between the DNA binding capabilities of
these three POT1 proteins39. Furthermore, the in vitro binding affinities of POT1a and
POT1b to both internal and terminal single-stranded telomeric DNA do not significantly
differ39.
The interaction between CST and POT1b, which requires specific residues in the
C-terminal domain of POT1b, provides one mechanism by which Apollo-mediated
resection is counteracted. However, in the POT1b-LVDII mutant, this function can be
dissociated from the inhibition of Apollo at lagging-end telomeres. The finding that this
mutant can counteract resection by Apollo while being unable to recruit CST suggests
that POT1b can negatively regulate resection by additional mechanisms besides the
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recruitment of CST. POT1b may interact with yet other factors that directly inhibit
Apollo or it may inhibit a factor that aberrantly stimulates Apollo activity.
With regards to other mechanisms by which POT1b inhibits Apollo, no direct
physical association has been identified between the two proteins.

Since unique

attributes of the C-terminal domain of POT1b confer the ability to suppress resection by
Apollo, the interaction between TPP1 and POT1b provides another potential point of
difference between the POT1 proteins. Previous studies reported no apparent differences
between the interactions of POT1b and POT1a with TPP129,435. Nonetheless, differences
between the recruitment of POT1a and POT1b to the telomere terminus in vivo might
allow POT1b but not POT1a to block terminal resection. In mouse cells, no gross
differences in RNA or protein expression of POT1a and POT1b have been noted in
different tissues or at different times during the cell cycle37, though the inability to
overexpress POT1b suggests that the protein levels are tightly regulated.

The balance between degradation and synthesis of the telomeric C-rich strand
Though aberrant nuclease degradation might accelerate telomere shortening in
pathological situations, the work described in this thesis suggests that the rate of telomere
shortening in telomerase-deficient cells does not depend primarily on nuclease activities.
Indeed, the transient elongation of overhangs by Exo1 has no apparent effect on the rate
of telomere shortening in the absence of telomerase. Furthermore, telomere shortening is
not slowed when Apollo is rendered unable to localize to telomeres in telomerasedeficient cells, though the interpretation of such experiments are complicated by the
transient DNA damage response that occurs at leading-end telomeres lacking Apollo.
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The results show that CST is an important determinant of overhang size, and the
recruitment of CST can limit the rate of telomere shortening in the absence of telomerase.
The proposed model is that POT1b recruits CST to mouse telomeres subsequent to
nuclease-mediated end processing. This final step likely involves the fill-in synthesis of
the C-rich strand and may ultimately contribute more significantly than nucleolytic
degradation to the rate of telomere shortening. The challenge will be in dissociating the
various roles of CST at telomeres, since this complex appears to not only limit overhang
size at the telomere terminus but also facilitates replication within internal telomeric
sequences and may have roles in regulating telomerase292.

Consequences of an aberrant structure at the telomere terminus
My work indicates that proper overhang generation is required to suppress the
activation of a DNA damage response, though the protective role of Apollo appears to be
limited to S phase. In the absence of Apollo, despite a persistent overhang defect
throughout the cell cycle, the accumulation of DNA damage factors to a subset of
telomeres is observed only in S phase cells. Furthermore, notably absent are the
chromosome-type fusions that would result if leading-end telomeres continued to be
vulnerable to fusion in daughter cells.
How the protected state is restored as cells progress through mitosis remains
unclear. One possibility is that intrinsic properties of telomeres allow protection of
unprocessed ends in G1 but not in S phase. For instance, leading-end telomeres with short
overhangs might still form t-loops at a slower rate. Another possibility is that additional
Apollo-independent processing could be sufficient to restore end protection. Indeed, the
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overhang signal transiently increases in late S/G2 in both wild type and Apollo-deficient
cells, and subsequent studies indicate that this additional processing is mediated by Exo1.
However, the extensive resection of telomeres by Exo1 in the absence of Apollo does not
appear to contribute to end protection. Rather, the MRN complex has a protective role in
suppressing additional leading-end fusions when Apollo is absent. Finally, it is possible
that the milieu of G1 and S phase exposes telomeres to different threats, requiring distinct
protective measures to ensure telomere protection in different stages of the cell cycle.
The conditional deletion of Apollo in MEFs causes a proliferation defect (Chapter
3) and mice homozygous for the null allele die with developmental abnormalities in the
perinatal period436, suggesting that overhang generation is crucial for viability. On the
other hand, excessive C-strand degradation in the absence of POT1b alone does not
compromise cell proliferation and only when combined with telomerase deficiency does
POT1b become essential for development187. Significant organ dysfunction reminiscent
of the human disease, dyskeratosis congenita, also occurs mainly in the setting of
telomerase haploinsufficiency187,437.

The relative tolerance of mammalian cells to

excessive degradation of the telomeric C-strand may explain why so many nucleases act
in partially redundant ways at telomeres in order to ensure appropriate overhang
generation despite an increased risk of telomere degradation if any of the nucleolytic
activities are not properly regulated.

The evolution of telomere end processing
The findings described here support the accumulating evidence of significant
evolutionary divergence in the pathways that modulate telomere length and function.
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The preservation of the appropriate terminal structure of telomeres is achieved by
multiple mechanisms involving different nucleases that do not appear to have conserved
telomeric functions across organisms.

For instance, whereas the MRX complex is

involved in end processing at budding yeast telomeres256-258, its role appears secondary to
Apollo in mouse cells.
In addition, it has been previously established that overhangs at mammalian
telomeres are almost an order of magnitude longer than those in lower eukaryotes (refer
to Introduction). Since mammalian telomeres are longer than those in yeast and other
unicellular organisms and single-stranded DNA binding proteins can suppress ATR
activation190, perhaps there is no inherent disadvantage to generating longer overhangs,
and thus the recruitment of many nucleases to telomeres by shelterin might have resulted
in the collateral effect of more nucleolytic degradation at the telomere terminus. It may
also be that proper telomere function in mammalian cells requires longer overhangs.
With regards to this question, it would be useful to know the minimal length of the
telomeric overhang that must be present at a single telomere in order to maintain both end
protection and telomere elongation by telomerase.
Additionally, the results presented here suggest that resection at least at leadingend telomeres in mouse cells may be more extensive than at human telomeres. Although
I have not been able to define the length distribution of telomeric overhangs in mouse
cells, the relative overhang signals at leading and lagging end telomeres are similar in
mouse cells whereas, in human cells, the leading-end telomeres have shorter overhangs
compared to lagging-end telomeres7. Though resection is regulated to some extent by
POT1b in mouse cells, limiting overhang length at leading end telomeres may be
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relatively less important than ensuring that overhangs of sufficient length are generated
and able to facilitate end protection. On the other hand, perhaps the absence of extensive
resection in the setting of shRNA depletion of human POT1210 may be due to the
presence of alternative or redundant mechanisms that protect human telomeres from
extensive resection.
Whereas in human cells, the single TPP1/POT1 complex30,31 appears to interact
with telomerase35,114, CST291, and coordinate end protection210, in mouse, the TPP1/POT1a
complex suppresses activation of ATR190, while the TPP1/POT1b facilitates the function
of CST in telomere end processing. TPP1 is presumed to form in complexes with either
POT1a or POT1b, and these two complexes reside simultaneously at telomeres. It is
unclear whether evolutionary advantages are conferred by this division of labor or if
these differences evolved and were retained in rodents simply due to the absence of major
disadvantages.

Implications for human disease
The findings on telomere end processing are relevant to the inherited bone
marrow failure syndrome, dyskeratosis congenita (DC), which has been attributed to
telomere dysfunction. DC can be caused by mutations in telomerase components and the
shelterin component TIN2, but shelterin accessory factors had not been implicated in the
disease241,438,439.
A recent study to understand the pathogenesis of Hoyeraal-Hreidarsson syndrome,
a severe variant of DC, identified a single patient expressing a dominant negative allele
of Apollo that lacks the TRF2 binding domain and induces an ATM-dependent telomere
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damage signal243. However, the Apollo locus appeared to lack a disease-causing mutation.
Our findings that Apollo deficiency is specifically associated with defective overhang
maintenance and leading-end telomere fusions may facilitate the identification of
additional patients with Hoyeraal-Hreidarsson syndrome or other forms of DC that are
caused by defects in Apollo. The finding that defects in the telomeric function of CST
can contribute to accelerated telomere shortening, which is in turn responsible for DClike phenotypes in POT1b-/-mTR+/- mice187, provides a basis for studying whether
mutations in human CST occur in DC.
Whether telomere dysfunction caused by changes in the telomeric overhang
contributes to genome instability during tumorigenesis remains an important open
question. A better understanding of the end processing activities that modify telomere
length could also provide new avenues for the development of drugs to complement the
telomerase inhibitor, imetelstat/GRN163L, currently in Phase I or II clinical trials for the
treatment of several cancer types440. The elucidation of multiple regulatory mechanisms
that govern the proper terminal structure of mammalian telomeres is hoped to provide
information that may someday guide the treatment of human diseases in which the status
of telomere function modifies pathogenesis or prognosis, a lofty challenge for
translational medicine.
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MATERIALS AND METHODS
Mammalian cell culture
Mouse embryonic fibroblasts (MEFs) were obtained from E13.5 embryos using
standard techniques and cultured in Dulbecco’s modified Eagle medium supplemented
with 15% fetal bovine serum (Gibco), 2 mM L-glutamine, 100 U/ml penicillin (Sigma),
0.1µg/ml streptomycin (Sigma), 0.1 mM non-essential amino acids (Invitrogen), 1mM
sodium pyruvate (Sigma), and 50 µM β-mercaptoethanol (Chemicon). Primary MEFs
were immortalized at passage 2 with pBabe SV40-LT (gift from G. Hannon) by retroviral
transduction (described below).
SV40-LT immortalized and p53-/- MEFs, Phoenix ecotropic packaging cell line
(ATCC), and 293T cells were grown in DMEM supplemented with 10-15% fetal bovine
serum (Gibco), 2 mM L-glutamine, 100 U/ml penicillin (Sigma), 0.1µg/ml streptomycin
(Sigma), and 0.1 mMnon-essential amino acids (Invitrogen).
All cells were grown at 37C in the presence of 5% CO2 and 95% relative humidity.
Cells were passaged by pre-rinsing with room temperature phosphate-buffered saline,
followed by incubation in trypsin-EDTA for 2-5 min. Trypsin was inactivated by adding
serum-containing medium. Cells were counted with a Coulter Z1 Particle counter and
seeded onto a new plate as desired.

Synchronization of primary MEFs in G0
Primary MEFs were grown to confluency on 10 cm dishes in DMEM
supplemented with 10% fetal bovine serum (Gibco).

Medium was refreshed daily

according to the following serum withdrawal protocol: 10% FBS (day 1), 5% FBS (day

	
  

191

2-3), 1% FBS (day 4-5), 0.5% FBS (day 6 and on). Cells were considered synchronized
and amenable to treatments on day 8.

Retroviral gene delivery
For infection of mouse cells, 24 h prior to transfection, 5x106 Phoenix ecotropic
packaging cells were plated in 10 cm dishes. Pheonix cells were transfected with 20 µg
of the appropriate plasmid DNA by CaPO4 precipitation (described below). The media
was refreshed 6-8 h later. 36 h after transfection, media was collected and filtered
through a 0.45 µm filter. Polybrene was added to a final concentration of 4 mg/mL and
the virus-containing medium was used to infected target cells plated 24 h earlier at a
density of 5 x 105 cells per 10 cm dish. Fresh media was added to the virus-producing
cells, and the same cells were used for a total of 3-4 infections at 12 h intervals. 12 h
after the last infection, cells were split into fresh media containing antibiotics for
selection, as appropriate (puromycin: 2 µg/ml, hygromycin: 90 µg/ml). Selection was
maintained for 3 days in the presence of puromycin or 5 days in the presence of
hygromycin, until uninfected control cells had died.

Experimental timepoints were

counted as hours or days from t=0 set at 12 h after the first infection.

Lentiviral gene delivery
24 h prior to transfection, 5x106 293T cells were plated in 10 cm dishes. 293T cells
were transfected with 10 µg of the appropriate plasmid DNA, along with packaging
plasmids (5 µg pVSVg, 3 µg pMDLg, 2.5 µg pRSV) by CaPO4 precipitation (described
below). The media was refreshed 6-8 h later. The first infection was performed at 36 h
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after transfection.

Target cells were infected for a total of 3-4 infections at 4-6 h

intervals. Experimental timepoints were counted as hours or days from t=0 set at 12 h
after the first infection.

Retroviral introduction of Cre recombinase
Cre recombinase was introduced using the retroviral transduction protocol
described above. MEFs were infected 4 times at 12 h intervals with pMMP Hit&Run Cre
retrovirus. Mock infection was used as a negative control. No selection was applied.
Experimental timepoints were counted as hours or days from t=0 set at 12 h after the first
infection.
For long-term analyses requiring selectable Cre expression, retroviral infection of
pWzl-hygro-Cre or empty vector, as a negative control, was performed, followed by
selection with hygromycin.

Tamoxifen-inducible Cre-ER system
Cells in 10 cm dishes were treated for 6-12 hours with 500 nM 4-OH tamoxifen.
Cells were washed with PBS and media was replaced. Experimental timepoints were
counted as hours from the time of media change.

Temperature-sensitive TRF2ts cell line
The temperature sensitive TRF2ts DNA ligase IV deficient cell line197 contains the
TRF2ts allele (mouse TRF2-I468A) in the context of TRF2F/-p53-/-Lig4-/- MEFs from
which the endogenous TRF2 allele was deleted with Cre. The cells were grown at the
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permissive temperature of 32°C and shifted to 37°C to induce the release of TRFts from
telomeres.

Growth analysis
For growth curves, 1 x 106 and 5 x 105 cells were plated on 10 cm dishes at 24 h
post-retroviral infection and counted, respectively, at 48 and 72 h post-infection. Cells
were harvested, counted, and replated at 5 x 105 per 10 cm dish, and counted every 48 h
afterward. Growth curves were presented as population doublings plotted over time.
PDs were determined by the following formula: PD = original PD + [ln(# cells at
passage/# cells seeded)/ln(2)].

Calcium phosphate transfection of 293T and Phoenix cells
16-24 h prior to transfection, 3-4 x 106 cells were plated in 10 cm dishes. For each
plate, 428 µl H2O, 62 µl 2 M CaCl2 and 10 µl total plasmid DNA were mixed with an
equal amount of 2 x HBS (50 mM HEPES pH 7.05, 10 mM KCl, 12 mM dextrose, 280
mM NaCl, 1.5 mM Na2PO4). During the process of mixing, the solution was aerated by
blowing air through a 10 mL pipette with a Pipet-aid (Drummond).

Medium was

refreshed 6-8 h after transfection.

Whole cell lysates and immunoblotting
Cells were lysed in 2 x Laemmli buffer (100 mM Tris-HCl, pH 6.8, 200 mM
DTT, 3% SDS, 20% glycerol, 0.05% bromophenol blue) at 104 cells per μl, denatured for
7 min at 100°C, and sheared with a 28 gauge insulin needle before loading the equivalent
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of 1 x 105 per lane. Protein samples were separated by SDS-PAGE and blotted on
nitrocellulose membranes. Membranes were blocked in 5% milk in PBST (0.5% Tween20 in PBS) for 30 min at RT and nutated with primary antibodies in 5% or 0.1% milk in
PBST overnight at 4°C.

Membranes were washed 3 times with PBST, nutated in

secondary antibody in 5% milk in PBST for 1 h at RT, and washed 3 times with PBST.
Blots were developed with enhanced chemiluminescence (Amersham).

Co-immunoprecipitation of overexpressed proteins in 293T cells
For immunoprecipitation of proteins transiently expressed in 293T cells,
transfection was performed as decribed above. 48 h after transfection, cells were
harvested, washed with PBS, and resuspended in 200-500 μl of lysis buffer (50 mM TrisHCl pH 7.4, 1% Triton X-100, 0.1% SDS, 150 mM NaCl, 1 mM EDTA, 1 mM DTT, 100
μM PMSF, with a complete mini-protease inhibitor tablet [Roche] per 10 ml). The NaCl
concentration was raised to 400 mM, and the lysate was incubated on ice for 5 min. The
NaCl concentration was reduced to 200 mM with an equal volume of cold water, and cell
debris was removed by centrifugation at 13000 rpm for 10 min at 4°C. 50 μl of 2x
Laemmli buffer was added to 50 μl of lysate and set aside as input. 5 μl of anti-myc
antibody (9E10, oncogene) was added to 800 μl of lysate. Samples were nutated at 4°C
for 5 h.

60 μl of a Protein G sepharose slurry (50% (v/v) Protein-G sepharose

[Amersham] in PBS in 1 mg/ml BSA) was added, and the sampled were nutated at 4°C
for an additional 60 min. Beads were washed 4 times at 4°C with lysis buffer, and
immunoprecipitated protein was eluted with 60 μl of 2x Laemmli buffer. Samples were
boiled for 5 min before loading onto SDS-PAGE gels.
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Immunofluorescence
Cells grown on coverslips were rinsed with PBS, fixed with 2%
paraformaldehyde in PBS for 10 min at room temperature and washed twice with PBS for
5 min. Cells were either stored in PBS with the addition of 0.02% azide or processed
immediately. If extraction was required, prior to fixation, cells were treated for 1-2 min
with Triton X-100 extraction buffer (0.5% Triton X-100, 20 mM HEPES-KOH pH 7.9,
50 mM NaCl, 3 mM MgCl2, 300 mM sucrose). Extracted cells were fixed with 3%
paraformaldehyde/2% sucrose for 10 min at room temperature, and washed twice with
PBS.

Cells were permeabilized with Triton X-100 buffer after fixation.

After

permeabilization, cells were washed three times with PBS and blocked with PBG (0.2%
(w/v) cold water fish gelatin (Sigma), 0.5% (w/v) BSA (sigma) in PBS) for 1 h at RT.
Cells were incubated with primary antibody, diluted in PBG for 2 h at RT or overnight at
4°C, washed 3 times with PBG at RT, incubated with secondary antibody 1:250 in PBG
for 1 h at RT, and washed 3 times with PBS. To the second PBS wash 0.1 μg/ml 4,6diamidino-2-phenylindole (DAPI) was added. Coverslips were sealed onto glass slides
with embedding media (ProLong Gold Antifade Reagent, Invitrogen). Digital images
were captured with a Zeiss Axioplan II microscope with a Hamamatsu C4742-95 camera
using Improvision OpenLab software.

Telomere fluorescence in situ hybridization (FISH)
MEFs were grown to approximately 80% confluence on 10-cm dishes and
incubated for 90 min in 0.2 μg/ml colecmide (Sigma).

Cells were harvested by

trypsinization, centrifuged at 1000 rpm for 5 min, and resuspended in 0.075 M KCl
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prewarmed to 37°C.
inversion.

Cells were incubated at 37°C for 15-30 min with occasional

Cells were centrifuged at 1000 rpm for 5 min and the supernatant was

decanted. 500 μl of cold 3:1 methanol:glacial acetic acid fixative was added dropwise
while cells were mixed gently on a vortexer (<1000 rpm). Another 500 μl fixative was
added slowly with mixing. Tubes were then filled to 10 ml with fixative and fixed at 4°C
for at least 24 h. To prepare metaphase spreads, cells were centrifuged at 1000 rpm for 5
min and the supernatant was decanted. Cells were resuspended in 1 ml remaining
fixative and 100 μl was dropped onto glass slides in a temperature- and humiditycontrolled chamber set at 4°C and 50% humidity (Thermotron). Slides were washed with
fixative and dried overnight.
For peptide nucleic acid (PNA) FISH, slides were washed in PBS once and fixed
in 4% formaldehyde for 2 min at room temperature. After three PBS washes for 5 min
each, spreads were digested for 10 min at 37°C with 1 mg/ml pepsin dissolved in 10 mM
glycine, pH 2.2. Slides were then washed in PBS, fixed again in 4% formaldehyde for 2
min at room temperature, and washed in PBS before dehydration by 5 min incubation
with 70%, 95%, and 100% ethanol.

After air-drying, hybridizing solution (70%

formamide, 1 mg/ml blocking reagent (Roche), 10 mM Tris-HCl, pH 7.2) containing
FITC-OO-(AATCCC)3 PNA probe (Applied Biosystems) was added, and spreads were
denatured by heating for 3 min at 80°C on a heating block. Spreads were then allowed to
hybridize in the dark for 2 h at room temperature or overnight at at 4°C. Two 15-min
washes were performed in a mixture containing 70% formamide, 10 mM Tris-HCl, pH
7.2, followed by three washes in a mixture containing 0.1 M Tris, HCl, pH 7.2, 0.15 M
NaCl, and 0.08% Tween-20, with DAPI added to the second wash to counter-stain the
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chromosomal DNA.

Slides were mounted in embedding medium (ProLong Gold

Antifade Reagent, Invitrogen), and digital images were captured with a Zeiss Axioplan II
microscope with a Hamamatsu C4742-95 camera using Improvision OpenLab software.

CO-FISH
Cells were incubated in the presence of BrdU:BrdC (3:1, final concentration: 10
µM) for 16 hours with the addition of 0.2 μg/ml (Sigma) for the last 90 min. Cell
fixation and preparation of metaphase spreads was performed as described above for
FISH. Slides were treated with 0.5 mg/ml RNase A (in PBS, DNase free) for 10 min at
37°C. Slides were stained with 0.5 µg/ml Hoechst 33258 (Sigma) in 2xSSC for 15 min at
RT. Slides were then exposed to 365-nm UV light (Stratalinker 1800 UV irradiator) for
30 min (equivalent to 5.4x103 J/m2). The slides were digested twice with 80 µl of 10
U/ µl Exonuclease III (Promega) in buffer supplied by the manufacturer (50 mM TrisHCl, 5 mM MgCl2, and 5 mM DTT, pH 8.0) at RT for 10 min each. The slides were
washed with PBS and dehydrated with 70%, 95%, 100% ethanol at RT. After air-drying,
spreads were incubated for 2 hours at RT with hybridizing solution (70% formamide, 1
mg/ml blocking reagent (Roche), 10 mM Tris-HCl, pH 7.2) containing TAMRA-OO(TTAGGG)3 PNA probe (Applied Biosystems). Slides were rinsed for a few seconds in a
wash containing 10 mM Tris-HCl pH 72, 70% formamide, then hybridized for 2 hours at
RT with hybridizing solution containing FITC-OO-(AATCCC)3 PNA probe (Applied
Biosystems). Slides were washed and mounted as for FISH.
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Southern blotting and detection of telomeric DNA
Digested genomic DNA in solution was electrophoresed in 1% agarose in 0.5x TBE
at 1 V/cm for at least 2 hours, followed by raising the voltage to 3-4 V/cm until the
Orange-G dye in the loading buffer ran off the gel. The DNA was denatured (1.5 M
NaCl, 0.5 M NaOH – 2 times 30 min), neutralized (3 M NaCl, 0.5 M Tris-HCl, pH 7.0 –
2 times 30 min), then transferred to a Hybond-N membrane in 20x SSC (3 M NaCl, 300
mM Na3-citrate, pH 7). The DNA was UV-crosslinked to the membrane, which was then
pre-hybridized in Church mix (0.5 M Na phosphate buffer [pH 7.2], 1 mM EDTA [pH 8],
7% w/v SDS, 1% w/v BSA) for 1 h followed by hybridization with an end-labeled
[32P](CCCTAA)4 oligonucleotide at 50°C for at least 4 hours. The membrane was washed
at 55°C, three times for 30 min in 4x SSC and once for 15 min in 4x SSC/0.1% SDS.

Analysis of telomeric DNA by in-gel hybridization
For the analysis of mouse genomic DNA, cells were suspended in PBS and mixed 1:1
(v/v) with 2% agarose (SeaKem) in PBS to obtain between 5x105 to 1x106 cells per plug.
Plugs were digested overnight with 1 mg/ml Proteinase K (in buffer containing 10 mM
Tris-HCl pH 8.0, 250 mM EDTA, 0.2% sodium deoxycholate, 1% sodium lauryl
sarcosine), washed four times for 1 h each with TE buffer (10 mM Tris-HCl, pH 8.0, 1
mM EDTA), including 1 mM PMSF in the last wash. Plugs were washed once more with
H2O and digestion buffer. Plugs were incubated overnight at 37°C with 60 U MboI and
60 U AluI. The following day, the plugs were washed once in TE, and once in 0.5x TBE,
and loaded onto a 1% agarose/0.5x TBE gel. Samples were run for 24 h on a CHEFDRII PFGE apparatus (BioRad) in 0.5 x TBE running buffer. The settings were as
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follows: initial pulse, 5 s; final pulse, 5 s; 6 V/cm; 14°C. The gels were dried and
prehybridized in Church mix for 1 h at 50°C. Hybridization was performed overnight at
50°C in Church mix with 4 ng of a γ-32P-ATP end-labeled (AACCCT)4 probe (labeling
protocol described below). The gel was washed at 55°C three times for 30 min each in
4x SSC and once for 30 min in 4x SSC/0.1% SDS.

The gel was exposed to a

PhosphoImager screen overnight. After the image was captured, the gel was denatured in
0.5 M NaOH, 1.5 M NaCl for 30 min, neutralized with two 15-min washes in 0.5 M TrisHCl pH 7.5, 3 M NaCl, prehybridized in Church mix for 1 h at 55°C, and hybridized
overnight with the same probe at 55°C. The gel was washed and exposed as above. The
single-stranded G-rich overhang signal in the native gel was quantified with ImageQuant
software and normalized to the total telomeric DNA quantified after the gel had been
denatured and re-hybridized with the telomeric probe.

γ-32P-ATP end-labeling of oligonucleotides with T4 polynucleotide kinase (PNK)
2 μl H2O, 1 μl 10x T4 DNA PNK buffer (NEB), 1 μl 10 U/ μl T4 DNA PNK
(NEB), 1 μl 50 ng/μl (AACCCT)4 oligonucleotide and 5 μl 10.0 mCi/ml γ-32P-ATP
(NEN) were mixed and incubated for 45 min at 37°C. 80 μl TES (10 mM Tris-HCl pH
8.0, 10 mM EDTA pH 8.0, 0.01% SDS) were added to stop the reaction. The probe was
loaded onto a 3 ml G25 Sephadex column equilibrated with TNES (10 mM Tris-HCl pH
7.4, 10 mM EDTA, 100 mM NaCl, 1% SDS). The column was washed with 700 μl
TNES, and the probe was eluted with 600 μl TNES and diluted in 25 ml Church mix.
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Exonuclease I digestion in solution or in plugs
Fragments recovered after MNase digestion were subjected to treatment with E.
coli exonuclease I. Approximately 2 μg MNase-treated DNA was incubated with ExoI (1
U/μl, New England Biolabs) in reaction buffer (New England Biolabs) at 37°C overnight.
DNA fragments were recovered by phenol- chloroform extraction followed by
precipitation with isopropanol in the presence of 0.2 M sodium acetate (pH 5.5).

FACS
Cell cycle analyses were performed using standard techniques to evaluate BrdU
incorporation and propidium iodide (PI) staining of DNA content. Cells were pulsed
with 10 mM BrdU for 30 minutes, then fixed and stained with FITC-conjugated antiBrdU antibody (BD Biosciences) and PI. Flow cytometry was performed on
FACSCalibur-1 (Becton Dickinson), and data were analyzed using FlowJo 8.7.1
software.

FUCCI-FACS to isolate cells in different cell cycle phases
For the FUCCI sort experiments, MEFs were transduced with three infections of
mKO2-Cdt1 30/120 (lentiviral) followed by three infections of mAG-Geminin 1/110
(lentiviral) at 6 hour intervals (gift from A. Miyawaki,

421

).

Cdt1+Gem+ cells were

collected by FACS, replated, and infected with two rounds of Hit&Run Cre. Sorting of
G1 and S phase cells according to levels of Cdt1 and Geminin was performed on BD
FACSAria-1 and Aria-2 cell sorters (BD Biosciences) with excitation by the 488 nm and
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561 nm lasers. Cells were collected in PBS and immediately plated on coverslips or
embedded in agarose for DNA analysis.

Separation of leading- and lagging- daughter telomere DNA
MEFs were cultured in the presence of 100 μM of BrdU for 16 hours. To prevent
nicking of DNA after BrdU incorporation, all steps were performed with minimal
exposure to light. Cells were harvested, and genomic DNA was extracted by with
phenol-chloroform, precipitated with isopropanol in the presence of 0.2 M sodium acetate
(pH 5.5), and resuspended in TE (10 mM Tris, 1 mM EDTA [pH 8.0]). 250 μg DNA was
digested overnight with 200 U MboI and 200 U AluI and loaded uniformly onto CsCl
solution (density of 1.800 g/ml) in a total volume of 5 mL.

Samples were

ultracentrifuged at 55,000 rpm for 20 hr at 25°C. 100 µL fractions were collected from
the bottom of the centrifuge tube. Aliquots of DNA from each fraction were denatured in
0.1 M NaOH for 20-30 min at 37°C. An equal volume of 12× SSC was added to
neutralize the samples. Samples were loaded on a Minifold® II Slot Blot (Schleicher &
Schuell, Inc.) onto Hybond-N+ nylon transfer membrane (GE Healthcare/Amersham).
The membrane was washed twice with 20x SSC, dried, and baked in a drying oven for 2
h at 80°C. The membrane was pre-hybridized at 55°C with Church mix, and hybridized
at 55°C with a 32P-(TTAGGG)4 probe (end-labeled as described) in Church mix. The
membrane was washed three times with 4x SSC for 30 min each, and once with 4x
SSC/0.1% SDS. The membrane was exposed to a PhosphorImager screen to detect
fractions containing telomeric DNA. Pooled DNA from each peak was then surface
dialyzed by rocking the solution on a layer of 2% agarose in a 50 ml tube for 30 min at
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room temperature to reduce the CsCl concentration. The DNA was ethanol precipitated
and resuspended in TE.

MNase digestion of nuclei
Nuclei were prepared for digestion with micrococcal nuclease (MNase). Briefly,
cells were trypsinized, suspended in growth medium, and harvested by centrifugation in a
RT6000 centrifuge at 1,500 rpm for 5 min. Cells were suspended at 2 x 106 cells/ml in
buffer A (100 mM KCl, 10 mM Tris [pH 7.5], 3 mM MgCl2, 1 mM CaCl2, 0.5 mM
PMSF), washed twice with buffer A, then resuspended at 5 x 106 cells/ml in buffer A
with 0.6% Nonidet P-40 to lyse cells. After gently mixing and incubating on ice for 5
min, nuclei were harvested at 2,000 rpm for 5 min and resuspended in buffer A without
NP-40 at 2.5 x 107 cells/ml. Nuclei were homogenized in a dounce with 10 strokes with a
tight B-type pestle. Aliquots of 150 μl were digested for 5 min at 30°C with MNase
(Roche Diagnostics) at concentrations ranging from 5 – 600 U/ml. Reactions were
stopped by adding one volume of TEES/protK (10 mM Tris HCl [pH 7.5], 10 mM
EDTA, 10 mM EGTA, 1% SDS, 50 μg/ml proteinase K) and incubating at 37°C for 2
hours to overnight. DNA was extracted with phenol-chloroform, precipitated with
isopropanol in the presence of 0.2 M sodium acetate (pH 5.5), and resuspended in 500 μl
TE (10 mM Tris, 1 mM EDTA [pH 8.0]).

MNase digestion of DNA in agarose plugs
Agarose-embedded DNA plugs were prepared as described above. Plugs were
washed extensively with TE, then equilibrated in buffer A for 1 hour at 4°C. Digestions
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were performed by incubating plugs for 10 min at 30°C with MNase in buffer A at
concentrations ranging from 0 – 8 U/ml in a total volume of 500 μl. Reactions were
stopped by adding an equal volume of TEES/protK and incubating overnight at 37°C.
Plugs were washed in TE in preparation for PFGE.

Assay for the last nucleosomes
DNA associated with the last nucleosome was isolated by a variation on the
previously described telomere purification protocol (44). Following MNase digestion of
nuclei, the recovered DNA fragments were annealed to a biotinylated oligonucleotide in a
50 μl reaction containing ~40 μg MNase-digested DNA, 0.25 pmol biotin-(CCCTAA)6,
1x SSC, and 1.0% Triton X-100 was incubated for 30 min each at 37°C, 30°C, 25°C,
15°C, 10°C, and 4°C. The mixture was rotated overnight at 4°C with 0.5 mg/ml
streptavidin-coupled Dynabeads (Dynal, Invitrogen), which were pre-washed with
1xSSC,

pre-coated

with

5x

Denhardt’s

solution

(0.1%

Ficoll

400,

0.1%

polyvinylpyrrolidone, 0.1% BSA) for 30 min at room temperature, and resuspended in
cold 1x SSC.
To isolate the annealed DNA, a magnet (Dynal Magnetic Particle Concentrator)
was used to concentrate the beads, and the supernatant was removed. The beads were
washed twice with 150 μl 1x SSC, once with 150 μl 0.2x SSC, and once with 50 μl TE.
All washes were performed on ice. The beads were then resuspended in 20 μl TE and
heated to 65°C for 10 min. The supernatant was recovered, fractionated on 1% agarose,
and the telomeric signal was detected by Southern blot hybridization as described above.
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Construction of model telomeric fragments
A 226 bp BglII/KpnI fragment containing 25 TTAGGG repeats was excised from
pSXneo.25(T2AG3), dephosphorylated with calf intestinal phosphatase, and purified by
gel extraction. The BglII end of the double stranded telomeric fragment was ligated
overnight at 16°C to the phosphorylated oligonucleotide 5’-GATC(T2AG3)12-3’ with T4
DNA ligase. Reactions lacking either the double stranded fragment or the single stranded
oligonucleotide were used as controls.

Apollo gene targeting
The targeting vector for modification of the mouse Apollo locus was generated in
pSL301 by standard cloning techniques using Bac-derived DNA fragments extending
from the NheI site upstream of the Apollo gene to the SacI site in the 3’ UTR. A TKneomycin cassette flanked by FRT sites and carrying one loxP site was inserted into the
PacI site in the third intron of the Apollo gene. A second loxP site was introduced into the
NseI site in intron 1 by insertion of a loxP oligonucleotide that also contained an NsiI site
used in genomic analysis of targeted ES cells. ES clones with the correct integration were
identified by genomic blotting of NsiI-digested DNA using a probe upstream of the NheI
site and the presence of a single neo integration was confirmed. Targeted ES cells were
used to generate chimeras and offspring with the targeted genotype. The neo cassette was
removed using the FLPe deleter mouse strain (Jackson labs). The resulting ApolloF/+
genotype was maintained on a mixed background (129/C57Bl/6J).
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RT-PCR transcript analysis
RT-PCR was performed with the oligo-dT ThermoScript RT-PCR system
(Invitrogen). RNA was isolated from approximately 106 cells with the Qiagen RNAeasy
kit. Two to three micrograms RNA was reverse transcribed with the ThermoScript RTPCR system (Invitrogen) by using oligo dT priming and the protocol provided by the
manufacturer. The primers used for PCR after cDNA synthesis are as follows:
Apollo RT1:
Forward: CACGGTGGGTTTGTCTAGC
Reverse: GTTGCTCCAGCAGTGATTC
Apollo RT2:
Forward: CTCCCATCACTGCTTGCCTC
Reverse: GCAACTGTACCAACTCCAGG
GAPDH:
Forward: TGAAGGTCGGTGTGAACGGATTTGGC
Reverse: CATGTAGGCCATGAGGTCCACCAC
Ap4b1 RT1:
Forward: GACGATGCCATACCTTGGCTC
Reverse: GTTCAGTACTTCAGCCTG
Ap4b1 RT2:
Forward: GACGATGCCATACC TTGGCTC
Reverse: CTGCTCTTGAGATAGCTGTC
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Plasmid constructs
N-terminal FLAG-[HA]2-tagged Apollo alleles were generated by PCR-mediated
mutagenesis and expressed using the pLPC puromycin-selectable retroviral vector. Nterminal myc-tagged TRF2-F120A was generated by site-directed mutagenesis and
cloned in a pLPC puromycin-selectable retroviral expression vector.
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LIST OF CELL LINES
Mouse embryonic fibroblasts
ApolloF/F

SV40-LT

this work

BLMF/F

SV40-LT

this work, mice from P. Leder

Exo1-/-

SV40-LT

this work, mice from W. Edelman

mTR-/-

SV40-LT

this work, mice from C. Greider

Nbs1F/F

SV40-LT

this work, mice from A. Nussenzweig

POT1aS/F

SV40-LT

D. Hockemeyer, ref. 37

POT1bS/F

SV40-LT

D. Hockemeyer, ref. 37

POT1bF/-

SV40-LT

D. Hockemeyer

TRF2F/F

SV40-LT

this work, mice generated by G. Celli

TRF2ts

SV40-LT

A. Konishi, ref. 194

ApolloF/FExo1-/-

SV40-LT

this work

ApolloF/FLig4-/-

SV40-LT

this work

ApolloF/FNbs1F/F

SV40-LT

this work

ApolloF/FPOT1bF/F

SV40-LT

this work

Exo1-/-BLMF/F

SV40-LT

this work

Exo1-/-mTR-/-

SV40-LT

this work

Exo1-/-Nbs1F/F

SV40-LT

this work

POT1aS/FPOT1bS/F

SV40-LT

D. Hockemeyer, ref. 37

POT1aF/FPOT1bF/F

SV40-LT

T. Davoli

POT1bF/FNbs1F/-

SV40-LT

N. Dimitrova, ref. 191

POT1bF/FROSA-Cre-ERT2

primary

this work
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LIST OF CELL LINES (cont.)
Mouse embryonic fibroblasts
TRF1F/FROSA-Cre-ERT2

SV40-LT

A. Sfeir

TRF2F/FKu-/-

SV40-LT

G. Celli, ref. 197

TRF2F/FmTR-/-

SV40-LT

this work

TRF2F/FNbs1F/F

SV40-LT

N. Dimitrova, ref.

TRF2F/-p53-/-

SV40-LT

G. Celli, ref. 190

ApolloF/FExo1-/-POT1bF/F

SV40-LT

this work

ApolloF/FNbs1F/F POT1bF/F

SV40-LT

this work

Exo1-/-Nbs1F/FPOT1bF/F

SV40-LT

this work

TRF2F/-Lig4-/-p53-/-

SV40-LT

G. Celli, ref. 190

Human cell lines
293T embryonic kidney

SV40-LT

Phoenix, ecotropic

SV40-LT
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LIST OF GENOTYPING PCR PRIMERS
Gene

Alleles

Primer sequences (5’ – 3’)

mApollo

WT, FL

3’ loxP2: ACATCTCCTCATCTTGTCTG
5’ loxP: CCTATCATGATAATCCCAGC
5’ neo: CTTGAGGGTTTCTTTTGGAG

mBLM

WT, FL

1: AGGTTGTCTGGCCTAGACATAAGG
2:TGGTGGGTAAACATTCCTCAGTGG
3: TCTACTGCTCAGTAAAGGCTC
5: ATTTAGGCTTCCATTCTGAGG

mExo1

WT, Δ

A: CTCTTGTCTGGGCTGATATGC
B: ATGGCGTGCGTGATGTTGATA
C: AGGAGTAGAAGTGGCGCGAAGG

mLigase 4

WT, Δ

WT1: CTCTGTAGGGCTTAGTGACATCTC
WT2: GCGCTCACCATCAAGCGCAGTTTCGATGTAG
MUT1: GACTCTTTTTACCCTGCAATGAGACTCATTC
MUT2: ACCGCTATCAGGACATAGCGTTGG

mTR

WT, Δ

Common: TTCTGACCACCACCAACTTCAAT
WT: CTAAGCCGGCACTCCTTACAAG
KO: GGGGCTGCTAAAGCGCAT

mPOT1b

WT, FL, Δ

Common2: ATGGTTCCCCAGTGCTTTGAC
WT2: CACTGGAAAGAAAGGGCTTTGTG
Delta2: TCCTTCCCCAAGTTGCTTTTG

mNbs1

WT, FL, Δ

com: GCGTAAATGGTTGATTGTCC
wt: GATTGTCAGCACAGAAATCTTCCC
mut: GCGCCTCCCCTACCCGGTAGAATT
LoxP-5N: CGTATAATGTATGCTATACGAAG
LoxP-R: TTCCCACTGTATCCTGAGTG

mTRF2

WT, FL, Δ

Common2: TTGGCACTATCTCAGCACTGCAAC
P4A: ATCCGTAGTTCCTCTTGTGTCTG
Delta: CATGCAAACCAGGCATTTAATCTC
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LIST OF SHRNAS
Target

Vector

Target sequence (5’ – 3’)

mATM

pSuperior (retro)

GGAAGTCAAGGAACAACTA

mATR

pSuperior (retro)

GGAGATGCAACTCGTTTAA

mBLM -1

pSuperior (retro)

GCATCCTAATAAAGAGTTA

mBLM-2

pSuperior (retro)

GGAGGGTTATTATCAAGAA

mBLM-3

pSuperior (retro)

GGACCTGCTGGAAGATTTA

mCtIP-1

pSuperior (retro)

GCAGACCTTTCTCAGTATA

mCtIP-2

pSuperior (retro)

GCATTAACCGGCTACGAAA

mExo1

pSuperior (retro)

GCATTTGGCACAAGAATTA

mRecQL5-1

pLKO.1 (lenti)

CCTAGATGAGAAGGTCCAGAT

mRecQL5-2

pLKO.1 (lenti)

GCCATAACGAAGAAGCTGGAT

mStn1

pLKO.1 (lenti)

GATCCTGTGTTTCTAGCCTTT

mTPP1

pSuperior (retro)

GGACACATGGGCTGACGGA
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LIST OF ANTIBODIES
Antigen

ID

Type

Source

Use(s)

HA

HA.11

M, mono

Covance

IB 1:1000
IF 1:1000

Myc

9B11

M, mono

Cell Signaling

IB 1:1000

Myc

9E10

M, mono

Sigma

IB 1:1000, IP

FLAG

M2

M, mono

Sigma

IB 1:1000

γ-tubulin

GTU88

M, mono

Sigma

IB 1:5000

mPOT1a

1221

Rb, poly

de Lange lab

IB 1:1000

mPOT1b

1223

Rb, poly

de Lange lab

IB 1:1000

hRap1

765

Rb, poly

de Lange lab

IB 1:2000

hTRF2

647

Rb, poly

de Lange lab

IB 1:2000

53BP1

100-304

Rb, poly

Novus

IF 1:1000

ATM

Mat3

M, mono

Sigma

IB 1:1000

ATR

N-19

FRP goat

Santa Cruz

1:1000

Chk2

Chk2

M, mono

BD Transduction

IB 1:250

mCtIP

H-300

Rb, poly

SC Biotech

IB 1:250

γ-H2AX

γ-H2AX

M, mono

Upstate

IB 1:1000

mNbs1

93’6

Rb, poly

gift, J. Petrini

IB 1:5000

mRecQL5

Rb, poly

gift

IB 1:1000

mStn1

M, poly

de Lange lab

IB 1:250
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